We’re excited to welcome John Barry as Parexel's Senior Vice President, FSP Alliance Partnerships and Strategy! In his role, he will bring together the right expertise, talent and solutions to meet customers’ evolving needs and drive growth of Parexel FSP Integrated Solutions.
Parexel
Parexel is an American contract research organization. It conducts clinical trials on behalf of its pharmaceutical and biotechnology clients to expedite drug development and clinical trial progress. More on Wikipedia
-
Parexel
@Parexel
-
Parexel
@Parexel
In @pharmaphorum Chief Medical Officer Charlotte Moser shares why questioning assumptions around enrollment, eligibility criteria and patient burden — before a study begins and as new data emerges — can help sponsors design studies around patients’ lives.🔗pharmaphorum.com/rd/why-best-cros-challenge-trial-plan-an…
-
Parexel
@Parexel
For biotechs choosing to advance assets individually, "going it alone" does not mean thinking locally. In his opinion piece for @biospace, Parexel's Paul Bridges makes the case for thinking globally from the start.🔗www.biospace.com/business/opinion-biotechs-going-to-marke…
-
Parexel
@Parexel
We're thrilled to announce that Parexel has been recognized by @GlobalBTA as the Industry Sustainability Leader in Pharmaceuticals, Healthcare, Biotechnology and Life Sciences! This award reflects how we make business travel more sustainable while supporting our teams and trials.
-
Parexel
@Parexel
At the @BioCentury China Healthcare Summit 2026, Parexel is sponsoring a welcome reception and breakfast roundtable, where Charlotte Moser, Chief Medical Officer, and Paul Bridges, President, Consulting will explore the industry's most prevalent topics.
Open to all attendees! -
Parexel
@Parexel
Join Parexel's Heidi Cho on Nov. 2 for the final session of the @CureSearch ONE webinar series. Experts from across industry, research, advocacy and regulatory agencies will discuss what's next for advancing innovative therapies for children with cancer.
🔗curesearch.org/curesearch-one/ -
Parexel
@Parexel
Congratulations to our @PharmaTimes Clinical Researcher of the Year - The Americas winners! Our colleagues traveled to Raleigh, N.C. to compete in on-the-day challenges and present to a panel of judges. Join us in congratulating them below!
-
Parexel
@Parexel
Yesterday, we welcomed biotech innovators, founders and academic leaders to Parexel's Raleigh headquarters to kick off the #parexelbiotech Incubator.
We're excited to connect emerging companies with the insights and support they need to move forward with confidence. -
Parexel
@Parexel
Parexel today announced it will lead discussions on site activation and engagement, recognize emerging sites and support initiatives designed to strengthen site partnerships at 2026 @MySCRS Global Site Solutions Summit™.
🔗newsroom.parexel.com/news-releases/news-release-details/p… -
Parexel
@Parexel
Sites are at the heart of clinical research, and as the research landscape grows more complex, the way we support sites is evolving too.
The goal is simple: reduce complexity, improve patient access and help bring forward new treatments faster.
⬇️ Meet part of the team. ⬇️This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
As more cell and gene therapies advance toward approval, sponsors face increasing pressure to align their strategies from the outset.
In this Q&A with @ContractPharma, Chris Learn shares what sponsors can do today to reach more patients tomorrow.🔗www.contractpharma.com/exclusives/addressing-barriers-to-… -
Parexel
@Parexel
On #worldsightday, we recognize the scientific advances transforming ophthalmic care. Listen as Parexel's Bharti Arya and Chris Learn and Health Advances' Patrick Symmonds share what it takes to navigate complex ophthalmic drug development.
Learn more: www.parexel.com/therapeutic-expertise/ophthalmology-cro -
Parexel
@Parexel
We're committed to partnering with sites to address patient access and recruitment challenges, reduce trial complexity and deliver a better clinical trial experience for patients. Meet 3 leaders driving that work every day. 👇
Learn more here: www.parexel.com/solutions/early-development-and-innovatio… -
Parexel
@Parexel
September is Prostate Cancer Awareness Month and it's important to highlight that prostate cancer affects more men than any other cancer. At Parexel, our experience in oncology and recruitment capabilities are how we contribute to fighting this disease.
➡️www.parexel.com/therapeutic-expertise/oncology-cro/prosta… -
Parexel
@Parexel
Parexel's global HQ in Raleigh, NC has achieved LEED Silver certification! 🩶LEED certifications are awarded to organizations for implementing practical and measurable strategies in areas like water savings, energy efficiency, materials selection and indoor environmental quality.
-
Parexel
@Parexel
The biotech funding rebound is real, but the rules have changed. 💡 In @pharmaphorum, Paul Bridges, President of Parexel Consulting, explores what this new funding cycle is actually rewarding. Find out what's changed and why it matters for your program. ➡️pharmaphorum.com/market-access/biotech-funding-has-return…
-
Parexel
@Parexel
Dr. Ronaldo Santiago, Medical Director of Ophthalmology, knows vision is everything. With a decade of experience across pharma, biotech and CRO industries, he's looking at the next frontier: gene therapy and gene editing.
Learn more: www.parexel.com/therapeutic-expertise/ophthalmology-cro -
Parexel
@Parexel
Is AI underutilized in clinical trials?
In an interview with BioXconomy, Tala Fakhouri, Chief AI and Regulatory Strategy Officer, discusses ways AI can further transform clinical trials and improve trial efficiency. Read her insights⬇️👀
Learn more: www.bioxconomy.com/clinical-and-research/ai-can-transform… -
Parexel
@Parexel
In a recent real-world data analysis, Parexel's Dr. Heidi Cho, Franchise Head of Hematology, examined how cardiac and pulmonary conditions influence cytokine release syndrome (CRS) outcomes and patient safety.
📰 Read the takeaways in @JournalofCP: www.hmpgloballearningnetwork.com/site/jcp/interview/cardi… -
Parexel
@Parexel
In the latest episode of Clinical Trialblazers, Dr. Briggs Morrison, CEO of Crossbow Therapeutics, shares lessons from his career in pharma and biotech.
Tune in wherever you get your podcasts: lnk.to/CTBs2e6i -
Parexel
@Parexel
Lung cancer does not only affect those who smoke—nearly 60% of those diagnosed have never smoked. But research drives discovery, earlier detection and treatments that save lives.
This #worldlungcancerday, learn more about our commitment to research: www.parexel.com/therapeutic-expertise/oncology-cro/lung-c… -
Parexel
@Parexel
Parexel has been recognized as a World's Top Disability Inclusive Business by the Disability Index® from Disability:IN! 🌟When we remove barriers, we accelerate the delivery of life-changing treatments to patients around the world. Read the press release: newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
The Parexel Emerging Site Scholarship Program is back—designed to support the next generation of clinical research sites like yours.
20 scholarships available ⏰ Application deadline: August 14, 2026 📅 Winners announced by August 31, 2026
⬇️Details below ⬇️
Parexel
@Parexel
Winners receive:✅1 year @MySCRS membership with exclusive training resources ✅ Mentor sessions with experienced investigative sites ✅ A Parexel Site Alliance Manager for personalized support ✅ Free registration to SCRS Global Site Solutions Summit or European Summit
Parexel
@Parexel
Eligibility: • Site established less than 5 years • Located in US, LATAM, Europe, South Africa, or Middle East • Established infrastructure & team • Minimum 3 clinical studies completed
Ready to apply? Click here: parexelcore.iad1.qualtrics.com/jfe/form/SV_aWtiilEbCe3WkaG -
Parexel
@Parexel
Have you cast your vote for the 2026 @MySCRS Eagle Award? This honor recognizes one sponsor and one CRO that exemplify exceptional leadership, professionalism, integrity and a commitment to advancing clinical research through strong site partnerships.🗳️
sitesolutionssummit.com/event/global/eagle-award/ -
Parexel
@Parexel
In an interview with Elets eHealth, President, Global Head Safety & Logistics, Country Head of India, Sanjay Vyas explains how listening to patient advocates and educating patients on clinical trials as a care option can help close representation gaps.
🎥www.youtube.com/live/tLWCdu7-VPE?cbrd=1&ucbcb=1 -
Parexel
@Parexel
Parexel's Paul Bridges and Charlotte Moser joined @pharmaphorum to discuss how bringing stakeholders to the same table—integrating regulatory, clinical, and market access decisions—is driving faster, smarter execution in biotech.
🎙️pharmaphorum.com/rd/parexel-flawless-execution-policy-shi… -
Parexel
@Parexel
At #ada2026 in New Orleans, Shipra Patel sat down with HCPLive to discuss her research on obesity trial design. In this video, she shares phase-appropriate strategies to maximize patient retention and data integrity.
Watch it here 🎥www.hcplive.com/view/structuring-obesity-trials-optimize-… -
Parexel
@Parexel
Today Parexel announced the launch of the Parexel Biotech Incubator, a new initiative that connects early-stage therapeutics companies with the clinical and regulatory expertise they need to advance their programs. newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
On World Sickle Cell Day, we honor the strength and resilience of individuals and families living with sickle cell disease. We stand with you and will continue moving the science forward toward the treatments you deserve.
Learn about our CAGT expertise: www.parexel.com/therapeutic-expertise/cell-and-gene-thera… -
Parexel
@Parexel
The biotech funding landscape has changed. Investors once backed promising ideas. Today, they fund clinical validation.
At #fiercebiotechweek, Sheela Hedge and Rajiv Gangurde broke down what's changed: www.fiercebiotech.com/sponsored/biopharma-moves-reduce-de…This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Voting is OPEN for the 2026 @SCRS #eagleaward! This prestigious honor recognizes one CRO and one sponsor demonstrating exceptional leadership, integrity & commitment to site partnerships.
Voted on entirely by you—our clinical research site partners: sitesolutionssummit.com/event/global/eagle-award/ -
Parexel
@Parexel
We're thrilled to showcase our expertise across eight thought leadership sessions at @DrugInfoAssn's 2026 Global Annual Meeting June 14-18 in Philadelphia!
Visit us at Booth #1503 to connect with our experts.
Read more in the press release: newsroom.parexel.com/news-releases/news-release-details/p… -
Parexel
@Parexel
In this @ACROhealth Blog, Andreas Lysandropoulos explores why Alzheimer's disease has become a proving ground for a very different CRO model — one built on orchestrating complexity across every segment: sponsors, sites, regulators, payers and patients.
👉 www.acrohealth.org/informed-content-hub/executing-at-scal… -
Parexel
@Parexel
Parexel announced seven research posters to be presented during the @EHA_Hematology 2026 Congress in Stockholm and the launch of a hematology playbook grounded in expertise from 250 hematology programs across nearly 70 countries over the past five years: newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
Why do some cell and gene therapy programs succeed while others stall? In Drug Discovery & Development, Chris Learn explores four critical factors that can define clinical outcomes:👉 www.calameo.com/read/008183692bdb242350f10?page=43
-
Parexel
@Parexel
This June, Parexel is proud to celebrate #pridemonth2026 —a time to honor the resilience, courage and contributions of the LGBTQ+ community while reaffirming our commitment to creating a workplace where everyone feels valued and respected.
Happy Pride!🏳️🌈
#parexelwithpride -
Parexel
@Parexel
Today, Parexel announced two virtual research posters accepted for presentation at the @ASCO Annual Meeting. As part of #asco2026, Parexel also launched From Insights to Life, a new patient-focused creative campaign. newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
Congratulations to our Parexel colleagues who medaled in the 2026 @PharmaTimes International Clinical Researcher of the Year competition in London!👏Let's celebrate all of our winners and finalists who represented Parexel throughout this competition! #ptintcr #pharmatimes
-
Parexel
@Parexel
Today, on #internationalclinicaltrialsday, we honor our colleagues, partners and customers whose work drives progress in global health and our patients who inspire us to accelerate the delivery of life-saving treatments.
Watch our CEO Peyton Howell share why this day matters. 💙 -
Parexel
@Parexel
🚀 We're excited to introduce ParexelAI™, an innovative, proprietary suite of human-led AI services and capabilities that power Parexel operations and deliver greater speed, quality and efficiency to customers and, ultimately, patients.
Parexel
@Parexel
ParexelAI combines our proprietary tools, internal innovation, strategic partnerships and expertise of our 22,000+ global team members — all while prioritizing human judgment, scientific and regulatory expertise, and patient safety.
Learn more: parexel.ai
Parexel
@Parexel
Read the full announcement: newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
The FDA's plausible mechanism framework is here and it's a significant shift for individualized therapy development. Dr. Mwango Kashoki breaks down what sponsors need to know in a new video series with @Clin_Trials. www.appliedclinicaltrialsonline.com/view/fda-plausible-me…
-
Parexel
@Parexel
Parexel recently earned a 2025 Cornerstone Galaxy Award for "Excellence in AI-Driven Talent Strategy" from @CornerstoneInc! We created and use an AI digital worker that automates how training updates are received and resolved so colleagues can focus on more value-driving work.
-
Parexel
@Parexel
We’re proud to share our new sustainability & impact report! Inside, discover our key achievements and steadfast commitment across our patients, environment, people and governance.
Explore our path forward: www.parexel.com/application/files/3417/7809/3169/PXL_2025… -
Parexel
@Parexel
⏩Clinical research in APAC is changing rapidly but what is making this change possible and can we predict the future of this landscape?
Vera Zheng, SVP, APAC Strategy and Head of Greater China, gives her insights below:
Read more in @pharmaboardroom: pharmaboardroom.com/interviews/vera-zheng-svp-asia-pacifi… -
Parexel
@Parexel
In a new article from @biospace, Parexel's Charlotte Moser M.D. explores why patient centricity shouldn't just be an industry buzzword. It's how we accelerate innovation and get life-changing therapies to market faster. www.biospace.com/drug-development/opinion-adopting-a-pati…
-
Parexel
@Parexel
Parexel's Chief Patient Officer, Stacy Hurt, joined industry leaders at the "Scaling Innovative Clinical Trial Approaches" workshop, co-convened by the Duke-Margolis Institute for Health Policy and the FDA. Watch below to hear from Stacy on advancing patient-focused research.
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
📢Today Parexel announced it has acquired Vitrana, a provider of an AI-enabled, end-to-end pharmacovigilance technology platform. The acquisition further expands Parexel's technology capabilities to better serve customers.
Read the press release: www.globenewswire.com/NewsRoom/ReleaseNg/7571800 -
Parexel
@Parexel
Parexel is proud to continue our partnership with @weave_bio on the launch of its new NDA Workflow, extending AI‑native support across the full regulatory lifecycle.
Learn more in our press release: www.businesswire.com/news/home/20260429322286/en/Weave-Bi… -
Parexel
@Parexel
S.Biomedics today announced the company has selected Parexel as its clinical trial partner for the U.S. clinical development of TED-A9, a cell therapy for Parkinson's disease.
Read the release: newsroom.parexel.com/static-files/137054d5-8701-454b-b6f0… -
Parexel
@Parexel
On #worldhemophiliaday, we acknowledge the ongoing challenges faced by patients living with hemophilia and the steady progress that continues to shape their future. Discover how we are helping to bring life-changing medicines to those who need them most: www.parexel.com/therapeutic-expertise/hematology-cro
-
Parexel
@Parexel
AI isn’t just accelerating clinical research—it’s reshaping what’s possible for patients. In this discussion at SXSW, Tala Fakhouri shares powerful examples of how AI is transforming decision‑making for clinicians, reducing patient burden and uncovering safety signals sooner.
-
Parexel
@Parexel
Today is Transgender Day of Visibility, a day that celebrates the lives of trans individuals and their contributions. Parexel is committed to uplifting the transgender community and amplifying their voices as we work together to break down barriers to comprehensive healthcare.
-
Parexel
@Parexel
In this episode of @PharmTechGroup's Ask the Expert, Siegfried Schmitt explores a misconception: orphan drug development means less competition. He advises working closely with regulators and, if needed, to bring in external experts.
Watch the video: www.pharmtech.com/preview/02213553-3546-4b44-994c-88b7365… -
Parexel
@Parexel
In celebration of Women's History Month, we are spotlighting Parexel co-founder Anne Sayigh. In an interview with Parexel CEO Peyton Howell, co-founder Josef von Rickenbach shares how he and Anne built Parexel together, her passion for science and her legacy.
🎥Watch below.This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
The landscape of breast cancer drug development has fundamentally shifted. Success requires more than traditional clinical operations—it demands precision in patient selection, regulatory harmonization and infrastructure. 🔗www.calameo.com/read/006113385a39474a4e1e4?page=22
-
Parexel
@Parexel
Emerging regions are proving they can lead more rare disease research. They're expanding access, accelerating timelines, reaching treatment-naive groups and delivering quality data. Learn how they're rethinking research and why it's critical in @ACROhealth:www.acrohealth.org/informed-content-hub/equitable-care-ac…
-
Parexel
@Parexel
Happy 115th International Women's Day! At Parexel, we're committed to fostering environments where all genders thrive. This year's #iwd2026 theme, #givetogain, reminds us that investing in women's advancement benefits everyone and we all have the power to make a difference.
-
Parexel
@Parexel
For 400 million patients globally, clinical trials aren't just research opportunities—they're the ONLY care option available. But geographic disparities create a devastating paradox: those who need trials most often can't access them. Read in @ACROhealth: www.acrohealth.org/informed-content-hub/equitable-care-ac…
-
Parexel
@Parexel
Parexel wins the @TriangleBIZJrnl's 2026 Space Award for Top Interior Space/Build-Out Project! Proud to call Raleigh's North Hills Innovation District home as we build the future of clinical research in innovative spaces!
-
Parexel
@Parexel
In #scripasks Andreas Lysandropoulos shares insights on long-term data in neuroscience trials highlighting why organizational readiness—not just algorithms—will define the competitive advantage in 2026. insights.citeline.com/scrip/scrip-asks/scrip-asks-what-do…
-
Parexel
@Parexel
Through our partnership with United Way Bengaluru, Parexel seeks to improve lives and strengthen communities in India. This past week, our CEO, Peyton Howell, was able to witness the impact of these initiatives. We see hope restored, confidence built and futures being reshaped.
-
Parexel
@Parexel
Parexel wishes you a Happy New Year as we celebrate The Year of the Horse! We want to thank our colleagues for their extraordinary success, progress and dedication to improving the lives of patients everywhere.
We look forward to what the new year brings! -
Parexel
@Parexel
Last week, Parexel Chief Executive Officer Peyton Howell began a nine‑day tour across India, one of our most important global locations. The visit was anchored around discussions with ACRO and invitations for Peyton to present at ISCR and the Global Business Summit. More to come!
-
Parexel
@Parexel
More than 400,000 children develop cancer each year. Many lack access to life-saving treatment. We're committed to: ✓ Accelerating breakthrough pediatric treatments ✓ Expanding access to oncology trials ✓ Reducing inequalities in cancer care
-
Parexel
@Parexel
Sponsors are evaluating their outsourcing models to reach operational excellency. In this @Clin_Trials article, Parexel's Kerri McCaul-Claus and Bristol Myers Squibb's Allison Covucci share how sponsors can transition without hurting quality or timelines📖www.appliedclinicaltrialsonline.com/view/developing-frame…
-
Parexel
@Parexel
According to Parexel's Jenny Denney, EVP, Global Head of FSP, sponsors are moving beyond the full-service outsourcing (FSO) vs. functional-service provider (FSP) debate and embracing more tailored hybrid models. See more predictions for biopharma in Scrip: insights.citeline.com/scrip/scrip-asks/scrip-asks-what-do…
-
Parexel
@Parexel
Congratulations to our four colleagues recognized with With Heart™ awards! 🎉These awards recognize Parexel colleagues who demonstrate exceptional leadership, live our Core Values and behaviors and always deliver With Heart. 💖
#withheart #proudtobeparexel -
Parexel
@Parexel
A recent NIHR case study highlights how Parexel supported two pivotal U.K. vaccine trials—for norovirus and influenza—achieving exemplary timelines. Read how it was done: www.nihr.ac.uk/story/inside-uk-clinical-research-delivery…
-
Parexel
@Parexel
This February is the 100th anniversary of Black History Month in the U.S. As we honor this centennial, we're proud of our resource group, Black Employees Advisory Consortium (BEACON), and its work to create change and we're committed to continuing this important journey together.
-
Parexel
@Parexel
How do we think the clinical trial industry's usage of real-world data and real-world evidence will evolve over the year?
We asked SVP, Global Head Real World Research Mike D'Ambrosio and he forecasts major impacts across the board.🌦️
🔮Read through his predictions below! ⬇️ -
Parexel
@Parexel
From micro to macro levels, Parexel's Chief Patient Officer, Stacy Hurt predicts that patient empowerment will continue to grow in 2026. 📈
Watch to learn how Stacy sees the patient's role in healthcare evolving from greater self-advocacy to gaining industry-wide recognition ➡️ -
Parexel
@Parexel
Congratulations to our colleagues who received a Parexel Sales Award! 🏆They were recognized for their drive and commitment to delivering for our customers to enable getting treatments to patients faster.
#proudtobeparexel -
Parexel
@Parexel
In the latest from Pharmaceutical Technology, Rajiv Gangurde joins other industry experts to shed light on analytical testing strategies and the impact of AI in aseptic processing. 📰 Read it:
www.pharmtech.com/view/analytical-strategies-for-aseptic-… -
Parexel
@Parexel
Each year, @PharmaVoice offers predictions from industry leaders for the year ahead in drug development. Parexel's Anne Kasmar expects to see significant blurring of therapeutic boundaries thanks to overlapping immunobiology. 💡www.pharmavoice.com/news/pharma-crystal-ball-2026-predict…
-
Parexel
@Parexel
🚨During our prediction conversations last year, Karen McIntyre discussed a worrying trend: soon there may be more trials than there will be sites to run them.
🗓️This year, we asked Karen for an update and what is most important when selecting a site. Read her insights⬇️ -
Parexel
@Parexel
Today we honor Dr. Martin Luther King Jr., whose dreams of hope, unity and inclusivity remind us to reflect and act. MLK Day is also a "Day of Service” – a time to make a positive impact in our communities. See photos from our employee group, BEACON, serving local charities.
-
Parexel
@Parexel
As part of our "Shine Light on Patients" sponsorship with @BloodCancerUtd, Parexel brought #lightthenight to patients undergoing cancer treatment at @UNC_Health_Care. This event is close to our hearts as it provides a way for us to connect with the patients in our community.🫂
-
Parexel
@Parexel
After a year of big industry changes, what do Parexel experts predict for 2026?
🧠Andreas Lysandropoulos answers that for neuroscience — innovative clinical trial design and long-term data generation will be essential for addressing the complexities of these trials. See below.⬇️ -
Parexel
@Parexel
We're proud to share that we have been recognized for our commitment to sustainability by EcoVadis and the Carbon Disclosure Project (CDP)! These achievements reflect our dedication to driving environmental progress and building a more sustainable future for clinical research. 🌍
-
Parexel
@Parexel
Parexel wishes you a happy New Year! 🎆
Together with our dedicated colleagues and industry partners around the world, we are stepping into 2026 determined to continue innovating and conquering new heights as we work to improve patient outcomes.
#parexelwithheart #patientsfirst -
Parexel
@Parexel
We are still thrilled to have been named "Best CRO" in the Full-Service Provider category by Scrip! We are always striving to be a better CRO partner and push drug development forward. See our team members with the award below!📸
Read our press release: ➡️newsroom.parexel.com/news-releases/news-release-details/p… -
Parexel
@Parexel
Parexel's Sanjay Vyas, President, Safety and Logistics, Country Head of India, spoke about the FDA simplifying the regulatory pathway for biosimilar registrations and approvals during a rebound in funding for R&D. Read his insights below and the article: insights.citeline.com/pink-sheet/pathways-and-standards/r…
-
Parexel
@Parexel
Happy Holidays from Parexel! Watch our video for a special message from our team to yours 🎁www.parexel.com/parexel-holiday-card
-
Parexel
@Parexel
From new appointments and awards to refurbished office spaces and community outreach, these achievements are helping Parexel excel in our mission to accelerate the delivery of life-changing treatments to patients. We can't wait for 2026!
See what we've been up to this year ⬇️ -
Parexel
@Parexel
Lola Fashoyin-Aje, SVP, Head of Regulatory Oncology, Cell & Gene, co-authored a white paper on the underutilization of "seamless" clinical trial designs to develop potential rare cancer treatments. Read her insights below! @CancerResrch
Full article➡️ insights.citeline.com/pink-sheet/r-and-d/clinical-trials/… -
Parexel
@Parexel
⬇️Watch below to learn what Parexel's Tala Fakhouri, VP, Consulting, AI & Digital Policy, Real-world Research, has to say about the FDA's recently published guidance on using AI in regulatory decision-making or read the full article here: www.raps.org/news-and-articles/news-articles/2025/12/expe…
-
Parexel
@Parexel
If you haven't seen the new Parexel headquarters in Raleigh, North Carolina's North Hills Innovation District, don't worry because we're bringing the tour to you! Watch as Laura Cotto, VP, Talent Acquisition explores our favorite places in the new building. 🔎📹: @Chair8Media
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
🎉Parexel has been named "Best CRO" in the Full-Service Provider category at the 21st Annual Scrip Awards! This honor recognizes our excellence in partnering with biopharma companies and our contributions to drug development, patient impact and public health. See pictures below!
Parexel
@Parexel
Read the full release➡️newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
🔔Parexel is ringing in the new year by continuing our commitment to patients.
💝We're donating to #makeawish Foundation International, a non-profit that grants life-changing wishes to children with a critical illness.
🌟Happy holidays from Team Parexel!
#withheartThis media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Our office in Bengaluru has recently undergone a makeover, and we are thrilled to share it with you!
🌿Sustainability at the core
💼Versatile workspaces
🤝 Where patient-first innovation happens
📹 Check out our highlight video to see the transformation in action!
#parexelindiaThis media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Parexel has been selected to present 10 research posters at the 67th @ASH_hematology Annual Meeting and Exposition Dec. 6-9 in Orlando.
Read the release: newsroom.parexel.com/news-releases/news-release-details/p… -
Parexel
@Parexel
Parexel has been recognized as a Silver Employer in the India Workplace Equality Index (IWEI) 2025! This recognition celebrates our commitment to LGBTQ+ inclusion through meaningful policies, hiring practices, and culture-building initiatives.
-
Parexel
@Parexel
Parexel brought #lightthenight to patients undergoing cancer treatment at the @DukeCancer Institute as part of our "Shine Light on Patients" sponsorship with @BloodCancerUtd🏮Connecting with patients reflects our mission to accelerate the delivery of life-changing treatments.💕
-
Parexel
@Parexel
🕊️ Today, Parexel honors Transgender Day of Remembrance by recognizing transgender individuals whose lives have been lost to violence and discrimination. Together, we can build a more inclusive world where everyone can live authentically and safely.
-
Parexel
@Parexel
Parexel alumni and current colleagues recently gathered at our Newton, Mass office for a special night of reconnection and to celebrate Conal Burgess' 30+ year career at Parexel. Thank you to everyone who attended! Look through some of our favorite images from the event below!📸
-
Parexel
@Parexel
What’s really shaping the future clinical research workforce? Hear from Parexel’s Keri Mattox on the top trends impacting clinical research talent. 📽️ Watch the full interview: theconferenceforum.org/webinars/parexels-chief-business-o…
Parexel
@Parexel
📊 Download Parexel’s report to see the full data: www.parexel.com/optimizing-the-clinical-research-workforce
-
Parexel
@Parexel
Thrilled to announce Parexel won @GlobalBTA's Acceleration Award 2025 (Industry Leader, Pharmaceuticals) & made the Top 10 Global Leaderboard highlighting our sustainable travel leadership in clinical research. Thanks to our global teams for this achievement! 🌎🏆
-
Parexel
@Parexel
Congratulations to our colleagues who brought home Silver and Gold awards from the PharmaTimes Clinical Researcher of the Year Awards - The Americas Competition!🎉✨Join us in celebrating our winners and finalists for being exemplary members of Team Parexel!
#pharmatimes #ptcroy -
Parexel
@Parexel
For World Quality Week 2025, we’re highlighting how excellence in quality processes can drive better outcomes for patients. The Parexel Precision Pathway is an end-to-end operational approach that prioritizes the timely delivery of clean data while driving efficiency and quality.
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Unlocking generative AI time saving gains means investing in AI fluency across the workforce, redesigning processes (not just plugging in tools), and keeping humans in the lead. Read more in @EBRMagazine: www.calameo.com/read/006113385ec12c4787de3
-
Parexel
@Parexel
How are top CROs navigating the intersection of fast-evolving tech, regulatory landscape shifts and geopolitical factors? At @CNSSummit 2025, Parexel CEO Peyton Howell will weigh in.
Get all the event details here: www.parexel.com/about-us/events/cns-summit-2025 -
Parexel
@Parexel
This past weekend, nearly 200 members of #teamparexel lifted their lanterns at @BloodCancerUtd's #lightthenight event in Cary, NC.🏮In total, we raised $186,000+ for the fight against blood cancer!🌟Thank you to everyone who contributed and swipe to see our favorite moments!❤️
-
Parexel
@Parexel
Our Massachusetts team joined @BloodCancerUtd at Boston's Light the Night walk in support of #bloodcancer patients and survivors. 🏮Thank you to all who donated and participated! Excited to walk with colleagues in North Carolina this weekend in the Triangle!
#lightthenight -
Parexel
@Parexel
When Sanjay Vyas met Mohini, a mother participating in a clinical study, she was fighting for more precious moments with her family.
Behind every data point is a person hoping for more of life's milestones. #tedx
🎥 www.youtube.com/watch?v=k4KSCHMMI78 -
Parexel
@Parexel
📃Why Your Data Strategy Makes or Breaks Regulatory Success📃
In this article from GEN, Parexel's Christiane Niederlaender shared how one company faced multiple FDA revision rounds because their potency assay results were unclear. Read her advice for ATMP developers⬇️ -
Parexel
@Parexel
Parexel’s Stephen Pyke sat down with the Life Sciences DNA Podcast to discuss the state of AI adoption in the industry. We must prepare teams today for a future where AI is everywhere, used every day and in every role in clinical development. Watch here: www.youtube.com/watch?v=gNTNJhLfzT0
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Inclusion and belonging are not just ideals but foundational elements that energize and drive our mission to accelerate the delivery of new therapies for patients everywhere. Our 2024 sustainability & impact report outlines some of the latest milestones:
newsroom.parexel.com/static-files/a80eb464-c89f-4a09-a884… -
Parexel
@Parexel
Parexel has enhanced and expanded our Site Alliance Program. When compared to non-alliance sites, Parexel's Site Alliance sites have demonstrated 40% faster activation, nearly 20% faster study start up timelines and 4x more patient enrollments per site. Read the release ⬇️
-
Parexel
@Parexel
The future of clinical research isn't just about scientific innovation. It's about patient-centered design.
Here are some of our initiatives that reflect our #patientsfirst focus in clinical trials: -
Parexel
@Parexel
Parexel today announced a partnership with @weave_bio, a pioneer in AI-native regulatory automation management solutions, aimed to accelerate regulatory submission processes and the time to market for new therapies. 🔗newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
Take a closer look at our new Raleigh, N.C. headquarters. 📷 Our new office space represents Parexel's vision for the future—where sustainable practices, innovative thinking and dedication to improving patient lives converge.
-
Parexel
@Parexel
More snaps from our recent headquarters Open House event in Raleigh, N.C. 📸 Guided tours, meaningful connections and an additional $3,000+ raised for @BloodCancerUtd ! Our new headquarters is officially open for business!
-
Parexel
@Parexel
Parexel has once again been named a finalist for the Scrip Awards in the "Best CRO – Full-Service Providers" category! We're proud of this nomination, which reflects our team's commitment to patient guided drug development and building a better healthcare landscape worldwide.
-
Parexel
@Parexel
Congratulations to the 🌟9🌟 talented individuals and 1 team who are finalists in the #pharmatimes Clinical Researcher of the Year Awards – The Americas competition! We are thrilled for our teammates and cannot wait to cheer them on in the finals on Oct. 27! 🎉
#croy -
Parexel
@Parexel
September 17 was World Patient Safety Day — reminding us that protecting all patients is critical in our mission of putting patients first. In this ACRO blog, Sanjay Vyas and Stacy Hurt explore how we can ease the burden of reporting adverse events ensuring our patients' safety➡️
-
Parexel
@Parexel
Parexel CIO Jonathan Shough was in New York this week to accept Parexel’s Silver honor at @TheStevieAwards for "Healthcare Technology — Company of the Year." At Parexel, we're using AI to transform clinical development and accelerating the delivery of treatments to patients.
-
Parexel
@Parexel
Parexel's Nelly Nauman has been named a winner of the 2025 Enterprise CarolinaCISO ORBIE Award which recognizes outstanding chief information security officers (CISO) who consistently demonstrate excellence in technology leadership. Congratulations, Nelly! 🎉
#orbieawards -
Parexel
@Parexel
Parexel today announced the appointment of Rob Goodwin to the role of Chief Operating Officer (COO) further improving the company’s ability to continue creating value and bring life-saving treatments to patients faster. Read the release➡️www.globenewswire.com/NewsRoom/ReleaseNg/7147131
-
Parexel
@Parexel
Parexel today announced a strategic partnership with Paradigm Health to evolve how clinical trials are designed and conducted and accelerate the delivery of life-changing treatments to patients. Read more ➡️ newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
We're officially moved in and our colleagues explored every corner of our new Raleigh headquarters during Welcome Week!
🤳Tag yourself and your colleagues if your picture is featured! -
Parexel
@Parexel
We had a fantastic turnout at Wednesday's Open House celebrating our exciting new HQ in Raleigh! The afternoon included guided tours showcasing our sustainable, innovative workspace, refreshments hosted by CEO Peyton Howell and meaningful connections with colleagues.📸
Parexel
@Parexel
A highlight of the event was our raffle for Blood Cancer United (formerly LLS) with prizes donated by local businesses, bringing our fundraising total to $122,000+! We're proud to once again be the "Shine Light on Patients" sponsor and look forward to walking at #lightthenight.
-
Parexel
@Parexel
This week we’re officially welcoming colleagues to our new global headquarters in Raleigh's North Hills Innovation District! The team is exploring the collaborative and efficient spaces, modern amenities and sustainable design of our new home.
🎥 Take a peek!This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Today, we opened our new global headquarters in the North Hills Innovation District in Raleigh, North Carolina! This new, LEED-certified space will foster efficiency, innovation and flexible work while reinforcing our commitment to sustainability and presence in North Carolina.
This media couldn't be displayed. See it on the original post.
Parexel
@Parexel
Read more details in our press release.➡️ newsroom.parexel.com/news-releases/news-release-details/p…
Parexel
@Parexel
Learn about our global commitment to sustainability in our recently released Sustainability and Impact Report➡️newsroom.parexel.com/static-files/a80eb464-c89f-4a09-a884…
-
Parexel
@Parexel
At Parexel, We Care about our patients and people, our impact on the environment and delivering for customers and growing our business every day. Explore our 2024 Sustainability & Impact report:
-
Parexel
@Parexel
What if cancer treatments could zero in on tumors while preserving more healthy cells? That’s the potential of radiopharmaceutical therapy (RPT), but there are important questions.
Hear from Parexel's Dr. Lola Fashoyin-Aje and access the full article below. -
Parexel
@Parexel
Parexel has been selected as a finalist for the prestigious 2025 #scrseagleaward, recognizing excellence in clinical research site partnerships! We'll have our fingers crossed for a three-peat at this year's Eagle Award Gala during the @mySCRS Global Site Solutions Summit.🤞
-
Parexel
@Parexel
Connecting dots in clinical research is possible without revealing who the dots belong to. Tokenization replaces personal identifiers with encrypted codes so researchers can link datasets while protecting patient privacy. Hear from Mike D'Ambrosio in @Clin_Trials:
-
Parexel
@Parexel
Parexel today announced the appointment of Jim Anthony to the expanded role of Chief Commercial Officer (CCO) and President, Parexel Biotech, further strengthening the company’s customer focus and its ability to drive growth and value. Read the release ⬇️
-
Parexel
@Parexel
Parexel's SitePay Portal helps keep research sites focused on work, not admin.
🔍Better transparency and communication
⏱️Real-time tracking
Site professionals, if you're interested in a SitePay account with Parexel, send a note to sitepaymentsupport@parexel.com. -
Parexel
@Parexel
Something exciting is happening. 👀
Stay tuned for details about our new headquarters in Raleigh, N.C. ─ Coming soon! -
Parexel
@Parexel
🎙️Meet @stacy_hurt: care partner, stage 4 cancer survivor, patient advocate & Chief Patient Officer Parexel. In this rapid-fire round with Alex Maiersperger, her humor shines through, but her mission is serious—amplifying patient voices in clinical research. #healthpulsepodcast
-
Parexel
@Parexel
💡 GLP-1s are transforming obesity treatment, so running trials in this space requires a new playbook. In a new video series with @Clin_Trials, Parexel's Shipra Patel outlines 5 essential insights every clinical researcher should know.
-
Parexel
@Parexel
“AI isn’t a substitute for clinical expertise — it’s a new arrow in the quiver.” - Keri Mattox, Parexel’s CBO.
Our research report is sparking conversation because the future of drug development depends on how we prepare for an AI-enabled world.📰 See the latest: -
Parexel
@Parexel
Clinical research sites: your voice matters! Voting for the 2025 SCRS Eagle Award closes soon!
👉 Vote today: www.surveymonkey.com/r/LD23MZT
#scrseagleaward #clinicalresearch -
Parexel
@Parexel
Take a peek at our new Dublin office!📷👀Located in the heart of #ireland's capital, this space boasts easy access to public transport — ideal for eco-friendly commuting. Swipe➡️to see workspaces, break areas and modern amenities supporting work-life balance. #parexelcareers
-
Parexel
@Parexel
A major diagnosis can shock you, and it's tempting to rush into treatment. But patient advocates like Stacy Hurt learned that pausing for full test results can be important. Using her own patient experience to help others on theirs, Stacy shares why advocacy is essential:
-
Parexel
@Parexel
Parexel is a Silver honoree in the @TheStevieAwards Technology Excellence Awards in the "Healthcare Technology — Company of the Year" category!🎉We're using AI to reform clinical development, expedite first-time quality and bring life-saving treatments to patients faster.
-
Parexel
@Parexel
Parexel's Sanjay Vyas joined @RainmakerIndia's #theleadershiplounge to reflect on his career trajectory across different industries and the importance of risk-taking. Don't miss his advice for aspiring leaders and the rapid-fire "On the Clock" segment! ⏲️ www.youtube.com/watch?v=f6ZpdJ6JRt4
-
Parexel
@Parexel
Meet our new Chief Medical Officer: Dr. Charlotte Moser. Dr. Moser's experience as a clinician, researcher and principal investigator have shaped her deep-rooted belief in putting patients first. Click below to learn how her experiences will shape her leadership at Parexel.
-
Parexel
@Parexel
Imagine if your clinical research site could activate studies faster and quadruple patient enrollment? That’s the power of the Parexel Site Alliance Network. If Parexel has made a difference for your site, we’d be honored to earn your #eagleaward vote. 🗳️
-
Parexel
@Parexel
Parexel's Chief Information Officer Jonathan Shough has been named a Finalist for the 2025 Carolina ORBIE Awards, which honor CIOs who consistently demonstrate excellence in tech leadership. We'll be rooting for him at the awards ceremony on Sept. 19!👏
-
Parexel
@Parexel
We’ve officially opened our new Dublin office!
It’s a fresh space in the city center that reflects how we work and what we value. Take a peek inside to see our new workspaces. -
Parexel
@Parexel
Success in clinical trials isn't just about protocols—it's about site-level execution. At Parexel, we work to foster true partnerships through regular site engagement and shared problem solving.
Parexel
@Parexel
🗳️If you’ve received value from our site engagement initiatives, please consider casting your vote for the 2025 #scrseagleaward: www.surveymonkey.com/r/LD23MZT
-
Parexel
@Parexel
We could tell you how valuable Parexel’s Emerging Site Scholarship program is, but we’d rather let last year’s winners speak for themselves. ⬇️ This year's winners receive mentoring sessions with experienced sites, SCRS membership and a complimentary Summit pass. Apply today.
-
Parexel
@Parexel
We're proud to achieve a top score on the 2025 Disability Index and be named a “2025 Best Place to Work for Disability Inclusion" in the U.S., U.K. and Germany! We believe that our differences drive innovation and inclusivity leads to success. www.disabilityin.org
-
Parexel
@Parexel
Parexel's Cris McDavid has featured in two recent episodes of the @ACROhealth #goodclinicalpodcast: Check out Episode7️⃣and Episode🔟for the latest trends in RBQM. www.acrohealth.org/good-clinical-podcast/
-
Parexel
@Parexel
🩺 Physicians: Thinking about a career in clinical research?
At Parexel, Medical Directors work With Heart™ to change lives through:
• Diverse medical challenges
• Innovative study designs
• Patient safety focus
• Multi-therapeutic breakthroughs -
Parexel
@Parexel
Instead of thinking about compliance as a fence, look at it as an enabler. Parexel CIO Jonathan Shough recently joined @striimteam's What's New in Data podcast to share how we leverage compliance to accelerate delivery. www.youtube.com/watch?v=8yIYHLOrU7c
-
Parexel
@Parexel
Winners of our 2024 Emerging Site Scholarship program are bringing fresh passion to trials. We're proud to support them with by offering mentorship, SCRS resources and personalized guidance.⏰ Apply for this year by July 15, 2025!
parexelcore.iad1.qualtrics.com/jfe/form/SV_aWtiilEbCe3WkaG -
Parexel
@Parexel
For Mano Thiravong and Jeff Kopicko, Pride is more than just a celebration. As leaders of our Pride Inclusion Business Resource Group (BRG), they’re driving change that’s influencing how we develop and care for people — inside the company and in the communities we serve.
-
Parexel
@Parexel
"I've always felt comfortable at Parexel," Reyad shares. "This inclusive environment allows me to focus on my work without hiding who I am."
Reyad's time at Parexel has been a testament to our commitment to personal growth and inclusivity. Learn more: jobs.parexel.com/en/working-at-parexel-reyad-clinical-ope… -
Parexel
@Parexel
Parexel's Nelly Nauman has been named a Finalist for the 2025 Carolina ORBIE Awards, which recognize outstanding chief information security officers who demonstrate excellence in technology leadership. Wishing her the best of luck at the awards ceremony on Sept. 18. 🤞
-
Parexel
@Parexel
Today two FDA luminaries join Parexel: Lola Fashoyin-Aje, M.D., MPH, and Tala Fakhouri, Ph.D., MPH. They will bolster our regulatory expertise and join a team that supported nearly one-third of all sponsor NDA/BLA submissions approved by FDA in 2024.
-
Parexel
@Parexel
In the fast-paced world of clinical research, our holistic approach to #professionaldevelopment helps you thrive today and prepare for tomorrow. Find out how our blended approach keeps you ahead of the curve: pxl.careers/yf8
-
Parexel
@Parexel
"I am the voice of the patient when the patient's not in the room."🎙️- Stacy Hurt, Parexel's Chief Patient Officer. In this Health Pulse Podcast episode, Stacy shares her journey from patient to patient advocate and how she navigated complex health decisions.🎧Hear her advice.⬇️
-
Parexel
@Parexel
🎥Now on-demand: Community-based site partnerships are transforming cancer studies.
Why? Watch CEO Peyton Howell and expert panelists discuss community sites' impact on inclusive trials, CRO-sponsor-site partnerships and CROs' role in preparing sites for early-phase trials. -
Parexel
@Parexel
ACRO recently released a report on key findings from six years of trial-level data on adoption of risk-based quality management (RBQM) components. Parexel's Cris McDavid, Sr. Director of Global Clinical Operations, joined ACRO's #goodclinicalpodcast to unpack it all. Tune in!🎙️
-
Parexel
@Parexel
AI is reshaping clinical operations, including outsourcing models. Parexel's Michelle Verhaeghe shares how flexible outsourcing models can help us fully embrace the potential of tech innovations.
-
Parexel
@Parexel
Early-phase oncology research is shifting toward community-based site partnerships to meet patients where they are. Parexel CEO Peyton Howell will join experts to discuss how a community-based approach is transforming early-phase cancer research in this Endpoints webinar. ⬇️📅
-
Parexel
@Parexel
At Parexel, we're proud to collaborate with our trusted site partners. Together we've established: • An emerging site scholarship program • A new site payment platform • Site Pulse Forums for open dialogue. Please consider voting for Parexel for the 2025 @MySCRS #eagleaward!🏆
-
Parexel
@Parexel
As we commemorate #juneteenth, we celebrate the change our Black Employees Advisory Consortium is driving: promoting diverse representation in research, celebrating achievements of Black colleagues and ensuring Black voices are heard as we design more inclusive clinical trials.
-
Parexel
@Parexel
In today's rapidly evolving healthcare landscape, how do you stay ahead? CEO Peyton Howell recently participated in @TriangleBIZJrnl's "CEO Confidential" series to share insights on how Parexel is facing today's business challenges while preparing for tomorrow's opportunities.📰
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Stephen Pyke, Chief Data Officer and Jenny Denney, Head of FSP @Parexel present our industry survey results at @DrugInfoAssn showing workforce need for adaptability to new tech/AI, problem solving, and critical thinking. Call to action is to invest in our people #dia2025
-
Parexel
@Parexel
51% of biopharma leaders named AI experts a top hiring priority, revealed in our recent report, “Optimizing the Clinical Research Workforce.” In @PharmaVoice, Parexel’s Keri Mattox describes the ideal AI candidate and how to adapt hiring and training strategies for AI talent.📖⬇️
-
Parexel
@Parexel
Parexel will lead important conversations at @LongwoodLeaders #mitceo this week.1️⃣Jim Anthony, President & Global Head of Parexel Biotech, will moderate the "Advances in Clinical Trials" panel.2️⃣Chief Medical Officer, Dr. Charlotte Moser, will host a Fireside Chat.
-
Parexel
@Parexel
Welcome to Buenos Aires, Argentina, where our office has been a cornerstone of our global clinical operations since 2013. Located in Vicente López, this newly refreshed office fosters collaboration and supports the 500+ colleagues based there. 📷 below! #lifeatparexel
-
Parexel
@Parexel
We're thrilled to announce that Parexel has received the inaugural @WCGClinical #wcgpinnacleaward for Leadership in Technology!🏆This award highlights our use of technology to strengthen site relationships and streamline research. Thank you to everyone who made this possible!
-
Parexel
@Parexel
Struggling to stand out in interviews? Our recruiters suggest using the STAR Method to turn your professional experience into impactful storytelling.⭐Watch it through, get confident and the next time you're asked, "Tell me about a time when...", remember STAR! Apply now:
-
Parexel
@Parexel
As Keri Mattox shared at the Financial Times U.S. Pharma and Biotech Summit, the opportunity for elevating your workforce is clear: invest in people who can think alongside AI, not just operate it.
📘 Read the full story in Forbes:
Parexel
@Parexel
📥 Download our “Optimizing the clinical research workforce” report:
www.parexel.com/optimizing-the-clinical-research-workforce
#optimizingtheclnicalresearchworkforce #aiinpharma #patientsfirst -
Parexel
@Parexel
Our Parexel behaviors are the spark that ignites us to do everything With Heart™. But what does that look like in action? It's:
1️⃣Commit to Excellence
2️⃣Win as One Team
3️⃣Deliver With Heart™ and Determination
4️⃣Own the Outcome
They are the basics of breakthrough research.🚀 -
Parexel
@Parexel
What industry changes do patients want? Andreas Lysandropoulos, SVP, Global Therapeutic Area Head, Neuroscience, shares the results of our patient advisory council meeting with patients and care partners living with Parkinson’s, Alzheimer’s and multiple sclerosis on @VJNeurology.
-
Parexel
@Parexel
Congratulations to the 10 Parexel colleagues who represented Parexel with distinction and earned Silver Awards in the 2025 @PharmaTimes International Clinical Researcher of the Year competition in London!👏#ptintcr #pharmatimes
-
Parexel
@Parexel
Rescue studies are challenging—but with the right approach, they’re entirely manageable. At OCT Europe, Parexel's Suzanne McNally shared how her team supports sponsors through complex trial transitions with speed, agility and strategic foresight.
-
Parexel
@Parexel
Congrats to our CEO, Peyton Howell, on being honored with the "Clinical Trials Day Award" from @Walgreens! Peyton was recognized at the Walgreens #clinicaltrialsday event for her commitment to advancing research innovation and breaking down barriers to study participation.
-
Parexel
@Parexel
In letter to @Clin_Trials, our Chief Patient Officer, Stacy Hurt, states that embedding the patient voice at each stage of drug development is not only moral, but drives efficiency, recruitment and real-world relevance. Learn how patient engagement can be a key differentiator.📰
-
Parexel
@Parexel
As the NIH embraces human-based research technologies, Parexel guides clients using expertise rooted in real-world experience. In @PharmaVoice, our Mwango Kashoki shares how strides in non-animal testing are meeting regulatory progress—and how sponsors can stay ahead.📖
-
Parexel
@Parexel
Parexel today launched “Optimizing the clinical research workforce: An industry analysis by Parexel,” a report aimed at understanding the role that culture, key skill sets and talent delivery models play in driving innovation in clinical development.
Read the release. 📰 -
Parexel
@Parexel
Congratulations to Teri Karcher on her recognition as a 2025 HBA Luminary! Thank you, Teri, for your work that advances treatments for patients and is inspiring future leaders! #hbawoty25
-
Parexel
@Parexel
Our Early Phase Clinical Units conduct first-in-human trials generating high-quality data, promoting patient inclusion and bringing new treatments to those in need. Click to explore opportunities in: Clinical🔹 Project Management🔹 Laboratory🔹 Medical🔹 Recruitment🔹Pharmacy.
-
Parexel reposted
SAS Software
@SASsoftware
Jonathan Shough, CIO at @Parexel: "At the end of the day, we’re delivering a data pack that says "we believe this protocol, and we believe this therapy or this treatment is actually going to do what it’s going to do because our SAS data sets help prove it."" #sasinnovate
-
Parexel
@Parexel
Once Parexel, always Parexel.✨Last week, more than 75 former Boston-based colleagues gathered to network and make connections at the annual #parexelalumni Community event. CEO Peyton Howell shared exciting updates and Founder Josef von Rickenbach spoke to our enduring community.
-
Parexel
@Parexel
CEO Peyton Howell joined leaders at @USAIC's Biopharma & Healthcare Summit to share insights on India's regulatory landscape and opportunities for the clinical trial sector. #clinicalresearch #india #usaic25
-
Parexel
@Parexel
At the @advarra #onsemble2025 Conference, Chief Patient Officer, Stacy Hurt, delivered a powerful keynote sharing her journey as a🔹Caregiver🔹Stage IV colorectal cancer survivor🔹Industry executive🔹Patient engagement expert🔹Patient advocate.🎙️"Now is the time to be bold."
-
Parexel
@Parexel
📢 The deadline for Parexel Academy's Summer Virtual Postgraduate Certificate Program (vPGC) is fast approaching! This 6-month program—now updated to prepare you for changes in the ICH-GCP guidelines—will help you stay ahead.📅Applications close on Wednesday, May 7, so apply now!
-
Parexel
@Parexel
💪Santino Tin began at Parexel as a Project Specialist and has climbed the ranks in Clinical Operations, embodying our #patientsfirst promise every step of the way. Learn why he chose Parexel, about his hobbies and how you can join him in changing patients' lives.
#parexelcareers -
Parexel
@Parexel
What unites us? We asked the team! ➡️
Discover what drives our shared passion and commitment to advancing healthcare and improving patient outcomes.
Join us: pxl.careers/6jk
#parexelcareers #clinicalresearch -
Parexel
@Parexel
Parexel was a proud sponsor at the Triangle Take Steps fundraiser, presented by Duke GI and the @CrohnsColitisFn. Our team showed up to support patients and the research that could change the lives of those living with inflammatory bowel disease (IBD).
#patientsfirst #takesteps -
Parexel reposted
SASanalytics
@SASanalytics
Sure, organizations realize AI can be a path to better business outcomes, but how long does it really take to see actual value from AI investments? We'll close out #sasinnovate on May 9 by focusing on acceleration, joined by CIO of @Parexel on main stage. 2.sas.com/60182vCSM
-
Parexel
@Parexel
Meet Sofia, whose precision and commitment are advancing patient care.
💪Her strength: An eye for detail to keep global projects on track.
🌍Her impact: Aligning international teams to deliver novel treatments.
Learn how professionals like Sofia shape healthcare. #parexelcareers -
Parexel
@Parexel
🧠How can we accelerate progress in #neuroscience research?
In this exclusive interview with @pharmaboardroom, Andreas Lysandropoulos shares his vision for more inclusive, accessible and patient-focused #clinicaltrials. Read the full interview: pharmaboardroom.com/interviews/andreas-lysandropoulos-sen…
#alzheimers -
Parexel reposted
Ogilvy Health
@OgilvyHealth
We're honored to be recognized as a 2025 @shortyawards finalist for two innovative campaigns: the @abbvie “Eczema Experience" and @Parexel's “Insight-Generation Engine"!
Vote now: www.ogilvy.com/ideas/ogilvy-earns-18-finalists-for-2025-s… -
Parexel reposted
World Orphan Drug Congress USA
@OrphanConf
#worldorphanusa 2025 kicks off in Boston TOMORROW! You don't want to miss the day 1 𝐊𝐞𝐲𝐧𝐨𝐭𝐞 𝐏𝐚𝐧𝐞𝐥 ➤ 𝐕𝐢𝐬𝐢𝐨𝐧 𝟐𝟎𝟑𝟎: 𝐂𝐡𝐚𝐫𝐭𝐢𝐧𝐠 𝐚 𝐛𝐫𝐢𝐠𝐡𝐭 𝐟𝐮𝐭𝐮𝐫𝐞 𝐟𝐨𝐫 𝐫𝐚𝐫𝐞 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞 – featuring industry leading speakers:
𝘔𝘰𝘥𝘦𝘳𝘢𝘵𝘰𝘳:
✴︎ Rachel Smith, Executive Director, Global Head of Rare Disease, @Parexel
𝘗𝘢𝘯𝘦𝘭𝘪𝘴𝘵𝘴:
✴︎ Wendy Erler, SVP, Patient Affairs, @Sarepta
✴︎ Susan Winckler, CEO, @reaganudall
✴︎ Jennifer McNary, Co-Founder, Canary Advisors®
✴︎ Amy Comstock Rick, Director of Strategic Coalitions, Rare Disease Innovation Hub, @US_FDA [Recored remarks]
💡 𝘗𝘢𝘯𝘦𝘭 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝘧𝘰𝘤𝘶𝘴: The immediate outcomes of the Rare Disease Innovation Hub as a new model of collaboration between CDER and CBER, and it's promising opportunity to introduce a more systematic approach to prioritizing and streamlining rare disease drug development.
💭 𝘗𝘢𝘯𝘦𝘭 𝘥𝘪𝘴𝘤𝘶𝘴𝘴𝘪𝘰𝘯 𝘴𝘶𝘣-𝘵𝘰𝘱𝘪𝘤𝘴:
➛ Vision for Rare Disease Innovation Hub
➛ Advice for the RD community
➛ Impacts to endpoint assessments, trial design, patient recruitment and development efficiency
𝐋𝐢𝐦𝐢𝐭𝐞𝐝 𝐭𝐢𝐜𝐤𝐞𝐭𝐬 𝐫𝐞𝐦𝐚𝐢𝐧. 🎟️ Get yours now before they sell out & join us this week in Boston: terrapinn.com/bookwodc_tw
Final 𝐕𝐈𝐏 𝐩𝐚𝐬𝐬𝐞𝐬 selling out fast – patient advocates & hospital practitioners, apply here to secure yours: terrapinn.com/freewodc_tw -
Parexel
@Parexel
Where's the clinical research industry headed? Tune in to the latest episode of the Leaders & Legends podcast for insights from Parexel CEO Peyton Howell.🎧Thank you @DiligentPharma and Patty Leuchten for hosting this conversation.🎬Watch the full episode: linktr.ee/leadersandlegendspod
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Transforming clinical research from the inside out. Meet @stacy_hurt, our trailblazing Chief Patient Officer. As a cancer survivor, caregiver, and healthcare executive, Stacy brings a unique 360-degree perspective to our work. Explore her story:
-
Parexel
@Parexel
Parexel today announced the appointment of Dr. Charlotte Moser as Chief Medical Officer. Dr. Moser will provide medical and scientific leadership globally, building on the company’s regulatory and therapeutic expertise with a focus on drug development strategies and trial design.
-
Parexel
@Parexel
Our offices in the APAC region have been buzzing with events designed to bring colleagues together and strengthen our Parexel community. Click through photos below! 📷
-
Parexel
@Parexel
At Parexel, patient-focused drug development is a state of mind. Andreas Lysandropoulos, Global Head of #neuroscience, shares his view on putting #patientsfirst: “For us, nothing can happen without the patient.”
Learn how his team changes lives and explore ways to join us.⬇️ -
Parexel
@Parexel
Thank you @VJNeurology for highlighting @LysandropoulosA's insights on integrating patient perspectives into neurology clinical trials. We're looking forward to watching the full interview!
VJ Neurology
@VJNeurology
Thanks so much to @LysandropoulosA for speaking with us at #aanam today!
He discussed the gaps between patient experience and outcome assessment in #ms, as well as patients' perspectives on neurology clinical trials.
Stay tuned on vjneurology.com for the full interview🎥
@AANMember #neurology #neurotwitter -
Parexel
@Parexel
We're proud of our Parexel family for coming together to support charities and non-profit organizations in recent months:
🏃♀️#rarediseaseday Run @Syngap1Germany
🏠#ronaldmcdonaldhouse Charities of the Triangle
❤️@American_Heart at the Boston Heart and Stroke Ball -
Parexel
@Parexel
At Parexel, we believe in putting people first.🌟Through flexible work options, our 'Bravo' recognition program and comprehensive wellbeing services, we're committed to helping our team balance their work and personal lives while making a difference for patients. #parexelcareers
-
Parexel
@Parexel
Want to nail your Parexel interview?🎯Recruiter Stephanie Gallagher reveals how to showcase your expertise and secure that second round spot: respond to questions using the STAR method.💡 Find your next opportunity with our global team.⬇️ #parexelcareers
-
Parexel
@Parexel
Parexel's global reach means our Clinical Research Associates (CRAs) work across borders to bring treatments to market. From monitoring trials to ensuring data integrity, a #cra drives clinical research forward for patients worldwide.
Find what fits you.⬇️ #parexelcareers -
Parexel
@Parexel
In a recent poll we asked what drives patients to join clinical trials or holds them back? Responses point to concerns about transparency, complexity and logistics. Xoli Belgrave recently shared with @PharmaVoice what areas still require work. Read more⬇️
-
Parexel reposted
Healthcare Businesswomen’s Association (HBA)
@HBAnet
Congrats, Rising Stars & Luminaries!🌟Denise Campbell, @Novartis; Lauren Holder, @Novartis; Karen Wang, @Novartis; Weina Wang, @Novartis; Cate Banden, @novonordisk; Kristina Fusella, @novonordisk; Tivonnia Harvey; @novonordisk; Teri Karcher, @Parexel. Stay tuned for more!
-
Parexel
@Parexel
Congratulations to Teri Karcher on being named a 2025 @HBAnet Luminary! Teri leads our efforts in optimizing the drug development process to get new medicines to patients faster. She and other honorees will be recognized at a ceremony in Chicago in May.👏 #hbaimpact #hbawoty25
-
Parexel
@Parexel
We're excited to announce Parexel has earned an improved climate change score for 2024 from the Carbon Disclosure Project (CDP)! It's another milestone in our Environmental Sustainability program and we're committed to continuing to move the needle. 🌿
-
Parexel
@Parexel
What if you could use data to transform patients' lives? Our Data Management team:
✅Ensures data accuracy and integrity
✅Tackles complex challenges
✅Reveals insights that unlock new therapies
Join us and help shape the future of healthcare. #parexelcareers -
Parexel
@Parexel
The clinical trial landscape is evolving but patients still face major hurdles. In a recent @PharmaVoice article, Parexel's Xoli Belgrave shared insights on patient burdens, patient-led trial design and how sponsors can improve the trial experience. Explore key takeaways below.⬇️
Parexel
@Parexel
Check out the full article: www.pharmavoice.com/news/americans-clinical-trials-barrie…
-
Parexel
@Parexel
With 18 years of industry expertise, Iram Qayum shares: ◼ Why she chose Parexel ◼ What fuels her ◼ Tips for aspiring leaders ◼ And a unique passion rooted in her childhood. 🐅At Parexel, we bring our whole selves to work to make a difference for patients.
#parexelcareers -
Parexel
@Parexel
Congratulations to the 28 colleagues - a record number for Parexel - who are finalists in the @PharmaTimes International Clinical Researcher of the Year Awards! 🏆We’ll be excited to follow the results as our colleagues compete in the finals on May 21.
#ptintcr -
Parexel
@Parexel
Meet some of the newest leaders behind Parexel’s global regulatory expertise and members of our Oncology Center of Excellence, a powerhouse team that includes former regulators from around the globe. Learn how our experts and strong agency relationships can support your strategy.
-
Parexel
@Parexel
Today's #iwd2025 theme, #accelerateaction, resonates deeply with our commitment to workplace inclusivity. This week we hosted Harvard Kennedy School gender experts and authors, Iris Bohnet and Siri Chilazi, for a discussion on embedding fairness in the workplace.
-
Parexel
@Parexel
Parexel India has been honored at the annual @herkeyofficial_ AccelHERate & #divhersityawards for the 6th consecutive year, earning accolades in several categories! ✨This recognition highlights our ongoing commitment to promoting women's inclusion and nurturing future leaders.
-
Parexel
@Parexel
Today Parexel announced the appointment of Jeff Bernstein, Partner, Private Equity, Goldman Sachs Asset Management, and Co-Head, Goldman Sachs Healthcare Private Equity Investing, to its Board of Directors. Read the release. ⬇
-
Parexel
@Parexel
Introducing Clinical Trialblazers – where science meets human stories. Host Alberto Grignolo dives into the decisions & risks shaping healthcare’s future with biotech visionaries. Trailer is now LIVE! First episodes drop March 11, 2025. Subscribe wherever you get your podcasts 🔗
-
Parexel
@Parexel
Today, Feb. 28, is #rarediseaseday. For the third consecutive year, over 300 Parexel colleagues globally participated in the Syngap Elternhilfe e.V. Rare Diseases Run! We walked, ran, rolled and cycled to support rare disease research and patients. See photos below!📸
-
Parexel
@Parexel
We are proud nominees in the upcoming Vaccine Industry Excellence (ViE) Awards for "Best Clinical Trial Network" and "Best Contract Research Organization." Please consider casting your vote for Parexel before Feb. 24!
#vieawards -
Parexel
@Parexel
On behalf of our cross-functional team working to revolutionize infectious disease and vaccine trials, please consider voting for Parexel for the Vaccine Industry Excellence (ViE) Awards! 🏆
-
Parexel
@Parexel
One year ago, our colleague Kristen Paskins bravely shared her story of living with Functional Neurological Disorder (FND). In the lead up to #rarediseaseday 2025, we’re excited to bring you an update on her journey.🧵
Parexel
@Parexel
"I'm no longer trying to be a completely new Kristen, nor am I attempting to reclaim exactly who I was before. Instead, I'm embracing a more holistic view of myself that acknowledges my experience, celebrates my resilience, and looks forward to the chapters yet to be written."
Parexel
@Parexel
From small, everyday milestones to becoming Great Britain's No.1 Female Wheelchair Padel player, Kristen has embraced a new identity while advocating for FND awareness. Read on for her thoughtful look back at the past year. 🔗www.linkedin.com/pulse/embracing-change-update-kristens-j…
-
Parexel
@Parexel
In this #fastforward, experts in #rwe, site engagement and #fsp predict innovations we can expect in 2025. Which do you think will have the biggest impact—or is there another shift on your radar? Retweet with your comments. 🔁
-
Parexel
@Parexel
We share stories about Parexel's most unique insight-generation engine: our people. Learn how Anne Kasmar's teenage interest in motorcycles sparked her scientific career, and explore your next opportunity in research. ⬇️
-
Parexel
@Parexel
Parexel kicked off 2025 with our Sales and Growth Summit bringing together Commercial, Project Leadership and functional leaders from across the globe instrumental in accelerating the development of new therapies for patients. 🌍
-
Parexel
@Parexel
ICYMI: In the latest issue of @PharmOutsource, Jenny Denney dives into the rise of #fspmodels and how they enable biopharma companies to stay competitive. See below for 5 key principles for building strong models. 👇
-
Parexel
@Parexel
A round of applause for our Parexel colleagues who were recognized with this year's Sales Awards! 👏These individuals have demonstrated unwavering dedication and enthusiasm to our mission of delivering for customers and improving patient outcomes #withheart.
-
Parexel
@Parexel
#fastforward with our experts:
➡️Jim Anthony explains why regulatory approval isn't the last hurdle for new #biotech therapies.
➡️Andreas Lysandropoulos reveals the importance of delivering tangible patient benefits for commercial viability.
What's your take? 🔁 -
Parexel
@Parexel
We are passionate about advancing life-changing medical breakthroughs through:
✔Patient-guided approaches that drive innovation
✔Diversity that fuels creativity
✔Continuous learning from industry leaders
✔Prioritizing personal growth and flexibility
Learn more.👇 -
Parexel
@Parexel
We began our 2025 Sales and Growth Summit this week with Peyton Howell reaffirming our commitment to integrating patient insights while ensuring delivery for sponsors. Then, @stacy_hurt spoke with Jimmy Bechtel of @MySCRS about how CROs can better support sites. 👇🧵
Parexel
@Parexel
1️⃣"Establish a feedback loop." Make changes based on input and communicate when changes are made.
2️⃣"Get in their corner." Advocate for new sites with sponsors.
3️⃣"Right-size recruitment efforts are key." Let experienced sites advise on recruiting based on what they know works.
Parexel
@Parexel
4️⃣ "Focus on interoperability and integration of tools." Sites are ready for new tech for the sake of an improved patient experience, but data entry is duplicative and burdensome if the tools don't communicate.
Let us know how you think sites and CROs can better collaborate. 🔁 -
Parexel
@Parexel
🕊️On Martin Luther King Jr. Day, we reaffirm our commitment to inclusivity in clinical research and health equity. We recently hosted Dr. Jayne Morgan, a cardiologist and women's health expert, for an insightful lunch and learn discussion. She highlighted the (🧵):
Parexel
@Parexel
➡️Health disparities affecting Black Americans, especially Black women.
➡️Need for diversity in trials and research.
➡️Importance of lived experiences and social determinants when addressing inequity.
➡️Need to eliminate racial bias in medical formulas and diagnostic tools.
Parexel
@Parexel
As we honor Dr. King's legacy, we're inspired to continue our work toward a future where clinical research truly represents all communities, ensuring better health outcomes for everyone.
#mlkday #healthequity -
Parexel
@Parexel
At Parexel, we're not just about jobs—we're about cultivating careers and unleashing potential. We're committed to your growth and dedicated to helping you reach new heights. 🚀Ready to transform your potential into reality? Join us!
#parexelcareers #clinicalresearch -
Parexel
@Parexel
What's next for #patientengagement in clinical research? Our #fastforward series has the scoop: 👇 💬 Join the conversation—what do you think will be the biggest opportunities in patient engagement next year? #clinicaltrials
-
Parexel
@Parexel
🚑Served in the military and worked as a paramedic.
🏕️Loves to camp and cycle.
🌟Finds success in adaptability and empathy.
Meet Laura Hiijame, Manager of Project Planning and Support. Her story showcases the diverse experiences that make Parexel an ideal place to build a career. -
Parexel
@Parexel
Karen McIntyre from Parexel warns: Soon, we may have more trials than sites to run them. 🤔 What's causing this? 💡 How can we address it? Tune in for Karen's insights on this critical site strategy challenge. 🎙️ #clinicaltrials #researchsites
-
Parexel
@Parexel
Amidst shifting sentiments around DEI efforts, Parexel is staying the course by building strong community connections, embedding #diversity goals into trial design and publishing new research on socioeconomics. Hear from Xoli Belgrave in @PharmaVoice 👇
-
Parexel
@Parexel
Happy New Year from all of us at Parexel! 🎉We’re inspired by the milestones we’ve reached together and energized by the possibilities ahead. Here’s to a new year filled with innovation and working together to advance clinical research and improve patient outcomes. #patientsfirst
-
Parexel
@Parexel
From winning the SCRS Eagle Award and enhancing our early phase facilities to supporting philanthropic efforts and welcoming Peyton Howell as CEO. ✨Thank you to all who made 2024 so special. Here’s to 2025 and continuing to advance healthcare for patients!
-
Parexel
@Parexel
Parexel colleagues worldwide celebrated holidays and gave back! 🌎🎉 From Mid-Autumn festivals in Asia 🏮 to bowling in Bucharest 🎳, cooking in Bogota 🍽️, donating in Newton 🧸 and holiday parties in Toronto and Wavre 🎁. #lifeatparexel
-
Parexel
@Parexel
In @Inside_PM, Xoli Belgrave explains that the path to more inclusive trials starts with patient voices, data-driven insights and intentional site selection. Q: What steps do you think the industry can take to further ensure diversity and inclusion in clinical trials?
Parexel
@Parexel
Read the full article in @Inside_PM to gain more insights into why increasing diversity in clinical trials is critical for improving patient outcomes:
www.insideprecisionmedicine.com/topics/translational-rese… -
Parexel
@Parexel
At last week's @Bloomberg's #ai and #drugdevelopment Forum, Parexel’s Stephen Pyke joined other industry experts to weigh in on the integration of AI into drug development.
💬What area of clinical development do you think could benefit most from AI integration, and why? -
Parexel
@Parexel
What a blast! Parexel India's #wefest2024 event buzzed with excitement for the year ahead, featuring 🎵 colleague performances 🏆 "Celebrating Success Awards"💪 and excellence, innovation and teamwork in many forms. Thank you to all who helped make this event a success!
-
Parexel
@Parexel
Despite the hype, psychedelic treatments aren’t shielded from regulatory scrutiny. 🚧 Parexel’s Mwango Kashoki says there is a path to regulatory approval, but with the right trial strategies. Read her recommendations for navigating the challenges in @PharmaVoice. ⬇️
-
Parexel
@Parexel
We share stories of Parexel's most unique insight-generation engine: our people. Meet Jo, VP, Consulting. Find out how she helps ensure compliance, expedite life-changing treatments and the unexpected connection she draws between regulatory strategy and her knitting hobby! 🧶
-
Parexel
@Parexel
We're looking for a Clinical Operations Leader to:
🚀 Independently lead global studies
💼 Excel in budget management
🤝 Thrive in a collaborative, fast-paced environment.
Your expertise can help us bring medicines to patients faster. Apply now👇
insde.co/5czj -
Parexel
@Parexel
In our 2024 holiday card, colleagues share what drives them to bring their passion and focus on the patient to progress healthcare. 🎥 Inspired by the dedication of everyone involved in clinical research, Parexel is donating to @MakeAWishIntl this holiday season.🌟
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
At #ash24, our team connected with leading experts, presented on innovative solutions and discussed the latest developments in blood disorders. From cutting-edge research to inspiring conversations, @ASH_hematology reinforced our commitment to advancing hematological treatments.
-
Parexel
@Parexel
🎙️This week, Parexel's Stephen Pyke will join other industry experts at @Bloomberg's #ai and Drug Development Forum to explore how AI is revolutionizing the drug development industry. We're proud to participate in conversations shaping the future of AI in drug development.
-
Parexel
@Parexel
Yena is a Site Contracts Associate who went from nursing💉 to clinical research📋. She uses her expertise to create contracts that help patients access vital treatments through clinical trials. Want to make a difference in #clinicalresearch like Yena? Explore careers at Parexel!
-
Parexel
@Parexel
Our team of #hematology experts are headed to San Diego this weekend for the #ash24 annual meeting and exposition! 🎉
Scroll through for more information on our thought leaders’ presentations throughout the week or visit us at Booth 126. -
Parexel
@Parexel
Meet David Dent, VP of Integrated Solutions Strategy and co-leader of our ParAbility Committee. Thanks in part to his leadership, ParAbility is creating a space where everyone can thrive. Discover how colleagues like David are making Parexel a leader in #disabilityinclusion:
-
Parexel
@Parexel
We share stories of Parexel’s most remarkable insight-generation engine: our people. Meet Alexis, a CRA II, who sets the gold standard in communication, operational excellence and commitment to patients. Learn more about her growth through the APEX CRA program. #parexelcareers
-
Parexel
@Parexel
✨Parexel has been recognized as a 'Bronze' employer in the India Workplace Equality Index (IWEI) for five straight years! ✨IWEI showcases employers in India who are committed to programs and initiatives that create a more inclusive organization for their LGBT+ colleagues.
-
Parexel
@Parexel
We were glad to have the opportunity to present at the 2024 KoNECT International Conference! Thank you to all who visited our booth and joined our presentations! We look forward to continuing these great conversations and partnerships 🤝
#konect2024 #mohw #mfds #clinicalresearch -
Parexel
@Parexel
🕯 Today marks Transgender Day of Remembrance. 🕯 We honor and mourn those who've lost their lives to anti-transgender violence and reflect on the ongoing struggles faced by the transgender community. Want to be a better ally? Use these resources we shared with our colleagues🧵:
Post not available here, view on X
Parexel
@Parexel
Learn more about the violence and threats faced by transgender people in the U.S. and many other countries: www.forbes.com/sites/jamiewareham/2024/11/16/350-transgen…
Parexel
@Parexel
Consider joining the @HRC’s webinar on supporting gender expansive youth today at 4 p.m. ET: www.hrc.org/resources/project-thrive-webinars
#tdor #transdayofremembrance #transrightsarehumanrights -
Parexel
@Parexel
For the @statnews 'Who to Know' series, @KatieMPalmer asked Stephen Pyke and other industry leaders about how AI and machine learning are game changers when it comes to streamlining processes and automating key administrative aspects of #clinicaltrials. Read the article:
-
Parexel
@Parexel
Join Parexel to help shape the future of clinical research as a Project Leader! 🔬 Drive innovation 👥 Inspire teams 🤝 Partner with global customers ❤️ Change patient lives. Apply today. 👉 insde.co/dlkw
#parexelcareers #clinicalresearchjobs #projectmanagement -
Parexel reposted
CNS Summit
@CNSSummit
Afternoon spotlight sessions are in full-swing! Here,
@stevenrosenberg, @GilliesMurray, @Stacy_hurt, Judy Montero and Michael Gold unpack how a new generation of mobile technology has paved the way for innovation in #clinicaltrials. #cnssummit2024 -
Parexel reposted
CNS Summit
@CNSSummit
Stephen Pyke, Mariann Miscinai-Balan, Jingshu Liu, and Hongmei Huang highlight how #biopharma companies are implementing #ai to release value and establish a normal business workflow. #cnssummit2024
-
Parexel reposted
Hexaware Technologies
@HexawareGlobal
In the latest episode of the CEO Tech Live podcast series, Nelly Nauman, CISO of @Parexel, shares with host @BenFanning1 how taking strategic risks early can set the foundation for leadership growth and resilience. Tune in: spoti.fi/3ALsHMs
-
Parexel reposted
CNS Summit
@CNSSummit
"We have to make #clinicaltrials easier - they're not as adaptive as they should be. I'm hopeful that in the next 15 years we wiIl make adaptive clinical trials the norm."
@PeytonRHowell shares her hopes for the future of the #lifesciences industry. #cnssummit2024 -
Parexel reposted
CNS Summit
@CNSSummit
"Patient engagement is not a rescue strategy — it’s an initial strategy. Speaking to patients from the very beginning & earning their trust is critical."
Our community's patient advocate leaders, @stacy_hurt & @cvonraesfeld offer insights on patient centricity. #cnssummit2024 -
Parexel
@Parexel
In honor of #veteransday and #armisticeday, Parexel joined @VetBridgeHome at Veterans Freedom Park in Cary, N.C., to lay flags in recognition of those who served in the U.S. armed forces. Read more about our partnership in @CBJnewsroom. 👇 www.bizjournals.com/charlotte/news/2024/11/08/military-ve…
-
Parexel
@Parexel
At Parexel, we empower you to thrive: 🏡 Flexible work options: office, home, or hybrid 🩺 Comprehensive benefits for total well-being 🌟 Year-round recognition through "Bravo!" program. insde.co/cf56-2 #parexelcareers #worklifebalance
-
Parexel
@Parexel
In this episode of #ceotechlive, Parexel's Nelly Nauman shares how a personal connection to clinical trials led her to biopharma and explores her leadership philosophy: Be authentic, know your strengths and weaknesses and always tie your work back to its impact on peoples' lives.
Hexaware Technologies
@HexawareGlobal
Join Nelly Nauman, @Parexel CISO, on the CEO Tech Live #podcast series with @BenFanning1 as she reveals how her #leadership centers on purpose-driven goals that go beyond daily operations to impact patients’ lives. Tune in open.spotify.com/episode/2Ic3rj2gRtI3SxO9pN0l5x
#ceotechlive -
Parexel
@Parexel
In our latest report, we explore the concept of true diversity in clinical trials, including patient limitations, challenges in diagnosis and participation, and crucial considerations for developers aiming to enhance their trial data through diverse populations. #novelinsights
-
Parexel
@Parexel
Parexel India's 13th Annual Symposium was a huge success! 🌟 Industry leaders gathered in Hyderabad to discuss innovative ways to shape the future of clinical research in India through launch excellence, regulatory strategies, patient-guided insights and more.
-
Parexel
@Parexel
At Parexel, we've created a range of virtual career and #professionaldevelopment programs to help you reach your goals and unlock your full potential.🤝 Ready to grow with us and make a lasting impact on healthcare? Learn about our initiatives:
-
Parexel
@Parexel
In our fifth consecutive year partnering with @LLSusa, Parexel colleagues helped us raise more than $190,000 for cancer research and patients! Together, we're igniting hope, fueling research and lighting a path toward a future free of blood cancer.🏮
#parexelwithheart -
Parexel
@Parexel
As a Principal #statisticalprogrammer, Bindu uses her industry experience to help bring better medicines to patients. Her role involves leadership responsibilities, mentoring and delivering high-quality results for customers. Learn more about her role and impact.🌟👇
-
Parexel
@Parexel
The Cary, N.C. #lightthenight walk served as a poignant reminder of the lives touched by blood cancer and the need to fund research. We're proud to have been this year's "Shine Light on Patients" sponsor and grateful to everyone who contributed to our fundraising efforts! @llsusa
-
Parexel
@Parexel
Congrats to our @PharmaTimes Clinical Researcher of the Year - The Americas winners: 🥇Jake Andary (Novice CRA) 🥈Allie Bara, Alison Combs, Annie Hounnoukpe (Start Up Team) 🥉Nicole Steele (Global Project Manager) #pharmatimes #croy #clinicalresearch
-
Parexel
@Parexel
📣 Parexel's Mwango Kashoki recently wrapped up a compelling interview series with @Clin_Trials to weigh in on the FDA's new Oncology Guidance. Click through for insights shared in Parts 1-5 of the series. ⬇ #regulatory #oncology #clinicaltrials
Parexel
@Parexel
🎥 1. Initial Reactions: Thoughts on the FDA's latest guidance on multiregional clinical trials in oncology and its potential to transform the landscape. www.appliedclinicaltrialsonline.com/view/mwango-kashoki-p…
Parexel
@Parexel
🌍 2. Driving Diversity: How by promoting more diverse trial site locations and patient populations, there’s potential for more inclusive oncology studies. www.appliedclinicaltrialsonline.com/view/ensuring-greater…
Parexel
@Parexel
📅 3. Planning Ahead: Why sponsors will need to be even more strategic in planning their oncology trials to align with the new guidelines. www.appliedclinicaltrialsonline.com/view/planning-ahead-f…
Parexel
@Parexel
⚖️ 4. Regulatory Challenges: On the complexities of meeting multiple regulatory requirements across different regions. www.appliedclinicaltrialsonline.com/view/challenges-fda-m…
Parexel
@Parexel
🔍 5. Better Trials Ahead: How this guidance could lead to better design in oncology trials and ultimately greater diversity in patient representation. www.appliedclinicaltrialsonline.com/view/future-impact-fd…
-
Parexel
@Parexel
The Parexel team is thrilled to be participating in the #worlddrugsafety Congress Americas in Boston! Don't miss our insightful discussion exploring the transformative potential of generative AI in pharmacovigilance and its role in shaping the future of drug safety.
-
Parexel
@Parexel
At the #longwoodhealthcareleaders Fall Boston CEO, Jim Anthony, President & Global Head, Parexel Biotech, will lead an esteemed panel exploring the evolution of clinical development and the importance of incorporating patient perspectives into protocol design. #parexelbiotech
-
Parexel
@Parexel
🌿We have achieved a Silver Award in the 2024 @ecovadis Sustainability Rating program for the third year running, underscoring our sustainable and responsible business practices. Read more about our #sustainability targets in our 2023 Environmental, Social and Governance Report:
-
Parexel
@Parexel
Parexel today announced the appointment of Keri Mattox to the newly created role of Chief Business Officer. As part of the company’s senior leadership team, she will help drive the next phase of Parexel’s growth. Click through highlights from the press release below. 👇
-
Parexel
@Parexel
🔍Parexel is looking for talented #clinicalresearch professionals who want to spark change in their roles. Senior Project Leader Carolina shares how you can join Parexel to shape your career, embrace your potential and make a real impact. Watch below and click to learn more:
-
Parexel
@Parexel
#teamparexel gathered at the Boston #lightthenight✨walk to raise awareness for #bloodcancer, honor loved ones and support patients and survivors. Thank you, Boston-area colleagues, for all your contributions and we can't wait to ‘Light the Night’ next week in North Carolina!🏮
-
Parexel
@Parexel
Parexel collaborated with @TuftsCSDD to research the impact of socioeconomic status on access and participation in clinical trials. Click to learn about the survey findings and how socioeconomically vulnerable groups are often excluded from vital research: www.nature.com/articles/s43856-024-00586-9
-
Parexel
@Parexel
🚨October is #cybersecurityawarenessmonth so let's discuss #recruitment fraud. Scammers use fake job opportunities to trick applicants into sending personal information or money. Don't hesitate to reach out to us for verification and use these tips to protect yourself.👇
-
Parexel
@Parexel
We are sharing stories of Parexel’s most remarkable insight-generation engine: our people. Matt is a Clinical Operations Leader who uses his expertise to balance the needs of sponsors, sites and patients. Read his story and learn what it takes to thrive in clinical operations:
-
Parexel
@Parexel
While traveling to meet with customers and sites, Parexel senior leaders are taking the opportunity to also connect with local colleagues and reinforce our commitment to close collaboration across our global teams. Recent stops include Japan, China, Korea and the Netherlands!✈️🌍
-
Parexel
@Parexel
📸 Check out highlights from our time this week at @totalbiopharma's #wdsceurope2024 🌟
Thank you to everyone who attended our presentations and stopped by our booth throughout this incredible week in Amsterdam!
#wdseu #wdsc2024 #genai #pharmacovigilance #rwd #drugsafety -
Parexel reposted
Hexaware Technologies
@HexawareGlobal
Jonathan Shough, CIO, @Parexel explains why expecting the unexpected and preparing for disruptions is critical for leadership success in the latest episode of CEO Tech Live hosted by @BenFanning1.
Listen to the full episode here: Spotify (spoti.fi/3Y44rwT) -
Parexel
@Parexel
⏰ The deadline for EU-CTR slim transitions is now just a few days away! Get actionable guidance for ensuring compliance with EU-CTR to maintain the validity of your clinical trials in the EEA.
#euctr #eea #ctis #regulatorycompliance #clinicaltrials -
Parexel
@Parexel
Parexel is proud to announce that Teri Karcher, Ph.D., has been named to the 2024 @PharmaVoice 100 list of inspirational leaders in the #lifesciences industry! Join us in congratulating Teri and read what CEO Peyton Howell had to say in the press release.👇 #pharmavoice100
-
Parexel
@Parexel
As a dedicated #clinicalresearch professional with a commitment to patient safety, Inhye explains why she joined Parexel, shares how our corporate values align with her personal ethos and describes the collaborative atmosphere. Curious about #lifeatparexel? Hear more from Inhye:
-
Parexel
@Parexel
Parexel Chief Information Officer, Jonathan Shough, joined @HexawareGlobal's #ceotechlive podcast to discuss the role of tech leaders, emphasizing the importance of planning and adaptability in the face of sudden challenges. Listen below and stay tuned for the video interview!
-
Parexel
@Parexel
📣 We're thrilled to announce Parexel is a finalist for "Best Contract Research Organization" at the 3rd annual #citelinejapan Awards! We're honored to be recognized among the leading innovators in our field. Winners will be announced Oct. 22 in Tokyo. Stay tuned for results!
-
Parexel reposted
Hexaware Technologies
@HexawareGlobal
Great leadership starts with making time to think, plan, and connect. Join Jonathan Shough, CIO of @Parexel , on the latest episode of our CEO Tech Live podcast series with host @BenFanning1. Discover what it takes to lead in today’s world. Tune in now open.spotify.com/episode/4ZBBQj5sFs8Hb83uHfXkAn?nd=1&dlsi…
#championsofchange #ceotechlive #poweredbyhexaware -
Parexel
@Parexel
We kicked off #scrs2024 with a special breakfast for recipients of Parexel's "Next Generation" Site Scholarship program. Our 10 scholarship recipients joined program mentors and Parexel leaders to network and set goals. 🚀#sitepartnerships
-
Parexel
@Parexel
Colleagues gathered in our Newton, Mass. office for a Lunch & Learn in support of @llsusa and our upcoming sponsorship and participation in Boston's Light the Night walk.🏮 We're proud to raise funds for blood cancer research and look forward to helping #lightthenight!
-
Parexel
@Parexel
Parexel is excited to enter a strategic alliance with @DSPClinical, a leading clinical research organization (CRO) specializing in reproductive endocrinology/fertility and women’s health research.
Parexel
@Parexel
This alliance builds on our collaboration with @DSPClinical in the U.S., providing customers with an enhanced offering in this specialized area. DSP's expertise in #fertility studies along with Parexel's global capabilities is setting a new standard in women’s health research.
Parexel
@Parexel
We’re excited to accelerate sponsors’ development of safe and effective #fertility therapies through our expanded collaboration and to improve patient outcomes. www.parexel.com/therapeutic-expertise/general-medicine @DSPClinical
-
Parexel
@Parexel
Last week, Jim Anthony, President and Global Head of Parexel Biotech, spoke at a Goldman Sachs Fall Symposium panel on the importance of biotechs in drug development and how Parexel Biotech serves customers through personalized approaches, operational support and vast expertise.
-
Parexel
@Parexel
Congratulations to the 🌟16🌟 #teamparexel members who are finalists in the @PharmaTimes Clinical Researcher of the Year Awards–The Americas competition! We're extremely proud of our talented team and can't wait to cheer them on in the finals on Oct. 21! See all finalists here:
-
Parexel
@Parexel
We're thrilled to once again be a finalist in the annual #scripawards, Best Contract Research Organization – Full-Service Providers category! Being a finalist reflects our team's dedication to putting #patientsfirst and revolutionizing healthcare. Here's hoping for another win!🏆
-
Parexel
@Parexel
Parexel is committed to a secure hiring process that ensures the right fit for you and our team. You explore our opportunities and we provide a seamless application, interview and onboarding experience. Reach out to us with any questions during the process! Learn more:
-
Parexel
@Parexel
Thank you for joining our sessions and stopping by our booth at #dpharm this week! We look forward to continuing to collaborate to drive the disruptive solutions needed to improve patient care and treatment options.
#patientsfirst #pharmainnovation -
Parexel
@Parexel
Working as a Clinical Research Associate (CRA) at Parexel combines on-site monitoring, data integrity assurance and collaboration with sites and sponsors. Our commitment to work-life balance, competitive compensation and career growth are ideal for aspiring and experienced CRAs.
-
Parexel
@Parexel
Our team is headed to @RAPSorg Convergence 2024!☀️
At Parexel, we leverage our regulatory expertise to drive clinical trial efficiencies and accelerate the development of more effective treatments, bringing them to patients in need faster than ever before.
#rapsconvergence -
Parexel
@Parexel
Meet Jamie, a Senior Project Leader with 12 years of experience at Parexel. Her passion for cell and gene therapy has led to exciting opportunities for growth.🚀Hear from Jamie on why Parexel is the place to be and learn more about our culture here:
#parexelcareers #careergrowth -
Parexel
@Parexel
Parexel today announced the strengthening of its Real World Research offering, bringing together the company’s Scientific Data Organization and Real World Evidence (RWE) capabilities to better meet growing customer needs.
Parexel
@Parexel
Parexel has appointed Mike D’Ambrosio as SVP, Global Head, Real World Research. Mike will lead strategic initiatives to enhance customer engagement and delivery across Real World Data (#rwd) and #rwe services. newsroom.parexel.com/news-releases/news-release-details/p…
-
Parexel
@Parexel
Parexel colleagues around the world gathered over the summer to share meals, enjoy time together and make memories.🌍☀️ Click through our gallery for a glimpse of #lifeatparexel! 📸
-
Parexel
@Parexel
Leading up to #lightthenight with @LLSusa in October, we’re sharing stories from Parexel colleagues impacted by #bloodcancer. Bhavani Pemmaraju spoke about her family’s experience with #multiplemyeloma, the strength of family ties and the impact of community support. Read below👇
-
Parexel
@Parexel
Transforming lives is possible when inflammation and immunology trials are designed with precision and compassion. Our team works to safely accelerate treatments while prioritizing the patient experience. Discover how our expertise can help you make a difference.
#patientsfirst -
Parexel
@Parexel
Parexel welcomes Dr. Benedikt Egersdörfer as SVP and Head of Global Data Operations! With 25 years of pharmaceutical and CRO experience, his expertise will be invaluable as we leverage innovative data collection methods to reduce site and patient burden.
-
Parexel
@Parexel
🚀 Clinical Operations Sr. Manager Cristina DiRenzo's 20-year career at Parexel is a testament to the power of professional growth, mentorship and dedication. If you're passionate about advancing healthcare through #clinicalresearch, join us and chart your own course to success!
-
Parexel
@Parexel
In episode three of Enabling Successful Sites, Karen McIntyre and Mitch Carter are joined by START Network's Angela Galindo. They discuss the unique challenges of oncology trials, why a site would pass on a study and how we can make oncology studies less burdensome. Tune in!🎙👇
-
Parexel
@Parexel
Last night was filled with hope and inspiration at the @MakeAWishEastNC 2024 Wish Ball!🌠Our team members were moved by the incredible stories of wish kids and their families. We're proud to support #makeawish in their mission to bring light to children with critical illnesses.💞
-
Parexel
@Parexel
Looking for that next binge-worthy podcast? Three of Parexel's top thought leaders recently joined @ACROhealth's Good Clinical Podcast to cover trending topics in the clinical research ecosystem. 👇🎙️Happy listening! #patientcentricity #aiinhealthcare #rbqm #podcast
-
Parexel
@Parexel
🌎 Parexel's near-term science-based greenhouse gas reduction targets have been validated by the Science Based Targets initiative (SBTi). We are proud to be one of the few global CROs with validated science-based targets. Read more about our progress on our net-zero roadmap. 👇
-
Parexel
@Parexel
Parexel is proud to partner with @llsusa in support of #lightthenight 2024! As the "Shine Light on Patients" sponsor, we're committed to supporting blood cancer patients and funding critical clinical research for cures. #lls #clinicalresearch
-
Parexel
@Parexel
Navigate the complex world of #regulatory affairs with confidence!
Introducing the Regulatory Navigator series—explore the evolving regulatory landscape, gain actionable insights from Parexel experts, maximize success in clinical development, and accelerate patient access. -
Parexel
@Parexel
🌍 As part of our climate initiatives, we introduced a first-class rail travel incentive in Germany to reduce air travel and environmental impact. This program increased train travel from 65% to 96% for trips under 4.5 hours, cutting air travel emissions by 30%! Read more below:
-
Parexel
@Parexel
For your next listen, tune in to the latest episode of ACRO's #goodclinicalpodcast with Parexel's Cris McDavid! Cris, Director of Global Clinical Operations for #rbqm, shares insights on moving past the "belt and suspenders" approach in clinical data quality. Sneak peek below👇👀
-
Parexel
@Parexel
Episode 2 of our "Enabling Successful Sites" series explores how to better empower sites with the tools and training necessary to recruit diverse patient populations successfully. Tune in 🎧✨
www.parexel.com/insights/podcast/empowering-sites-to-be-m…
Parexel
@Parexel
To our valued site partners, tomorrow is the last day to vote for the 2024 @MySCRS Sites #eagleaward. Your vote is important to us, and we appreciate your partnership in driving meaningful change in clinical research. www.surveymonkey.com/r/2024EAGLE
-
Parexel
@Parexel
Parexel today announced the release of its 2023 Environmental, Social and Governance ("ESG") Report. The ESG Report is part of Parexel’s annual commitment to communicate progress on sustainability priorities, underscoring the company’s core values of putting Patients First 👇
-
Parexel
@Parexel
This #disabilitypridemonth we celebrate the resilience, achievements and diversity of our colleagues in the disability community. At Parexel, ParAbility is leading the way in fostering an accommodating workplace where everyone can thrive.
#disabilitypride #proudtobeparexel -
Parexel
@Parexel
🌟 Exciting insights from our passionate Infectious Disease team ahead of World Hepatitis Day! 🌟 Join us in our commitment to advance research and bring hope to millions. Together, we can conquer Hepatitis B!
#worldhepatitisday #patientfirst #innovatetocure -
Parexel
@Parexel
The site feasibility and initiation process often poses several significant challenges for investigative sites. In the first episode of our "Enabling Successful Sites podcast," Parexel experts are joined by @mohammadmillwal of @DMClinical to discuss solutions. Tune in below🎙
-
Parexel
@Parexel
In the latest episode of the #parexelbiotech podcast, our experts focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Mitigate development risks and stand out among competitors by planning ahead.
#biotech #trialdesign -
Parexel
@Parexel
Nestled in the heart of Romania's capital, our Bucharest team works from the stunning Metropolis Center ─ originally built at the end of the 19th century as a printing house. This unique space blends historic architectural elements with modern functionality.🏢 #officespotlight
-
Parexel
@Parexel
Parexel has earned a top score on the Disability Equality Index® and been recognized as a "Best Place to Work for Disability Inclusion" by @DisabilityIN! Despite our progress, there's still work to do and we'll keep driving more inclusive initiatives. 💪#bestplacetowork24
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Thank you to our amazing @Parexel team who showed up at the #cposummit with energy, with ideas, and #withheart 🫶
-
Parexel
@Parexel
It's Disability Pride Month🌈and as part of our commitment to inclusive #clinicalresearch, we launched our Ophthalmology Patient Advisory Councils to understand and improve the accessibility of trials for patients in the Ophthalmology community. Recent meetings focused on 👇
Parexel
@Parexel
🔸Raising awareness of #clinicaltrials for blinding diseases 🔸 The role of care partners and the support needed for trial participation 🔸Communication aids for healthcare accessibility for the Usher Syndrome community 🔸 Better ways to give consent in clinical research
-
Parexel
@Parexel
📣We're thrilled to announce our "Next Generation" Site Scholarship program, exclusively for emerging investigative sites! These 10 scholarships will provide support and resources to help emerging sites ─ the next generation of #clinicalresearch ─ reach the next level.🚀
Parexel
@Parexel
Each recipient will receive🔹A 1-year SCRS membership with online training🔹Mentoring by experienced sites in our Site Alliance Program🔹A dedicated Parexel Site Alliance Manager🔹One complimentary pass to the 2024 SCRS Global Site Solutions Summit.
Parexel
@Parexel
Accelerate your site's success and apply today! app.smartsheet.com/b/form/8118358fead54a3db7238fa0f0cff2ee
-
Parexel
@Parexel
We are excited to announce that CPO @stacy_hurt will lead our on-site team at the #cposummit! Stacy will present with #patientadvocacy leaders on ways to improve trial experiences and the meaningful benefits.
Comment below about what you are looking forward to👇
#patientsfirst -
Parexel
@Parexel
On Episode 2 of @ACROhealth's #goodclinicalpodcast, Stephen Pyke discusses #ai's potential in clinical research. Learn about the FDA's evidentiary standards for AI, where Stephen thinks AI advancements will show up and what it means for patients. Watch below!
-
Parexel
@Parexel
Accelerating clinical trials takes on special urgency in #oncology. Martin Roessner explains how #parexelbiotech is advancing innovative approaches to optimize study design and streamline protocols.
-
Parexel reposted
ISPOR
@ISPORorg
ISPOR welcomes the following members to the 2024-2025 Board of Directors: @Liz_Fenwick1 of @Pharmerit; @regilardino of @MSDInvents; Daniel Ollendorf of @icer_review; Katja Rudell of @Parexel #heor www.ispor.org/about/our-leaders
-
Parexel
@Parexel
Chief Patient Officer @stacy_hurt joined @Medidata's Alicia Staley to kick off Season 2 of @ACROhealth's Good Clinical Podcast! 🎧 Hear how Stacy's experiences as a patient and caregiver have shaped her view on incorporating the patient voice and turning buzz words into action!💪
-
Parexel
@Parexel
For three years, Parexel and @veevasystems have used #veeva’s suite of technology applications to accelerate #clinicaltrials. Recently, our colleagues and the Veeva team met to discuss how to further enhance the trial experience for participants, patients and site professionals!
-
Parexel
@Parexel
📢Parexel is looking for talented professionals to make an impact in #regulatoryconsulting. Your #regulatoryaffairs expertise will help us bring forward ground-breaking medical advancements to shape the future of healthcare. Explore the possibilities at Parexel! #clinicalresearch
-
Parexel
@Parexel
Navigating regulatory complexities in the European Union (EU) can be challenging for biotech developers. Read our playbook on the current landscape of EU regulation, filled with sponsor perspectives and actionable strategies to plan for long-term success. #parexelbiotech #euctr
-
Parexel
@Parexel
Throughout June and July, colleagues are participating in our internal "Show Your Colors" initiative, sharing photos of how they’re celebrating and supporting #pridemonth. 🌈 See some of our favorites so far.👇 #parexelwithheart
-
Parexel
@Parexel
In this DIA Global interview, Parexel's Wyatt Gotbetter sits down with Johnson & Johnson's Kourtney Davis to discuss the revolutionizing impact of RWE on drug discovery, clinical research, regulatory decision-making and health equity. 🩺
-
Parexel
@Parexel
Everything biotechs need to know about the latest in #neoadjuvant therapy: new classes of agents, considerations for clinical trial design, the early evidence of improved outcomes & more! Read the first in our latest #oncology series from #parexelbiotech. www.parexel.com/insights/blog/the-potential-of-neoadjuvan…
-
Parexel
@Parexel
Parexel CEO @PeytonRHowell joined other industry leaders in contributing to @ContractPharma's Annual CRO Industry Report. She emphasizes how growing R&D investments and trends like #ai integration have helped CROs navigate challenges and shape the future of medicine. Read below:
-
Parexel
@Parexel
In Part 2 of our Q&A with the leaders of Parexel's Pride Committee, they share personal perspectives on the Committee's efforts to support a more inclusive future in healthcare: Check out their responses. 👇🌈
-
Parexel
@Parexel
Join Parexel's Biostatistics group and support the safety and efficacy of new treatments! 📋You'll contribute to trial design, protocols and statistical analysis plans - all centered around putting #patientsfirst.💕Do you have the skills it takes to succeed? Apply now! 👇 💪
-
Parexel
@Parexel
What a week in San Diego for #dia2024! The 60th anniversary meeting kicked off with @stacy_hurt, our Chief Patient Officer, sharing the importance of patient perspective as a panelist in the opening keynote address. Click through to see more from our team at DIA! #patientsfirst
Parexel
@Parexel
❤️ Xoli Belgrave, Senior Director, Head of Patient Inclusion, provided actionable insights on the cultivation of an inclusive workplace. #dia2024
Parexel
@Parexel
🏃♀️ Parexel ran in the Medical Heroes Appreciation 5K Run & Walk hosted by @CISCRP. #dia2024
Parexel
@Parexel
🤝 Jenny Denney, EVP and Head of FSP Clinical and Biometrics, provided insight into the evolution of FSP, providing global efficiencies across a portfolio of studies. #dia2024
-
Parexel
@Parexel
Parexel recently hosted its first Patient Advocacy Group Forum, focusing on how socioeconomic status impacts #clinicaltrial participation. Learn how our Forums are connecting representatives of diverse patient groups and using patient insights to shape clinical trials. 👇
-
Parexel
@Parexel
We honor #juneteenth, the day that celebrates Black American freedom and promotes education and achievement. Our Black Employees Advisory Consortium (BEACON) furthers our commitment to #dei in Parexel and clinical research. Check out photos from their recent activities below! 📸
-
Parexel
@Parexel
To learn more about challenges clinical investigative sites are facing today, Parexel partnered with @TuftsCSDD on a comprehensive study. The study sheds light on the urgent issues that sponsors and CROs MUST address to minimize site burden. View the key themes below:
Parexel
@Parexel
Parexel is committed to supporting our valued site partners through collaborations like this one. To all site professionals, we hope you will consider voting for Parexel for this year's SCRS #eagleaward. 🤝www.surveymonkey.com/r/2024EAGLE
-
Parexel reposted
MaryAnne Rizk, PhD 🤝🧬📱
@RizkManagement
@stacy_hurt shared a moving story on the #patientvoice needed to design patient first trials @DrugInfoAssn #dia2024
-
Parexel reposted
Drug Information Association (DIA)
@DrugInfoAssn
.@stacy_hurt @parexel: "Patients are the experts of our own lived experience. We are here to tell you how to design clinical trials for the least burdensome path. Unless you get out into the communities and understand the burdens and needs of these patients, we're not going to make any progress.
I would ask that you incorporate patient involvement as early as possible. Get the patient voice in there so that it’s early and sustained. It’s not tokenized or transactional. It’s sustained every stage all the way to market.” #patientvoice #clinicaltrials (4/6) -
Parexel
@Parexel
We are proud of our culture of respect, equality and inclusion in support of our colleagues, customers, partners and patients. Click through below to learn how our Parexel #pride Committee leaders are working to make Parexel an example of inclusivity. #pridemonth 🏳️🌈
-
Parexel
@Parexel
🎙️ Tune in to our Advancing Precision Oncology Podcast! This 3-part series explores how biomarkers and advanced testing capabilities are expanding patient access to precision #oncology and improving health outcomes for cancer patients. #novelinsights
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Chief Executive Officer @PeytonRHowell and Chief Patient Officer (yours truly) out here together raising awareness of #clinicaltrials and making them easier to participate in for ALL! We are always #patientsfirst at @Parexel 😊🤝❤️
-
Parexel
@Parexel
This week Parexel unveiled its newly renovated Baltimore Early Phase Clinical Unit, specially designed to improve the participant experience. We are dedicated to collaborating with our customers to set the gold standard for early phase research. Explore the new space below! 📸
-
Parexel
@Parexel
Going to #dia2024? Here’s your guide to connecting with Parexel’s thought leaders! Stop by booth 2301 to learn about our latest work and to meet our team of clinical research experts. 🤝
#lifesciences #clinicalresearch #patientsfirst #withheart -
Parexel
@Parexel
June is Alzheimer’s & Brain Awareness Month — a time to reflect on and raise awareness for brain health.🧠We hosted a webinar on the similarities between #alzheimers and #multiplesclerosis, featuring top #clinicalresearch experts and disease area specialists. Click to tune in!
-
Parexel
@Parexel
Parexel leaders are in Baltimore today for the unveiling of our refreshed Early Phase Clinical Unit (EPCU)! The redesign features state-of-the-art technology and improved amenities to enhance the trial experience for participants and staff. Follow along today for more updates!
Post not available here, view on X
Parexel
@Parexel
Today, @govwesmoore commented on Parexel’s renovations to the Early Phase Clinical Unit in Baltimore. "For more than two decades, Parexel has maintained a strong presence in Maryland contributing to the development of new therapies for patients around the world," he said.
Parexel
@Parexel
"We're excited the company is continuing its investment in our state – helping Maryland evolve into a biotech valley and be at the forefront of advancing new medical innovations,” said @govwesmoore.
-
Parexel reposted
Parexel
@Parexel
@RaremindsUK, one of our 2024 Corporate Patient Advocacy Partners, has released a Wellbeing Hub with mental health resources for those navigating the rare disease journey. Parexel was proud to provide an educational grant to support its development.
-
Parexel
@Parexel
@RaremindsUK, one of our 2024 Corporate Patient Advocacy Partners, has released a Wellbeing Hub with mental health resources for those navigating the rare disease journey. Parexel was proud to provide an educational grant to support its development.
-
Parexel
@Parexel
Last week Parexel joined forces with @MySCRS to host a budget training workshop for investigator sites. Parexel is dedicated to strengthening our relationships with our site partners through continuous collaboration. Please consider voting for us for the 2024 #eagleaward:
-
Parexel
@Parexel
We are thrilled to announce the completed renovation of our Baltimore Early Phase Clinical Unit! The space has been carefully redesigned to improve the #clinicaltrial experience for everyone. Watch below to hear from employees and study participants on the exciting changes!
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Last week in Mumbai, local and global industry stakeholders attended Parexel's annual India Symposium! Each year, this event features key voices, fosters partnerships, facilitates discussion and builds strategies for bringing new medicines to patients in India. #clinicalresearch
-
Parexel
@Parexel
Parexel is a recipient of the 2024 CRO Leadership Award for the 13th consecutive year! 🏆 Each year @ClinicalLeader1 evaluates CROs based on feedback from their sponsors. We extend our utmost appreciation to our sponsors whose feedback led to our recognition!
-
Parexel
@Parexel
Enter your next interview prepared to leave a lasting impression. Antoinette, from Parexel's University Recruitment team, shares #interviewtips for conveying your unique strengths and nailing the interview. Retweet with your own advice and view our global opportunities:
-
Parexel
@Parexel
We welcomed our 2024 NC-based summer interns to Parexel, where they'll broaden their skillsets and engage in work that has the potential to change patient lives. Discover how your interests align with our work and keep in touch for updates on our #internshipprograms:
-
Parexel reposted
Palantir
@PalantirTech
→ 6-7 hours saved per SME for each study design
→ Reduced time to data delivery by 50%
@Parexel takes the #aipcon stage to showcase their Study Design Optimization Tool. -
Parexel reposted
Lalarukh Haris Shaikh
@lalarukhharis
Live at AIPCon today @PalantirTech . With @Parexel Jonathan Shough, CIO and Dan Ballard, SVP. "We were looking for a partner that actually produces shit”.
$PLTR
#clinicaltrials #ai #aipcon -
Parexel
@Parexel
In this podcast, Paul Bridges moderates a discussion with clinical experts Jaime Kistler, Kristina Reeder, and Balazs Felcsuti on the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Create success by planning for it.
-
Parexel
@Parexel
This week, Team Parexel attended the #veevasummiteu in Madrid! For three years, Parexel has partnered with @veevasystems to accelerate clinical trials through technology and process. Together we drive efficiency and make participation easier for customers, sites and patients.💪
-
Parexel
@Parexel
Ahead of the Parexel India Symposium, Parexel leaders visited local offices, the @THubHyd and met Shakthi Nagappan, Dir. of Life Sciences and Pharma for the Govt. of Telangana. Later, symposium attendees will hear from experts on advancing #clinicalresearch to put #patientsfirst.
-
Parexel
@Parexel
Parexel leaders recently attended the PCMG Assembly where @PeytonRHowell introduced the keynote speaker, Nomi Bar-Yaacov, who shared crucial skills for enhancing partner dialogues. Our team will attend the PCMG 30th Anniversary Gala Dinner tonight as proud event sponsors!
-
Parexel
@Parexel
That’s a wrap from #asco24! Thank you to everyone who stopped by our new booth and to those who joined us Saturday evening for our networking reception! Our team had an amazing time connecting with some of the best minds driving #oncology research forward in 2024. #patientsfirst
-
Parexel
@Parexel
Parexel is proud to be under consideration for the 2024 SCRS #eagleaward. We were proud to be selected by you - our site partners - last year and we kindly ask you and your colleagues to consider casting your vote for Parexel again in the SCRS survey. Thank you for your support!
-
Parexel
@Parexel
When you join our Data Management team, you're not just taking on a job – you're embracing a mission that matters. 💪 Alongside a collaborative team, you ensure our data remains patient-focused as we propel healthcare advancements forward. Learn more: jobs.parexel.com/en
-
Parexel
@Parexel
Check out this sneak peek of the exciting renovations at our Baltimore Early Phase Clinical Unit. 👀 We're counting down to our June 12 Open House, where we'll showcase updated spaces like the new rec room, designed for the comfort and relaxation of our study participants.
-
Parexel
@Parexel
Congratulations to Parexel's Chief Information Officer, Jonathan Shough, on being named a finalist for the 2024 Carolina ORBIE Awards, which honor CIOs who are driving innovation and transforming leading organizations in North and South Carolina. 👏 orbie.org/carolina/2024
-
Parexel
@Parexel
In this @statnews article, @stacy_hurt addresses the critical need for financial support in #clinicaltrials and the impact financial barriers have on #healthequity. Click for more on the barriers that often deter patients from enrolling or continuing with clinical trials:
STAT
@statnews
Everyone working in clinical trials must embrace this opportunity to re-evaluate and standardize reimbursement policies as a way to get more people to participate. www.statnews.com/2024/05/23/clinical-trials-participation…
-
Parexel
@Parexel
How do Clinical Operations Leaders (COLs) support clinical research and the development of new therapies? Elizabeth Edwards, SVP, Clinical Operations, explains the impact of COLs, how Parexel supports their professional growth and what makes Parexel's work culture unique.
-
Parexel
@Parexel
Parexel colleagues recently attended the @VetBridgeHome "Star Spangled Salute" Gala, which raised over $1 million to support and connect local Veterans, service members and their families. We are proud to help bridge the gap between healthcare and access for veterans.
-
Parexel
@Parexel
This week we reunited with 50 former colleagues at our most recent #parexelalumni gathering in Newton, Mass. We look forward to the opportunity to continue to expand our Alumni program through in-person events and our LinkedIn Community page.
-
Parexel
@Parexel
Colleagues in Durham, N.C. celebrated the retirement of former CEO Jamie Macdonald who led the company during a pivotal time in its growth. Succeeding Jamie as CEO is @PeytonRHowell, who joined other leaders and colleagues to celebrate Jamie’s contributions. Photos below! 📷
-
Parexel
@Parexel
We're thrilled that Chief Patient Officer @stacy_hurt has won the @PM360online Elite 100 Award for Patient Advocacy! Stacy drives our patient-focused thought leadership initiatives and actively shapes our approach to serving patients and care partners. Congratulations Stacy!
-
Parexel
@Parexel
At Parexel, we're passionate about building strong relationships with patient advocacy partners worldwide to support, empower and educate patients and care partners. This week in recognition of #ctd2024, we're shining a light on our corporate advocacy partner, @PCR_news.
Parexel
@Parexel
@PCR_News is committed to improving and saving the lives of patients with prostate cancer. Their core programs focus on funding and supporting research, educating patients and empowering underrepresented and marginalized groups to take part in cancer research.
Parexel
@Parexel
Check out the video below, part of a clinical trials toolkit created by @PCR_News with funding from Parexel. This toolkit aims to raise awareness in the U.K. of clinical trials as a treatment option. #prostatecancerresearch #clinicaltrials #ictday2024 www.youtube.com/watch?v=wGhNYeks_88
-
Parexel
@Parexel
In this edition of the New Medicines, Novel Insights newsletter, Parexel’s Ester Gil, Celina Gonzalez-Colaco, and Claire Browne share guidance for navigating EU Clinical Trial Regulation 536/2014 (EU-CTR). #novelinsights
-
Parexel reposted
Moderna
@moderna_tx
On #clinicaltrialsday, we're sharing a message from @stacy_hurt, a cancer survivor and mom to a child with a ultra-rare chromosomal disorder.
We extend our heartfelt gratitude to clinical trials organizations, the dedicated individuals working there, and participants worldwide. You help bring hope to patients, and it is because of you that we're able to evaluate new treatments, advance research, and deliver the greatest possible impact to human #health.
#ctd2024This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
This #ictday2024, Parexel CEO @PeytonRHowell attended the @Walgreens Clinical Trials Day Celebration, where @HBAnet CEO Mary Stutts discussed diversity in clinical trials and the critical need to make care more accessible to women and ethnic minority communities. #patientsfirst
-
Parexel
@Parexel
Today on International #clinicaltrialsday, we recognize the often-unsung heroes who work tirelessly behind the scenes to make a difference in the lives of patients worldwide. Look below to see how our colleagues keep patients at the heart of everything they do on their job.💜
-
Parexel
@Parexel
Congratulations to Karen Gimenez, Associate Project Director, and Caroline Parry, Vice President, Client Delivery, who medaled at yesterday's PharmaTimes International Clinical Researcher of the Year awards ceremony! This unique event honors clinical excellence in our industry.
-
Parexel
@Parexel
We are pleased to reveal our 2024 patient advocacy partners. #patientadvocacy Groups are vital in educating, advocating for and supporting patients and families. Nearing International #clinicaltrialsday we’re wholly dedicated to empowering patients and care partners. Learn more:
-
Parexel
@Parexel
At #ats2024, our respiratory experts will explore the evolving world of asthma, including:
· New and emerging technologies in respiratory studies including the use of artificial intelligence
· Diversity requirements in #clinicaltrials
@atscommunity -
Parexel reposted
World Vaccine Congress
@vaccinenation
In conversation with @Parexel's Dr Anne Kasmar at #wvcdc we heard about the importance of #sustainability #speed and #scale in #vaccine development and how Parexel tackles these challenges.
#vaccinenation #vaccines #parexel #sustainable #wvc
vaccinenation.org/technology/go-fast-and-far-together-say… -
Parexel
@Parexel
After 30 impactful years in the CRO industry, Jamie Macdonald officially retires today as CEO of Parexel. We express our deep gratitude for his outstanding leadership and dedication. His legacy will inspire us as we strive to make a difference for of patients around the world.
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
At Parexel, we're committed to supporting our team members in their personal and professional growth. Chrishni's story is a testament to our culture of empowering colleagues to work in the way that suits them best. Chrishni found her perfect #worklifebalance. Ready for your own?
-
Parexel
@Parexel
.@ASGCTherapy's Annual Meeting was buzzing with #cellandgenetherapy experts sharing research and innovations driving progress for patients through cell and gene therapies. Thanks to everyone who joined our sessions. The future of #cgt is bright. #asgct2024
-
Parexel
@Parexel
An expert in clinical operations, Hina Saleem embodies everything important at the foundation of the insights-generation engine that is our people.
As we embrace the future ahead, we reflect on our foundation of world-class experts driving progress and innovation as a team. -
Parexel
@Parexel
Parexel recently hosted leaders from biotech and large pharma for a tour of our updated London Early Phase Clinical Unit. Oliver Fuhrmann and Anita Sands explained the facilities' capabilities and Kirsty Wydenbach gave an insightful talk on navigating the UK regulatory landscape.
-
Parexel
@Parexel
How important is human intervention with artificial intelligence (AI)? Don't miss the final part of this video interview with @Clin_Trials where Stephen Pyke sheds light on the critical role of #humanoversight in leveraging AI for decision-making in healthcare.
#clinicalresearch -
Parexel
@Parexel
What an incredible time at #isporannual! With 20 abstracts showcased, Parexel’s experts shared groundbreaking research and outcomes shaping innovation, value, and healthcare decisions.
A big thanks to all who joined us!
#heor #rwe #ai -
Parexel
@Parexel
Mary is a Principal Medical Writer who helps create drug labeling documents that directly impact patient care. Her work requires strong writing skills, creativity and a deep commitment to improving global health and patient outcomes. Learn what excites her about #medicalwriting:
-
Parexel
@Parexel
In this edition of New Medicines, Novel Insights, our experts provide updates and guidance on the recent global alignment of the CDE on viral clearance and the likelihood of these validation methods being accepted among other agencies (EMA, FDA, ICH). #novelinsights
-
Parexel
@Parexel
Our team will be at #asgct2024 this week discussing methods for evaluating multiple endpoints simultaneously to comprehensively describe treatment effects and increase the power of detection with smaller sample sizes. @ASGCTherapy #cgt #celltherapy #genetherapy
-
Parexel
@Parexel
Chief Patient Officer Stacy Hurt is a stage IV colorectal cancer survivor and a full-time caregiver to her son with a nano-rare disease. Nearing International #clinicaltrialsday, Stacy shares why care partners' perspectives are invaluable in shaping clinical trials.
#ictday2024 -
Parexel
@Parexel
We had an incredible time at the @OrphanConf 2024! Our team was honored to contribute to the discussions around accelerating rare disease treatments.
We're grateful to have played a part in the conversation around #orphandrugs and #raredisease treatments.
#wodc24 #worldorphanusa -
Parexel
@Parexel
In this recording from our recent webinar, our clinical research experts provide an update on recent early-phase regulatory timelines, resulting in trial efficiencies and accelerated approvals for biopharmaceutical companies. #parexelbiotech #regulatory #earlyphase #biopharma
-
Parexel
@Parexel
In the lead up to International Clinical Trials Day on May 20, we're spotlighting stakeholders like patient advocate Michael Frierson. Advocacy voices like Michael's are key to shifting the research landscape and improving access to life-saving treatments. Watch below:
#ctd2024This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Novel gene therapies offer extraordinary hope to patients with advanced cancers and genetic diseases but pose unique challenges for sponsors. In an interview with World Pharma Today, Leslie Johnston shares strategies to bring these complex treatments to market more efficiently:
-
Parexel reposted
AI Magazine
@AIMagazine_BC
@PalantirTech and @Parexel are pushing the boundaries of #ai in #clinicaltrials. Their expanded partnership promises accelerated and safer trials, driving better patient outcomes.
Read more: aimagazine.com/ai-applications/parexel-and-palantir-power…
#healthtech -
Parexel
@Parexel
Team Parexel returned to The Ronald McDonald House (RMH) this week to cook for families whose children are receiving medical care at a nearby children's hospital. RMH's mission to provide for families and care partners reflects our commitment to always put #patientsfirst.🍝♥
-
Parexel
@Parexel
In Part 4 of Stephen Pyke's @Clin_Trials interview, he shares novel #ai solutions related to patient participation in clinical research, such as AI's ability to improve access and the way that we think about and use imaging to guide diagnosis.
-
Parexel
@Parexel
According to Sanjay Vyas, our people are the reason Parexel was named "Best CRO" at the #scripawards. Our patient-focused colleagues strive to understand their perspective, amplify their voices and design studies around their lived experiences. #withheart! #bestcro
-
Parexel
@Parexel
Peyton Howell recently visited our CTS&L European Distribution Center in Berlin for a tour of its environmentally friendly shipping solutions and automated storage units. The Berlin EUDC is reflective of the capabilities of our depots around the world. 🌍
-
Parexel
@Parexel
It's #worldimmunizationweek, and we're still elated from our "Best CRO" recognition at the 17th Annual Vaccine Industry Excellence (ViE) Awards! We are committed to doing everything #humanlypossible to advance research that supports saving lives from vaccine-preventable diseases.
-
Parexel
@Parexel
Parexel and @PalantirTech, a leading builder of Artificial Intelligence (AI) systems, today announced a multi-year strategic partnership to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers:
-
Parexel reposted
JPA Health
@JPAHealthComm
While many challenges exist, panelists at @Parexel, @US_FDA, @EveryLifeOrg, @RocketPharma, and NEWDIGS at the @TuftsMedicalCtr talked about the opportunity ahead where rare diseases offer a proving ground for gene therapies. #worldorphanusa
-
Parexel reposted
EveryLife Foundation
@EveryLifeOrg
Closing this morning's sessions at #worldorphanusa discussing "Challenge and Opportunity with the Current Regulatory and Legislative Landscape in the US." The EveryLife's VP of Policy Jamie Sullivan, was joined by Rachel Smith, Mark Trusheim, Kinnari Patel and Peter Marks.
-
Parexel
@Parexel
Last week, Parexel leaders and customers toured our updated Early Phase Clinical Unit in Berlin to learn about the role of EPCUs in clinical trials. In addition to the tour, attendees networked and heard from Parexel's Peyton Howell, Oliver Fuhrmann and Matthias Lenk. 📷
-
Parexel
@Parexel
In our latest New Medicines, Novel Insights newsletter, our experts discuss the challenges and dazzling possibilities applications based on AI have to advance novel medicine, improve development efficiencies and continually enhance patient outcomes.
-
Parexel
@Parexel
Our team is thrilled to be returning to #worldorphanusa! Head of Rare Disease Rachel Smith will lead an esteemed panel, including Peter Marks from the FDA, exploring the latest regulatory challenges and opportunities in accelerating #raredisease treatments for patients in need.
-
Parexel
@Parexel
As part of @Clin_Trials's deep dive into #ai's impact, Stephen Pyke examined why data sharing is critical for refining generative AI models like ChatGPT. Hear why “fine tuning” is needed to advance these applications and why collaboration is key to fulfilling the promise of AI:
-
Parexel
@Parexel
In this article, Ola Lubojemska and @LysandropoulosA offer valuable insights on differentiating new #neuroscience drugs in crowded markets and the anticipatory steps to take, ensuring optimal go-to-market outcomes. #marketaccess #regulatory #parexelbiotech
-
Parexel
@Parexel
Ukraine has faced significant challenges due to the war but Parexel has remained committed to supporting our clinical operations throughout the crisis. In @PharmaVoice, Deb Tatton and Aleksei Zhmuro share how the company has ensured research continuity and access to trials:
-
Parexel
@Parexel
What an incredible week at #aan2024!
@LysandropoulosA shared his insights on patient recruitment and retention and held a poster presentation on current neuroscience clinical research trends, highlighting the increasing acceptance of RWE to inform regulatory decision-making.
Parexel
@Parexel
If you’re interested in learning more, join @LysandropoulosA for a webinar examining development challenges in #alzheimer’s Disease and #multiplesclerosis and the shared lessons from each that can propel novel approaches to more effective trial outcomes. www.parexel.com/about-us/events/alzheimers-disease-vs-mul…
-
Parexel reposted
Applied Clinical Trials
@Clin_Trials
📹In the final part of this video interview with ACT editor Andy Studna, Stephen Pyke, chief clinical data and digital officer, @Parexel, highlights the importance of human oversight when using artificial intelligence to aid in decision making
www.appliedclinicaltrialsonline.com/view/the-role-of-huma… -
Parexel
@Parexel
In Part 2 of his @Clin_Trials interview, Stephen Pyke reveals areas where we might see major advancements in our industry due to #ai. Integrating AI could drive speed, quality and productivity in clinical research, leading to transformative impact on patient outcomes. Watch here:
-
Parexel
@Parexel
Join us to hear perspectives from top clinical research experts and disease area specialists on the similarities and differences in Alzheimer’s Disease (AD) and Multiple Sclerosis (MS) treatments. 🧠
-
Parexel
@Parexel
Parexel is looking for #regulatory Consultants! We're focused on advancing the future of healthcare while keeping the patient at the heart of everything we do. Help us bring forward therapies that could change patient lives. Apply today:
#clinicalresearch #cro #clinicaltrials -
Parexel reposted
Parexel
@Parexel
@CPHI_Events 2024 Pharma Outsourcing Forecast reveals insights on outsourcing and how sponsor, CRO and vendor partnerships impact supply chain efficiency. Our #fsp experts Neil Berger and Kerri McCaul-Claus discuss collaboration through shared-risk outsourcing partnership models.
-
Parexel
@Parexel
@CPHI_Events 2024 Pharma Outsourcing Forecast reveals insights on outsourcing and how sponsor, CRO and vendor partnerships impact supply chain efficiency. Our #fsp experts Neil Berger and Kerri McCaul-Claus discuss collaboration through shared-risk outsourcing partnership models.
-
Parexel
@Parexel
In Part 1 of this series, Stephen Pyke joins @Clin_Trials to discuss the impact of #ai on clinical trials. In 2021 a shocking 132 submissions to the FDA included some aspect of AI, yet Stephen cautions there's still a long road ahead for widespread adoption. Learn why:
-
Parexel
@Parexel
Following our recognition as the "Best CRO" from @Scrip we asked our colleagues' opinion on why we won. To Dr. Amy McKee, the award symbolizes our #patientsfirst focus and our commitment to always bringing patient and care partner perspectives to the table.
-
Parexel
@Parexel
Meet Vivek, Senior Manager, Statistical Programming, who leads a local team of more than 18 programmers. Learn where he finds joy in his work ─ from continuous learning opportunities to the collaborative environment ─ and check out photos from recent events at Parexel Mumbai.
-
Parexel
@Parexel
"No matter how innovative the science, no matter how well designed the study — if payers won’t agree to reimburse the cost of a therapy, patients will never benefit from it."
In our latest New Medicines, #novelinsights newsletter, we share why patient insights are essential. -
Parexel
@Parexel
This year's #worldhealthday theme champions everyone's right to healthcare, yet many patients are underrepresented in clinical research. This research paper by @DukeMargolis, partly informed by Parexel's experts, explores how RWD/E can address such healthcare disparities.
-
Parexel
@Parexel
Members of Parexel’s Statistical Programming group analyze clinical data from a variety of therapeutic areas while working closely with sponsors and internal teams ─ and in an environment that fosters growth! Sound like you? Help us bring treatments to patients faster:
-
Parexel
@Parexel
Parexel's David Barrett breaks down the shortcomings of typical RWD in clinical research and offers a new study protocol leveraging secure tokenization to better link patient characteristics with RWD.
-
Parexel
@Parexel
We are thrilled to share that Parexel has been named "Best Contract Research Organization" at the #vieawards! This accolade is a tremendous honor and reflects our team’s dedication to advancing the development of safe and effective vaccines. Click through the photos below!
#wvcdc -
Parexel
@Parexel
The #worldvaccinecongress is underway!
📸 Today, Beth Marshall, Adriana Suenaga, Rohan J. Vilms, and Jonathan Shepard hosted an interactive roundtable on sustainable speed in vaccine development.
🗓️ Don’t miss Anne Kasmar’s presentation at 12:40 p.m. tomorrow!
#wvcdc -
Parexel
@Parexel
Meet Anthony, a veteran Medical Writer of over 17 years ─ although that wasn't his original plan! Find out why this Pittsburgh native, waterfall chaser and sports memorabilia collector has excelled at Parexel and how he keeps patients at the heart of his work.
-
Parexel
@Parexel
Thanks to everyone who stopped by our booth at #patientsaspartners2024 to discuss patients’ experiences in clinical trials and attended sessions with our Chief Patient Officer @stacy_hurt and our Global Head of Patient Inclusion Xoli Belgrave.
-
Parexel
@Parexel
On #transdayofvisibility we celebrate the lives and contributions of trans individuals. Parexel reaffirms our commitment to amplify trans voices and collaborate to ensure a healthcare system where every trans person receives the treatment, care and support they deserve. #tdov2024
Human Rights Campaign Rapid Response
@HRC
No matter what, we will keep showing up and living our best lives as our full, authentic selves. This #transdayofvisability and every day, we will:
🩵 celebrate trans joy
🤍 advocate for trans rights
🩷 uplift trans visibility
Join us: transvisibility.day 🏳️⚧️ -
Parexel
@Parexel
Curious about a career at Parexel and the mission that fuels our work? Dive into our Careers Blog to learn why our colleagues chose Parexel and work #withheart — from professional development opportunities and benefits like our inclusive culture and patient focus. Explore here:
-
Parexel
@Parexel
In the latest article from our neurosciences blog series, Chris Learn discusses the potential of gene therapies in addressing aging-related diseases like dementia and Alzheimer's, highlighting the need for increased inclusion of older patients in clinical trials. #genetherapies
-
Parexel
@Parexel
A recent study conducted by the Tufts Center for the Study of Drug Development and sponsored by Parexel shed light on differences in clinical trial recruitment efforts and barriers to participants based on socioeconomic status. Click through below to learn the 3 key insights:
-
Parexel
@Parexel
The #vaccine industry is converging in Washington, DC for #worldvaccinecongress! Parexel experts will be on-site, sharing the latest innovations in vaccines and infectious disease intervention. Stay tuned for insights shared after the event! Click to schedule a meeting. #wvcdc
-
Parexel
@Parexel
Associate Project Director Jessica helps guide drug developers' clinical trials through the regulatory landscape, ensuring patient access to new, approved treatments. Learn about her role and the impact you can make by joining the team: jobs.parexel.com/en/jessica-testimonial-regulatory
-
Parexel
@Parexel
Hear from Parexel experts at the @ASCPT_ClinPharm 2024 Annual Meeting!
Don’t miss our session "Unlocking Clinical Trial Success," where Angela Qu and Ana Novakovic will share insights and case studies about optimizing study efficacy through data-driven decision-making.#ascpt2024 -
Parexel
@Parexel
Diversity is critical in assessing drug outcomes in clinical studies. In our latest neurosciences blog, Karina D’Angelo sheds light on innovative real-world data strategies, including social determinants of health, improving diversity, participation, and access.
-
Parexel
@Parexel
According to a survey from @ACROhealth and @ResearchAmerica, a majority of Americans (87%) agree that clinical trials should be part of the standard of care, yet fewer than 10% participate. Lack of trust was cited as a top reason. What do you think? Take our poll on LinkedIn.
-
Parexel
@Parexel
In partnership with @NMFonline, Parexel Academy is excited to announce the second 2024 cohort for the Diversity in Clinical Trials Research (Dctr) program! This program aims to bridge gaps in the healthcare industry and elevate diverse perspectives in clinical research.
-
Parexel
@Parexel
Join us this week at the #patientsaspartners2024 conference as we explore the latest patient advocacy and involvement strategies driving efficiencies and inclusion in clinical research!
We’re thrilled to have @stacy_hurt participating as Co-Chair and Xoli Belgrave as a speaker. -
Parexel
@Parexel
Today, Parexel announced that Jamie Macdonald will retire and transition his role as Chief Executive Officer (CEO) to the company’s Chief Operating and Growth Officer @PeytonRHowell effective May 15, 2024. Mr. Macdonald will continue on the Board through Dec. 31, 2024.
-
Parexel
@Parexel
At Parexel, we’re all about finding the right fit and our transparent, step-by-step hiring process is designed to ensure a seamless experience. Click below to learn what you can expect as a candidate, from preparing your application to receiving an offer. Ready to join the team?
-
Parexel
@Parexel
🎉 We’re thrilled to announce that Parexel has 10 colleagues who are finalists for the @PharmaTimes Clinical Researcher of the Year – International competition! These individuals are driving the clinical research industry forward. We'll be cheering them on at the ceremony in May!
-
Parexel
@Parexel
📢 Last year marked a significant turning point in the treatment of Alzheimer's disease, with groundbreaking developments and several notable approvals.
Read the latest article from our neurosciences blog series to learn more: www.parexel.com/insights/blog/opportunities-and-strategie…
#alzheimers #parexelbiotech -
Parexel
@Parexel
At next week's workshop hosted by @DukeMargolis in collaboration with the FDA, Amy McKee will share her perspective as a former FDA regulator on opportunities to adopt innovative clinical trial approaches while adhering to GCP guidelines and other compliance requirements.
-
Parexel
@Parexel
🚧 Renovations of our Early Phase Clinical Unit in Baltimore are moving right along! The ongoing renovations are transforming our space and creating a more modern facility to meet the needs not only of participants, but also on-site professionals.
-
Parexel
@Parexel
Parexel’s Site Alliance Team held their quarterly Site Pulse meeting with over 100 investigative sites from the U.S., U.K. and Europe. We heard that communication and process improvement can effectively manage most sites' challenges. We look forward to collaborating further!
-
Parexel
@Parexel
What does the FDA’s final industry guidance on CAR-T mean for your development program? In our new Regulatory Navigator series, Steve Winitsky, Christiane Niederlaender and Rajiv Gangurde, Ph.D. share their insights into the clinical, non-clinical and CMC recommendations.
-
Parexel
@Parexel
When you work in Regulatory Affairs at Parexel, you help advance life-changing therapies and medicines for patients worldwide by developing creative regulatory strategies that provide an efficient path to market. Explore opportunities and learn more from one of our colleagues:
-
Parexel
@Parexel
After an investigation into safety concerns, the FDA is requiring the six marketed CAR-T therapies to add a boxed warning to their labels. Parexel's Mwango Kashoki and Steve Winitsky join @FiercePharma to weigh in on the decision and the implications for the future. Listen in:
-
Parexel
@Parexel
We are delighted to share that Parexel was honored at the @herkey_ #divhersityawards for the fifth consecutive year! 🎉🙌This continued recognition is a testament to our commitment to growing representation of women in senior leadership. Explore opportunities in India here:
-
Parexel
@Parexel
We are thrilled to share that Parexel has been named a finalist for "Best CRO" at the Vaccine Industry Excellence Awards! We are dedicated to tackling complex trials by integrating the scientific, medical and regulatory knowledge of our cross-functional team. Fingers crossed!🤞
-
Parexel
@Parexel
Don't miss Stephen Pyke at @DrugInfoAssn Medical Affairs & Scientific Communications forum in Orlando, Fla. this week!
Session 4 on Thursday, March 7 at 8:50 a.m. will discuss the responsible and ethical use of #ai in life sciences R&D.
#dia #masc24 #medaffairs -
Parexel
@Parexel
More than 800 Parexel colleagues worldwide supported #rarediseaseday by joining the @Syngap1Germany Rare Diseases Run! Participants walked, ran, rolled and cycled to raise awareness and funds for nonprofit organizations dedicated to rare disease research and patient support.
-
Parexel
@Parexel
When it comes to rare disease drug development, moving the needle for patients requires creative thinking and customized approaches - and your expertise could contribute to a new wave of therapies. Learn more about our work in rare disease clinical trials and how you can join us:
-
Parexel
@Parexel
In the 4th edition of our neurosciences blog series, former regulator, Simona Stankeviciute, M.D., shares best practices and creative approaches to assist biotech companies in developing effective trial design strategies and planning for successful regulatory submissions.
-
Parexel
@Parexel
Our Black Employees Advisory Consortium's (BEACON) activities for Black History Month included a discussion about "Black Man in a White Coat: A Doctor's Reflections on Race and Medicine," a memoir by Dr. Damon Tweedy.
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
It has been an incredible #rarediseaseday celebrating Emmett’s life and his amazing accomplishments as well as raising awareness of the need for #clinicalresearch to support #raredisease. Thank you @Parexel for the work you do further hope and treatments for our community 🦓❤️
-
Parexel
@Parexel
Our #rarediseaseday activities culminated in a virtual event featuring Chief Patient Officer @stacy_hurt, who shared her powerful personal experience as a care partner to her teenage son with a nano-rare disease. 💪💞
-
Parexel
@Parexel
New technologies offer greater opportunities and efficiencies at study sites, but they can also bring their fair share of headaches. Parexel VP of Global Site Alliances offers solutions for minimizing the growing technological burden, allowing sites to prioritize patient care.
-
Parexel
@Parexel
In our LinkedIn poll, half of respondents identified "reaching patients where they live" as the strategy that would be most impactful on more inclusive clinical trials. Parexel's Xoli Belgrave shared her own insights on more inclusive protocols in this interview with Scrip:
-
Parexel
@Parexel
Last week, our Rare Disease Patient Advisory Council met and explored the potential benefits, challenges and concerns of using AI in #raredisease healthcare and clinical trial research. Huge thanks to our patients and advocates whose insights help us shape patient-focused trials!
-
Parexel
@Parexel
Join a global community that empowers you to be your best self, transforms careers and prioritizes your well-being. With a comprehensive benefits portfolio, we support you at every stage of life and career, no matter where you are. 💼🌍
-
Parexel
@Parexel
In the third edition of our neurosciences blog series, Biostatics expert, Martin Roessner highlights the need for sensitivity in #alzheimers trial design, considering the diminishing ability of patients to communicate as the disease progresses.
Read more: www.parexel.com/insights/blog/building-a-program-for-pati… -
Parexel
@Parexel
Stephen Pyke will be speaking at AIRIS, in Seoul next week. His presentation is on #explainability and safe use of #llms in clinical development.
This event aims to review and promote the responsible use of #ai in medical product development.
Learn more: www.parexel.com/about-us/events/airis -
Parexel
@Parexel
In this article, Kristen Paskins shares her journey towards a diagnosis of a rare disease called Functional Neurological Disorder (FND). Her story exemplifies the power of self-advocacy, the importance of support networks and the strength found in embracing a new sense of self.
-
Parexel
@Parexel
Our report, based on recent #fdainsights, offers critical insights into marked shifts in the pursuit and grant of #highorderdesignations. Discover what these changes mean for #drugdevelopment and gain a deeper understanding.
Read the full report here: www.parexel.com/application/files/resources/assets/Breakt… -
Parexel
@Parexel
In 2023 The WSJ published an article highlighting the substantial pricing differences for generic drugs despite expectations of affordability and examined the impact of pharmacy benefit managers on pricing. Parexel's Wyatt Gotbetter and Brian Duda joined @DrugInfoAssn to discuss:
-
Parexel
@Parexel
Exciting changes in the industry for #biotech drug development! In this article featured in @Endpts, Goldman Sachs and Parexel share perspectives on hot topics such as #ai, the impact of the Inflation Reduction Act and more.
Learn more: endpts.com/sp/near-term-strategies-for-biotech-drug-devel…
#clinicaltrials -
Parexel
@Parexel
Marije began at Parexel as a CRA I and now leads the Dutch CRA and iCRA groups as a Clinical Operations Manager. Her story highlights a dedication to personal growth and illuminates a culture at Parexel that fosters and celebrates the contributions of each team member.
-
Parexel
@Parexel
We'll be in San Antonio this week for #tandem24
On Feb. 22 at 10:00 a.m., don't miss Parexel's Izaskun Elorza, who will share insights on the innovative approaches revolutionizing CAR T-cell therapies for patients.
Read more or schedule a meeting: www.parexel.com/about-us/events/tandem-meetings-transplan… -
Parexel
@Parexel
At Parexel, we are committed to driving inclusion through diversity strategies for clinical trials, growing DE&I programs for our colleagues and strengthening relationships with diverse suppliers. We're not just talking about change, we're living it. Learn how you can join us:
-
Parexel
@Parexel
The pace of trial recruitment for Alzheimer's disease is lagging behind scientific advancements, especially in early-phase clinical trials. In a new blog, experts Lydia Morris & Jakki James explain the importance of listening to and engaging with prospective trial participants.
-
Parexel
@Parexel
How can sponsors recruit and retain patients more effectively in clinical trials of rare neurological conditions? Our Global Head of Rare Disease explains. #rarediseaseday
www.parexel.com/insights/blog/how-sponsors-can-make-it-ea… -
Parexel
@Parexel
When it comes to technology, how can sponsors and CROs be better partners to their sites? Parexel VP of Global Site Alliances, Karen McIntyre, reviews site feedback and offers solutions to minimize the growing technological burden, allowing the prioritization of patient care.
-
Parexel reposted
Applied Clinical Trials
@Clin_Trials
Peyton Howell, Chief Operating and Growth Officer, @Parexel, shares important insights from the most recent @jpmorgan Healthcare Conference and addresses where the #clinicaltrials industry currently is with innovation 💬🗨️
www.appliedclinicaltrialsonline.com/view/the-healthcare-s…
#jpm2024 -
Parexel
@Parexel
For this week's spotlight on rare diseases, we're introducing Bernadette Haberman, a Parexel colleague and mother of children diagnosed with rare diseases. Read Bernie's powerful story and how she is ensuring her son Luke's legacy.💞
#rarediseaseday #rarediseaseawareness -
Parexel
@Parexel
Join our feasibility and RWD experts at #scopesummit for a presentation with @PurpleLabInc on strategies for ensuring the inclusion of diverse patient populations to meet FDA expectations and using innovative ways to link healthcare data with deidentified SDOH attributes.
-
Parexel
@Parexel
As a Site Care Partner, Adrian showcases the dedication and innovation that fuels our organization. We're looking for more Site Care Partners around the globe to join our Functional Service Provider (FSP) team. Learn more about Adrian, his projects and how you can join him!
-
Parexel
@Parexel
We're committed to increasing representation of women in senior leadership and closing the gap in STEM fields. This International Day of Women and Girls in Science, Amy McKee, M.D. shares what inspired her to pursue a career in science and her advice for other young women.
-
Parexel
@Parexel
As part of a new blog series covering challenges and opportunities in developing treatments for #alzheimer’s and #dementia, our Global Head of Neuroscience outlines a series of best practices for integrating the patient’s voice throughout drug development. #patientsfirst
-
Parexel
@Parexel
Parexel is nominated for Best CRO at the Vaccine Industry Excellence Awards! We've tackled complex vaccine trials by integrating scientific, medical and regulatory knowledge to help prevent and treat COVID-19, influenza, RSV and more. Click to cast your vote for Parexel!
-
Parexel
@Parexel
The Super Bowl isn’t the only thing kicking off on Sunday! #scopesummit is also getting underway, and we have an all-star line-up gearing up to explore the top innovations impacting clinical trials and digital health. Click for details or to request a meeting.
-
Parexel
@Parexel
The FDA emphasizes the importance of establishing diversity plans to ensure #diversetrials and treatments that are equally safe and effective across all populations. Xoli Belgrave joins @CancerResrch to discuss strategies for implementing diversity plans in clinical trials:
-
Parexel
@Parexel
To raise awareness for #rarediseases, we're sharing an article from academic clinician Claire Booth on some of the lessons she’s learned from working on the front lines at one of Europe’s largest and most experienced gene therapy research sites. insights.parexel.com/rare-disease-clinical-development/p/5
-
Parexel
@Parexel
Chief Operating and Growth Officer @PeytonRHowell spoke to @Clin_Trials about her panel at the #jpmorganhealth conference on the potential of tech like AI and machine learning as well as the increasing importance of the patient voice in clinical trial design. #patientsfirst
-
Parexel
@Parexel
Parexel's Oncology Center of Excellence has the expertise in medical, genomics and biostatistics along with key technologies and a multidisciplinary team to support your research across all development phases. Together we can create a world with no cancer. 💪 #worldcancerday
-
Parexel
@Parexel
Meet Dennis Childers, he is one of our exceptional Senior Clinical Operations Leaders who works on studies for pediatric rare diseases. We're looking for more people who share Dennis' empathy and commitment to transforming the lives of patients. Join us: jobs.parexel.com/en/search-jobs/Senior Clinical Operation…
-
Parexel reposted
Applied Clinical Trials
@Clin_Trials
Peyton Howell, Chief Operating and Growth Officer, @Parexel, shares important insights from the most recent @jpmorgan Healthcare Conference and addresses where the #clinicaltrials industry currently is with innovation 💬🗨️
www.appliedclinicaltrialsonline.com/view/the-healthcare-s…
#jpm2024 -
Parexel
@Parexel
Visit booth 51 at #octwest, Feb. 6-7. Kristina Reeder will share insights on how biopharma leaders are strategically utilizing patient feedback to improve trial outcomes and ultimately enhance patient experiences. #patientsfirst
-
Parexel
@Parexel
This month we are raising awareness for rare diseases that affect over 300 million people worldwide. Today we want to spotlight Austin Leclaire, who is living with Duchenne Muscular Dystrophy (DMD). Click to read his story. #rarewithheart
-
Parexel
@Parexel
This #blackhistorymonth, Parexel's Black Employees Advisory Consortium will host a discussion on "Black Man in a White Coat: A Doctor's Reflections on Race and Medicine" by Dr. Tweedy. Have you read it? Let us know what you thought!
-
Parexel
@Parexel
Parexel has announced the appointment of Susan R. Salka, retired Chief Executive Officer and President of AMN Healthcare Services, Inc., to its Board of Directors. Ms. Salka brings more than 30 years of healthcare leadership experience to Parexel. t.ly/qjFRQ
-
Parexel
@Parexel
Is your company up to date on the latest CTIS transparency rules? In this edition of “New Medicines, Novel Insights,” we review the impact of recent regulatory changes in the EU and how sponsors are adjusting their redaction approach to keep up. #novelinsights
-
Parexel
@Parexel
At Parexel, collaboration, innovation and teamwork are fundamental to the way we work. When you choose Parexel, you are choosing to make a difference for patients everywhere. Join us: jobs.parexel.com/en
-
Parexel
@Parexel
Parexel's sales and leadership teams connected last week for our annual Global Leadership and Sales Summit (GL&SS) to reflect on our achievements, realign on key priorities and begin the new year with renewed dedication to working With Heart™️ for patients everywhere!
-
Parexel
@Parexel
📣 Upcoming webinar📣
In this webinar, experts in clinical development and #rbqm will discuss how to evaluate study protocols, minimize risks and leverage valuable insights from study data.
Click below for details. Don’t miss it! 🎯
www.parexel.com/about-us/events/managing-complexity-cell-… -
Parexel
@Parexel
Congratulations to this year's recipients of the Sales and With Heart™ awards at Parexel's GL&SS, which recognize colleagues who’ve made outstanding contributions to our organization. Their passion and commitment help us deliver for patients and customers! #proudtobeparexel
-
Parexel
@Parexel
It's time for our annual Global Leadership and Sales Summit (GL&SS)! Parexel leaders from around the globe will gather this week to collaborate, celebrate our team's latest achievements and hear inspiring patient stories that reinforce why we do what we do. Stay tuned!
-
Parexel
@Parexel
📚 Are you a talented writer with a passion for science and healthcare?🔬 As a Medical Writer for Parexel, you'll work on the forefront of scientific breakthroughs that will impact patients around the globe. Start your rewarding career today. Learn more: jobs.parexel.com/en
-
Parexel
@Parexel
Our experts collaborate to expedite innovative treatments to patients like Robyn. By leveraging the right indications, identifying optimal trial sites, and adhering to global regulations, we ensure safe and swift market access for your treatment. Learn more:
#patientsfirst -
Parexel
@Parexel
It's time for another Parexel office spotlight! Our Guangzhou office offers stunning views of the city and Pearl River. This office was designed to promote work-life balance with comfortable breakout areas, collaborative spaces and amenities. 🏙️
#locationspotlight #lifeatparexel -
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Finally, an actual patient in the #healthcare C-Suite 👏💥@Parexel
Thank you to my family, friends, colleagues, fellow #patients/caregivers/advocates, etc who have contributed to & supported me in this success. I share my immense joy of this epic moment with you❤️ #dreamjob -
Parexel
@Parexel
Our colleagues in India recently gathered for the inaugural Parexel India Conclave across Parexel's Hyderabad, Bengaluru and Mohali offices, where 50+ employees engaged in panel discussions and showcased posters on topics like healthcare technology, regulatory affairs and more.💡
-
Parexel
@Parexel
Today in the U.S., we honor the life and legacy of Dr. Martin Luther King, Jr, whose work focused on social justice and equality. Parexel is committed to closing the health equity gap in clinical research and is equally committed to developing and nurturing our diverse talent.
Parexel
@Parexel
Parexel's Black Employees Advisory Consortium (BEACON) was formed to influence recruitment, development and retention of Black employees at Parexel. BEACON also engages with employees, leaders, allies and stakeholders to support inclusion of Black patients in clinical research.
Post not available here, view on X
Parexel
@Parexel
🚀 Launching a mentorship program.
💼 Attending and supporting @BWICR20, Catalyst Award and other DE&I conferences.
💕Volunteering with local non-profits like @NoteinthePocket and the @LLSusa.
Parexel
@Parexel
Today, as we commemorate the remarkable legacy of Dr. Martin Luther King, Jr., we reaffirm our commitment to diversity, inclusivity and social justice in both our organization and the world of clinical research.
-
Parexel
@Parexel
During our panel discussion "Decoding Healthcare’s Future" Parexel CEO Jamie Macdonald and Chief Medical Officer Amy McKee shared insights on innovations shaping the healthcare landscape.
Stay tuned for more insights from our conversations with #biotech leaders!
#patientsfirst -
Parexel
@Parexel
Parexel partnered this week with the Ronald McDonald House (RMH) to provide a home-cooked meal for families whose children are receiving medical care far from home. RMH's commitment to supporting families and caregivers is close to our heart. #parexelwithheart #patientsfirst
-
Parexel
@Parexel
Our Baltimore Early Phase Clinical Unit has undergone a recent renovation to enhance and improve the clinical trial experience. Refreshing our facilities with the latest technology and amenities is part of our commitment to keeping patients at the heart of what we do.
-
Parexel
@Parexel
Parexel Biotech joined dynamic conversations in San Francisco this week with global healthcare leaders.
Thank you for joining our panel discussion "Decoding Healthcare's Future: Investment, Clinical Research, and Regulatory Dynamics."
#parexelbiotech #biotech #clinicalresearch -
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
My word is: Authentic ✊
✅ Authentic about putting #patientsfirst
✅ Authentic in our partnerships with patients, sponsors, investigators, vendors
✅ Authentic in our internal communication with colleagues across our organization
Parexel
@Parexel
📣Calling all Parexel colleagues! If you could describe our culture in one word, what would it be?
We asked members of Team Parexel the same question, check out what your colleagues had to say and leave your word in the comments below! 💫
#parexelwithheart -
Parexel
@Parexel
📣Calling all Parexel colleagues! If you could describe our culture in one word, what would it be?
We asked members of Team Parexel the same question, check out what your colleagues had to say and leave your word in the comments below! 💫
#parexelwithheart -
Parexel
@Parexel
Parexel and the Japanese Foundation for Cancer Research (JFCR) announced an alliance to expedite access to oncology trials in Japan. JFCR will join Parexel's Global Site Alliance network and Parexel will utilize JFCR's expertise for streamlined clinical development in Japan:
-
Parexel
@Parexel
In this @CHI_Healthtech article, Parexel leaders Stephen Pyke and Xoli Belgrave shared their predictions for clinical trials in 2024, including AI-drafted protocols and industrywide DEI initiatives that place a greater emphasis on diversity and inclusion.
-
Parexel reposted
ACRO
@ACROhealth
Recruiting and retaining patients has a tremendous effect on how a #clinicaltrial moves forward, and financial burdens can limit patient availability. Watch experts talk with @Parexel about how to improve patient engagement and experience. www.parexel.com/insights/webinar/advancing-health-equity-…
-
Parexel
@Parexel
How do you include a patient-first approach to ensure equitable access? Jim Anthony joins @SeemaJJIC from Cure to discuss and Wyatt Gotbetter chats with @AmiMacMD from @genentech about the impact of US market dynamics on early access to new therapies! #biotechshowcase
-
Parexel
@Parexel
Happy New Year! It’s been an unforgettable year with customers, sites and patient advocacy groups. We’re grateful to work alongside you and look forward to another year of clinical research innovation for better patient outcomes. 🤍💜💚
#parexelwithheart #patientsfirst -
Parexel
@Parexel
Are you a #regulatoryconsulting professional looking for a new challenge?
Jo Wang, who came from a background at the U.S. FDA, describes how she was drawn to Parexel because of the opportunity to work on diverse and complex projects.
#clinicalresearch #recruitingwithheart -
Parexel
@Parexel
Join us at the Longwood Healthcare Leaders San Francisco CEO conference, where Jim Anthony, President and Global Head, Parexel Biotech, will lead a panel of biopharma leaders on the innovations expected to accelerate drug development in 2024.
-
Parexel
@Parexel
#datamanagement plays a crucial role in ensuring the accuracy, integrity and reliability of clinical trial data. As part of our Data Management team, you'll support #clinicalresearch, regulatory compliance and patient safety. And there's plenty of scope for career progression!
-
Parexel
@Parexel
🎙️ Stacy Charlerie recently joined the #healthcarerethink Podcast to share her journey from pharmacy to the world of tech and clinical data. Tune in to discover how Parexel is pioneering innovative strategies to transform the clinical research industry! @Fin_Thrive
-
Parexel
@Parexel
.@ACROhealth has announced the release of its “Principles for Responsible AI.” Parexel's Stephen Pyke, Chair of the ACRO AI/ML Committee, helped develop 10 recommendations that organizations can consider as they develop and use AI technologies.
-
Parexel
@Parexel
In a recent poll, we asked about best practices for developing clinical outcome assessments (COAs). COAs allow sponsors to measure patient experiences and perceptions that have not been measured by traditional clinical research endpoints. And that's truly a patient-led approach.
-
Parexel
@Parexel
Over the course of Jamie Pierson's 12-year career with Parexel, her expertise in cell and gene therapy has grown tremendously and is currently a Sr. Project Leader in this space. Hear from Jamie on how Parexel's culture leads to opportunities for growth and development. 👇
-
Parexel
@Parexel
Parexel, in client partnership with @MAPSmedaffairs, shares guidance for planning and developing concise summaries of published medical research as well as compliance and copyright considerations for both authors and sponsors.
-
Parexel
@Parexel
When patients participate in clinical research, they contribute to reducing the impact on the local healthcare system by enabling early interventions that can help slow disease progression and reduce the demand on healthcare providers.
-
Parexel
@Parexel
It's the time of year to reflect on the contributions of our amazing colleagues. We take every chance to celebrate each other's hard work through our internal recognition program, "Bravo!"
Liliana, a senior clinical research associate (CRA), describes "Bravo!" as a virtual hug. -
Parexel
@Parexel
🔑 Help us unlock the power of #data as a #statisticalprogrammer! 💥
In this role, you'll collaborate with experts, access cutting-edge technologies and contribute to ground-breaking research that improves patient outcomes worldwide.
#clinicalresearch #recruitingwithheart -
Parexel
@Parexel
In this podcast, Parexel's Rosamund Round is joined by @LUNGevity's Elizabeth Barksdale and @advarra's Luke Gelinas to advocate for a new industry framework that will positively impact many patients’ ability to join and remain in a clinical trial while improving health equity.
-
Parexel
@Parexel
Today @ACROhealth announced Peyton Howell, Chief Operating & Growth Officer, has been elected Chair of the ACRO Board of Directors for 2024. Mike Crowley, Chief Administrative Officer & General Counsel, has been elected Secretary of the association. Read the full release:
-
Parexel
@Parexel
📅 In this issue of the "New Medicines, Novel Insights" newsletter, our experts share four important strategies for a smooth EU-CTR transition. Get insights into average approval times, potential challenges and recommendations for sponsors. #novelinsights
-
Parexel
@Parexel
"Many companies claim that it's important to put patients first. At Parexel it’s an ongoing topic ingrained in everybody's work."
Doreen discusses the #patientsfirst value at Parexel and how she contributes to it ─ from improving patient materials to developing diversity plans. -
Parexel
@Parexel
Regulatory approval without a strategy for reimbursement can result in unrealized revenue and, most importantly, patients left untreated. Our market access strategy experts share early practical strategies to succeed in a rapidly-changing environment. #novelinsights
-
Parexel
@Parexel
#talentspotlight Meet Amelia, Senior Manager, Medical Writing Services!
As a medical writer, Amelia and her team deliver unique expertise to provide end-to-end communications services needed throughout each stage of research and drug development.
#recruitingwithheart -
Parexel
@Parexel
.@PeytonRHowell & @sabo_aida welcomed @J_McCollum1, CEO of @LinkageInc & author of “In Her Own Voice: A Woman’s Rise to CEO," to a virtual book talk hosted by Parexel. Jennifer discussed common hurdles for women in professional advancement and shared actionable strategies.
-
Parexel
@Parexel
Successful leadership demands a blend of strategic thinking, emotional intelligence and the courage to take calculated risks.
Tune in Dec. 11 for @MeSanjayvyas's perspectives on the leadership skills and vision it takes to grow and nurture a team of more than 6,000! @amity_aitd -
Parexel
@Parexel
Thank you and Happy Holidays to the sponsors, investigative sites, advocacy partners and others who work tirelessly with us every day to make a difference for patients. To honor each patient's unique journey, Parexel is donating this holiday season to @GGIgreatergift.
-
Parexel
@Parexel
Parexel colleagues are #positivelypurple in support #internationaldayofpeoplewithdisabilities! Today is an opportunity to raise awareness about the challenges faced by individuals with apparent and non-apparent disabilities, encourage action and drive social change.@MyPurpleSpace
-
Parexel
@Parexel
Anne Kasmar MD, SVP, Global TA Head, Infectious Disease & Vaccines, reflects on the early days of the AIDS epidemic, Parexel's contributions and our continued commitment to bringing an end to HIV.
#worldaidsday -
Parexel
@Parexel
In this @Xtalks webinar, Parexel experts will join @Regeneron's Amy Froment to unpack the complexities of global feasibility. They’ll share strategies and best practices for protocol optimization, geostrategy and site selection that strike the balance between priorities and risk.
-
Parexel
@Parexel
Christina DiRenzo, a Clinical Operations Manager, leads a team of talented Clinical Operations Leaders who manage cutting-edge trials for biotech customers. Hear more from Christina on her role and the leadership qualities that define working "With Heart™." #recruitingwithheart
-
Parexel
@Parexel
Parexel recently partnered with the @TuftsCSDD to conduct in-depth interviews with investigative sites on the current challenges they are facing, potential solutions and success measures for productive sponsor-CRO-site relationships.
-
Parexel
@Parexel
We’re proud to announce that for the fourth consecutive year, Parexel has been recognized as a 'Bronze' employer in the India Workplace Equality Index! We’re proud of our company culture and value the diversity of our colleagues around the world. 🌏
#parexelwithpride #iwei2023 -
Parexel
@Parexel
Our latest "New Medicines, #novelinsights" newsletter highlights the importance of involving patients and caregivers to better understand unmet medical needs and how COAs play a significant role in measuring patient experiences that traditional research endpoints may miss.
-
Parexel reposted
Applied Clinical Trials
@Clin_Trials
COMING UP 🔜
🔴Clinical Research Sites Have Spoken: How Can Sponsors and CROs Improve the Site Experience?🔴
Mon, Dec 4, 2023 11:00 AM EST with @Parexel
➡️globalmeet.webcasts.com/starthere.jsp?ei=1642836&tp_key=d… -
Parexel
@Parexel
Don't miss our team next week at #cte2023! Neil Berger will speak on optimal outsourcing models for enabling agile clinical development plans.
Holger Liebig and Robert Jacob from @BayerPharma will share their perspectives for building a successful alliance management framework. -
Parexel reposted
Xtalks Webinars
@Xtalks
In this webinar w/ @Parexel, delve into the intricacies of global feasibility and unlock valuable insights into strategies for seamless study start-ups. They will guide you through the complexities of protocol optimization, geostrategy, and site selection: xtalks.com/webinars/easing-the-challenges-of-global-feasi…
-
Parexel reposted
AstraZeneca
@AstraZeneca
Today we announce the launch of Evinova, a health-tech business within AstraZeneca. With strategic collaborations in place with @Parexel and @Fortrea, Evinova offers science based, globally scaled digital products & services to the life sciences sector. learn.az/6019u20nT!
-
Parexel
@Parexel
We are committed to the inclusion and safety of our LGBTQ+ community, cultivating a sense of belonging and combating discrimination. Let us unite as allies, inspiring each other with our stories and supporting those on their personal journeys. #transgenderdayofremembrance
-
Parexel
@Parexel
At Parexel, we recognize that a strong team thrives on respect and accountability. By prioritizing training, flexibility and diversity, we empower each colleague to reach their full potential. Click through below to see what Parexel colleagues had to say about #workplaceculture
-
Parexel
@Parexel
Our Oncology Patient Advisory Councill, who met for the first time last week, had unique insights to share on support services that would benefit clinical trial patients based on personal experience as cancer patients and caregivers.
Post not available here, view on X
Parexel
@Parexel
🎓 Focusing on educating communities before they fall ill.
Parexel
@Parexel
🙌 Establishing and expanding community outreach efforts.
Post not available here, view on X
Parexel
@Parexel
Thank you to @stacy_hurt, Patient Ambassador, a stage IV colorectal cancer survivor and caregiver to her son with a rare disease, who leaned on her own experiences with cancer to lead a dynamic conversation and make space for the advisory council to share their perspectives.
Parexel
@Parexel
To all the patient advocates who took the time to share their insights, we want to extend a huge thank you! Your contributions will help us improve the patient experience and shape the future of patient-guided #clinicalresearch. 🤍
#patientsfirst #parexelwithheart -
Parexel
@Parexel
We're thrilled that Parexel has been named the "Best Contract Research Organization" in the Full-Service Provider category at the 19th Annual #scripawards held last night in London. 🎉 Click to learn more about the Scrip Awards and why we were chosen as the Best CRO:
Parexel
@Parexel
Parexel also sponsored the “Pharma Company of the Year,” awarded to @EliLillyandCo. We extend a heartfelt congratulations to Eli Lilly for this important advancement that will have significant impact for patients as well as the other honorees from the evening.
-
Parexel
@Parexel
Milan ─ a hub for finance, football, fashion, architecture and design ─ buzzes with ideas and innovation, naturally it's a great fit for Parexel!
This office, designed for collaboration between departments, offers city views and is within walking distance of several landmarks. -
Parexel reposted
ACRO
@ACROhealth
Improving racial, ethnic, and cultural representation in #clinicaltrials is critical to ensuring the development of the most effective treatments. @Parexel explains what the industry can do to better tackle the barriers to inclusion. Find the report: www.parexel.com/insights/discussions-diversity/race-and-e…
-
Parexel
@Parexel
Thank you to everyone who joined our CEO Jamie Macdonald and Chief Clinical Data and Digital Officer Stephen Pyke at #cnssummit2023! We’re more inspired than ever to continue driving clinical research innovation into 2024!
-
Parexel reposted
J-E Poirrier
@jepoirrier
First day of #isporeurope, don’t miss this symposium on #ai in Health Technology Assessment with Jacqueline Vanderpuye-Orgle, Rito Bergemann and Sugandh Sharma!
And plenty of other RWE, PRO, Modeling activities from #parexel: www.parexel.com/about-us/events/ispor-eu
#hta @Parexel ❤️ @ISPORorg -
Parexel
@Parexel
Join us at the @MySCRS European Site #solutionssummit in Lisbon, where @ClareGrace_CPO Xoli Belgrave and Karen McIntyre will explore strategies for recruiting diverse European populations in clinical trials, getting patients more involved, and more.
#partnersinresearch -
Parexel
@Parexel
Ahead of Veterans Day in the U.S. and Armistice Day in many countries on Nov. 11, colleagues gathered at the Veterans Freedom Park in Cary, NC to lay flags with the non-profit @VetBridgeHome in observance and remembrance of veterans.
#veteransday #armisticeday #proudtobeparexel -
Parexel
@Parexel
At Parexel, we're dedicated to upholding the highest standards of quality and compliance in everything we do. 👏 Thank you to the colleagues working diligently to raise the bar and champion excellence in everything we do! #complianceandethics #worldqualityday #wqw23
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Proud for @Parexel to host this session and hear from Stephen Pyke, our Chief Data Officer who has helped guide our #ai strategy with integrity and transparency #cnssummit2023
Mike Rea
@ThenIf_
From excited chatter to real experience, #ai in pharma R&D @CNSSummit
-
Parexel
@Parexel
In our latest "New Medicines, Novel Insights" report, Jakki James, Director, Patient Communications, breaks down five key elements that are hallmarks of a successful clinical trial #communications plan. #patientsfirst #novelinsights
-
Parexel reposted
CNS Summit
@CNSSummit
“At Summit, we come together not just as industry professionals but as advocates for patients, as investors in change, and as stakeholders in a healthier world.”
@Parexel's Jamie Macdonald joins @akalali for a fireside chat on the mainstage of #cnssummit2023. -
Parexel reposted
GIL BASHE
@Gil_Bashe
Great exchange with Jamie Macdonald, Chief Executive Officer of @Parexel and @CNSSummit Founder and Curator @akalali on the evolution of #clinicaltrials.
-
Parexel
@Parexel
Experts from our Market Access and #heor Consulting teams are headed to Copenhagen for #isporeurope where they'll address topics like the use of real-world evidence, cross-border collaboration, affordability, and equity.
-
Parexel reposted
Healthcare Businesswomen’s Association (HBA)
@HBAnet
Congrats to ACE Award Winner @Parexel Priority: Advancing Women in Leadership! This award-winning initiative led to a 14% increase in women at the VP+ level. Bringing the representation of women in senior leadership roles to 47%
youtu.be/TIQ5RyrFSOw
#hbaace #hbaac23 #hbaimpact -
Parexel
@Parexel
In this issue of "New Medicines, Novel Insights," Nichola Gokool, Senior Director, Patient Partnerships, shares three actionable steps for engaging with patient groups ─ which can be applied to trials in almost any therapeutic area.
#novelinsights -
Parexel reposted
ACRO
@ACROhealth
Real-world evidence has serious potential in the areas of early asset planning, the regulatory landscape of clinical development, and the medical marketplace. @Parexel explains how the practice can bring greater connectivity to a #clinicaltrial. www.parexel.com/application/files/resources/assets/RWE Pl…
-
Parexel
@Parexel
We’re looking forward to "Collaborating for Novel Solutions" at the upcoming @CNSSummit! Jamie Macdonald will join @akalali, Chief Curator & Chairman of CNS Summit, for a fireside chat.
Stephen Pyke will join leaders from @bmsnews, @moderna_tx and @PartexNV for a lively debate. -
Parexel
@Parexel
We empower our employees to bring their passion, dedication and empathy to their work every day. It means going the extra mile for our clients, our teammates and most importantly, for patients.
Hear from our team on how we're working With Heart™
#patientsfirst #proudtobeparexel -
Parexel
@Parexel
📣 Earlier this week, our Head of Rare Disease Rachel Smith was at #wodc Europe in Barcelona and delivered a presentation discussing first-of-a-kind study designs to optimize rare disease drug development. Thanks to everyone who attended this session! @orphan_drugs
-
Parexel reposted
World Orphan Drug Congress
@orphan_drugs
Rachel Smith, Executive Director of Rare Diseases at Parexel takes the Clinical Development stage at #wodc
@parexel -
Parexel
@Parexel
Two Parexel colleagues were winners at this year's @PharmaTimes Clinical Researcher of the Year Awards — The Americas! Ileana Flores, Sr. CRA, earned a silver medal in the New CRA category & Mona Parikh, COL, earned a bronze medal in the Clinical Trial Manager category. #ptcroy
-
Parexel
@Parexel
In this #healthcarerethink Podcast, Parexel's Global Head of Scientific Data Jaime Smith, Ph.D., discusses innovative ways of accelerating access to medication and increasing diversity in clinical trials.
-
Parexel reposted
ACRO
@ACROhealth
The last episode of season one of the #goodclinicalpodcast turns back to the topic of women in #clinicalresearch. Host @sophmcleod is joined by Cyndi Verst and Peyton Howell to talk about leadership, mentorship, and gender representation. Listen now: www.acrohealth.org/good-clinical-podcast/
-
Parexel
@Parexel
The third report in our "New Medicines, Novel Insights" series offers strategies for fully integrating patients into the drug development process, optimizing trial protocols using patient insights, overcoming barriers to participation and more. Explore the report:
-
Parexel
@Parexel
At Parexel, our Statistical Programmers handle patient data on a daily basis — analyzing risks and collaborating to deliver high-quality products to patients. In this video, Amrita from our Statistical Programming team shares what working “With Heart™” means to her.
-
Parexel
@Parexel
Throughout October, Parexel colleagues have participated in various initiatives to recognize #breastcancerawareness Month.🚶♀️🚶♂️In Boston, colleagues, including Chief Strategy Officer @kushalgohil, joined the @SusanGKomen Walk in support of breast cancer research and patients.
-
Parexel
@Parexel
Attending Phuse EU Connect in Birmingham next month? Parexel will be exhibiting at Booth #12!
Stop by to chat with our Statistical Programmers about open career opportunities on their team and learn how they collaborate on innovative clinical research projects.
#phuseeuconnect -
Parexel
@Parexel
We're proud to be one of only two companies to raise more than $200k for @LLSusa's @LightTheNight in the Triangle, N.C. Thank you to everyone who supported this effort. Together we're making a real difference in the fight against blood cancer.
#proudtobeparexel #parexelwithheartThis media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
Yesterday Parexel joined @BioPharmaDive and @PharmaVoice for their virtual event, "The Next Frontier of the Life Sciences."
Parexel
@Parexel
🔑 @PeytonRHowell, Chief Operating and Growth Officer, delivered a keynote on the Patient of the Future — revealing results from our Global Patient Preference survey asking patients what they want in a clinical trial experience and ways our industry can be more patient-guided.
Parexel
@Parexel
🏆 Dr. Amy McKee was recognized as a part of the #pharmavoice100 list of influential people in the life sciences industry for her work creating breakthrough oncology strategies for sponsors and guiding the next generation of industry leaders. Congratulations, Amy!
#lifesciences -
Parexel
@Parexel
At Parexel We Care about our patients and people, We Care about our impact on the environment and We Care about delivering for customers every day. Our latest ESG Report demonstrates our “We Care” commitment and our progress across three key areas of focus. #parexelwithheart
-
Parexel
@Parexel
Curious about the potential value of the FDA's Breakthrough Devices Program? Our experts explore the main benefits and challenges, collaboration strategies with regulatory consultants and the FDA, and why your organization might consider seeking Breakthrough Devices designation.
-
Parexel
@Parexel
Throughout 2023 we have seen significant shifts in the FDA's regulatory framework for neurology and related therapies.
Our latest "New Medicines, Novel Insights" newsletter takes us through examples of these changes and what it could mean for the R&D pipeline in neuroscience. -
Parexel
@Parexel
Catia Campos, who first started as a Clinical Operations Leader (COL) and now supervises a team of almost 100 COLs, has made a significant impact during her 15 years at Parexel. Here Catia shares her essential lessons on adapting to new roles and effectively leading teams.
-
Parexel
@Parexel
As this year's Presenting Sponsor, Team Parexel had an amazing turnout at Saturday's #lightthenight walk in Cary, N.C.! Thank you to everyone who attended and contributed in support of vital research and patients battling blood cancer. #parexelwithheart @LLSusa
-
Parexel
@Parexel
Our 2023 India Symposium brought together local and global industry stakeholders, academia, patients and investigators to discuss the future of #clinicaltrials in India and strategies for successful delivery of new medicines to the patients who need them.
This media couldn't be displayed. See it on the original post. -
Parexel
@Parexel
The @bwicr20 conference took place this weekend where Parexel was the lead Gold sponsor. More than 30 Parexel employees attended. @sabo_aida, spoke on a panel on inspiring change in the C-Suite.
To cap off a great event, we were honored to receive the Sponsor of the Year award! -
Parexel
@Parexel
We're excited to share that @PeytonRHowell will be a keynote speaker at the @BioPharmaDive and @PharmaVoice event — "The Next Frontier of the Life Sciences."
Peyton will reveal results from our survey asking patients what they really want when it comes to clinical trials. -
Parexel
@Parexel
In @EBRmagazine’s autumn issue, Rachel Smith delves into how we can ensure orphan-designated drugs get to market and reach patients sooner to help patients suffering from rare diseases.
Read the full article and catch Rachel at @ESGCT 2023 in Brussels next week! -
Parexel
@Parexel
In @ACROhealth's Good Clinical Podcast, Stephen Pyke, Lisa Moneymaker of @saamatechinc and Sophia McLeod discussed the role of #ai and #ml tools in clinical trials.
Stephen shared his thoughts on the possibility of establishing a framework for global harmonization of AI. -
Parexel
@Parexel
Coming soon! Join Chris Learn and Steve Winitsky as they share insights to help you accelerate your cell and gene therapy (CAGT) programs to market.
Don't miss the chance to hear from a top CAGT expert and a former FDA official on the path to success in CAGT product development. -
Parexel
@Parexel
October is #globaldiversityawarenessmonth and what a great time to be recognized by @TriangleBIZJrnl as a 2023 Leaders in Diversity!
Read more about why Parexel was recognized here:
www.bizjournals.com/triangle/news/2023/10/13/2023-leaders…^22314944 -
Parexel
@Parexel
According to our colleague Barbara B., a good Clinical Operations Leader should have three key skills:
📝 Have the ability to plan ahead, but stay flexible.
💥 Able to prioritize and making quick decisions.
💡 Approach problem solving with a positive mindset. -
Parexel reposted
Ametris (formerly ActiGraph)
@actigraph
Don't miss @CPathInstitute's webinar, “What is (and What is Not) Appropriate Wearable Device for Use in Clinical Trials” on Oct 19! #ecoa experts from #actigraph, @Koneksa, @Parexel & @uMotif will discuss successful use of #wearable tools.
Register today: c-path-org.zoom.us/webinar/register/WN_OsnWN0a6TMKsb2dqDK… -
Parexel reposted
Society for Clinical Research Sites (SCRS)
@MySCRS
SCRS and the clinical research community congratulate the 2023 recipients of the prestigious SCRS Eagle Award: @Merck as the sponsor recipient and @Parexel as the CRO recipient.
Read the official announcement ⇢ myscrs.org/2023-eagle-award-recipients/ -
Parexel reposted
Healthcare Businesswomen’s Association (HBA)
@HBAnet
Learn two ways to create a more inclusive workplace from 2022 Luminary Aida Sabo, Global Head of Diversity, Equity, & Inclusion, @Parexel.
#hbaimpact #genderequity #inclusion #dei
hbanet.org/our-impact/advancing-women-healthcare -
Parexel
@Parexel
As #hispanicheritagemonth comes to a close, we continue to celebrate the diverse perspectives and vibrant cultural backgrounds of our colleagues. 🌎
Drop a comment and let us know why you're proud of your Hispanic or Latinx heritage!
#celebratediversity -
Parexel
@Parexel
Today CEO Jamie Macdonald joined @n_lorem at their first Nano-rare Patient Colloquium in Cambridge, Mass. to speak about our partnership and shared commitment to making a difference for nano-rare patients. #patientsfirst
-
Parexel
@Parexel
The @MySCRS #eagleaward recognizes the sponsor and CRO dedicated to advancing the clinical research profession through strong site partnerships. We're grateful to be selected by the global site community for this honor. Read the full press release:
-
Parexel
@Parexel
Amy Kissam Sands watched a close friend endure a cancer diagnosis for their child. Throughout that difficult time, she witnessed the profound impact @LLSusa has on the lives of patients, their families and the community.
We are proud to support #lls
#lightthenight #patientsfirst -
Parexel reposted
FirstWord Pharma
@fwpharma
Explore how #genetherapies are rewriting the rules of medicine. Industry experts from @Parexel and Resilience share invaluable insights on effectively crafting and delivering messages that resonate. Register today: us02web.zoom.us/webinar/register/6816908964143/WN_jdXfmIO…
-
Parexel
@Parexel
We are thrilled to share that Parexel was awarded the 2023 @MySCRS Eagle Award (CRO category) at the annual Global Site Solutions Summit!
Strong collaboration with sites is fundamental to the drug development process and our ability to better serve patients.
#eagleaward -
Parexel
@Parexel
Meet Mark, CRES Manager and proud U.S. Navy veteran.
In this Q&A, Mark shares how his experiences in the Navy helped shape his current career and how military veterans lead with accountability and support their teams.
#recruitingwithheart #veteranemployment #militaryveteran -
Parexel reposted
CNS Summit
@CNSSummit
.@Parexel CEO Jamie Macdonald attends the annual #cnssummit to break free from compartmentalized work and embrace the wider ecosystem.
Join Jamie and other #lifesciences leaders at #cnssummit2023 in November. Apply today: web.cvent.com/event/788b080c-faac-4e6e-bb24-febfed6631fc/… -
Parexel reposted
The Prescription For Better Access Podcast
@RX4BetterAccess
Patient access needs to be easier. Today Mark and Scott talk to @PeytonRHowell from @Parexel on breaking down barriers. Check out the episode here:
prescriptionforbetteraccess.com/breaking-down-barriers-an… -
Parexel
@Parexel
In this @fwpharma webinar, Parexel's Chris Learn will share how gene therapy drug developers can better convey the unique advantages and value propositions of gene therapies to key stakeholders.
#genetherapy #clinicaltrials -
Parexel
@Parexel
📢 Are you on the lookout for your next big career move in healthcare? Join our Talent Community today and boost your job search! 🚀 As a member, you'll receive tailored job alerts right to your inbox — keeping you one step ahead.
#recruitingwithheart -
Parexel
@Parexel
How does Parexel define operational excellence? Deb Tatton, who leads a global team tasked with delivering first-time quality across a range of therapeutic and specialty areas, explains what #operationalexcellence means to her and what sponsors can expect from Parexel.
-
Parexel
@Parexel
At the @MySCRS Global Site Solutions Summit, our experts will be onsite to explore everything from recruiting outside the industry to constructing risk mitigation plans to improving sites for people with disabilities. Visit us at booth 306!
#sitealliances -
Parexel
@Parexel
Yesterday at @DatavantHQ's Future of Health Data Summit, Parexel CEO Jamie Macdonald joined a panel of experts from @JanssenUS, @TriNetX, @Walgreens Clinical Trials and @KomodoHealth to discuss new ways to leverage #healthdata and technology.
#fohd2023 #clinicaltrials -
Parexel
@Parexel
Parexel's Center of Excellence for Rare Diseases helps sponsors maximize success in rare disease drug development by integrating clinical and regulatory consulting expertise to design, plan and execute even the most complex trials. #raredisesaseresearch
-
Parexel reposted
ACRO
@ACROhealth
Today's the day! ACRO’s Good Clinical Podcast has finally launched. We're hosting weekly conversations with experts about the issues that matter most in the #clinicaltrial world — and this week is all about women in #research. Listen in: www.acrohealth.org/good-clinical-podcast/
-
Parexel
@Parexel
Congratulations @stacy_hurt for being named a 2023 #fierce50 honoree — spotlighting trailblazers who have pioneered groundbreaking therapies, overhauled patient care models and spearheaded innovative approaches to address the most pressing challenges in biopharma and healthcare.
-
Parexel
@Parexel
Parexel is seeking talented individuals to join our team as #projectleaders. If you're ready to take charge of exciting clinical research projects that make a lasting impact on the lives of patients, then this could be the rewarding role you've been looking for!
#clinicaltrials -
Parexel
@Parexel
20+ million lives are lost every year to cardiovascular disease (CVD), making it the leading cause of death globally. On this #worldheartday, Parexel acknowledges the significant impact of CVD, the progress that has been made in CVD treatments & the important work that remains.
-
Parexel
@Parexel
Members of our newest Patient Advisory Council recently met to discuss strategies for increasing awareness and accessibility of neuroscience trials and better supporting this patient community.
Thank you to those who participate in our Patient Advisory Councils.
#patientsfirst -
Parexel
@Parexel
Light The Night is right around the corner! We're continuing to share our colleagues' stories about how #bloodcancer has affected their lives.
Post not available here, view on X
Parexel
@Parexel
"LLS was vital for me to understand what I was going through and what Gareth was going through. It was one of my go-to resources, and it's important that we join together in our fundraising efforts to support LLS this year." - Natalie Snow
Parexel
@Parexel
We are looking forward to raising our lanterns with @LLSusa at #lightthenight next month and we hope you'll join us! pages.lls.org/ltn/ma/BostonL23/parexelboston
-
Parexel
@Parexel
At the World Drug Safety Congress Europe, @MeSanjayvyas and @KausikMaitiMD will explore the use of big data and AI in pharmacovigilance and the recent advances enabling our industry to better predict and prevent adverse drug reactions while protecting patient safety.
-
Parexel
@Parexel
Last week was all about disruptive thinking at #dpharm2023! Parexel senior leaders were onsite challenging industry peers to think outside the box in how we approach #clinicaltrials. Check out photos from the week below! @ConferenceForum
-
Parexel
@Parexel
Did you know that under the EMA’s newly released guidance on joint scientific consultations (JSCs) that drug sponsors can request parallel scientific advice prior to finalizing the protocol for a pivotal study? Our experts outline the selection requirements on new treatments.
-
Parexel
@Parexel
The value of using #realworlddata to inform decision-making in clinical research has never been in doubt. The question remains whether it will be leveraged more as a lead component that drives healthcare decisions versus its traditional and secondary confirmatory role. @MMMnews
-
Parexel reposted
SAS Software
@SASsoftware
.@Parexel CEO, Jamie Macdonald shares what excites him about the potential of #ai in clinical development and health care. #cro
-
Parexel
@Parexel
Parexel alum Jose Manuel Malaga Cardoza, who grew up in Peru but lives in Dublin, Ireland, loves exploring his adopted city’s culinary scene and recreating many of the recipes on his popular YouTube channel. In this video, he shows us how to make croquetas.
#hispanicheritagemonth -
Parexel
@Parexel
We are so proud to once again be named a Scrip Award finalist in the Best CRO – Full-Service Providers category. This finalist recognition is a testament to our #patientsfirst focus and our commitment to helping bring new medicines to patients around the world. #scripawards
-
Parexel
@Parexel
Dr. Amy McKee, Chief Medical Officer and Global Head, Oncology Center of Excellence, has been recognized on the 2023 @PharmaVoice 100 list for her commitment to guiding the next generation of industry leaders and her leadership in creating breakthrough strategies for sponsors.
-
Parexel
@Parexel
Parexel joined @LLSusa (LLS) and @PDAonline at @cellectis in Raleigh, NC for "Tours and Talks", where we heard directly from survivors of blood cancer. Events like this highlight the importance of LLS' mission to advance oncology research and develop a cure for blood cancers.
-
Parexel
@Parexel
Parexel today announced the appointment of Gwyn Bebb, BM, BCh., Ph.D., as Senior Vice President and Global Therapeutic Area Head – Oncology.
In this role Dr. Bebb will lead the research and development of new cancer treatments for biopharmaceutical customers worldwide. -
Parexel
@Parexel
Congratulations to Ileana Flores, Jana Pool and Mona Parikh on being named finalists for the @PharmaTimes Clinical Researcher of the Year Award - The Americas competition!🎉
#clinicalresearch #cra #clinicalresearcheroftheyear -
Parexel
@Parexel
Become a #statisticalprogrammer at Parexel! You'll help advance #clinicalresearch and data analysis.
At Parexel, you'll have access to cutting-edge technology and the opportunity to work on diverse and challenging projects. Help us improve outcomes for patients worldwide. -
Parexel
@Parexel
Today marks the beginning of Hispanic Heritage Month🎉
Our Hispanic/Latin colleagues at Parexel play a pivotal role in our organization's success. Our colleague Nathalia Cruz is celebrating both Hispanic/Latin Heritage and Brazilian independence.
#hispanicheritagemonth -
Parexel
@Parexel
At the @iscrindia - ISCR's 10th Annual Pharmacovigilance Symposium, @MeSanjayvyas and @KausikMaitiMD will share actionable insights on strengthening pharmacovigilance frameworks and accelerating drug development through innovative therapeutics.
-
Parexel reposted
Clare Grace
@ClareGrace_CPO
This is one not to miss. One of the biggest issues in clinical research will be addressed by this panel hosted by @Parexel's Roz Round.
#patientsfirst #clinicalresearch #scrs #parexel share.parexel.social/65ez7 -
Parexel
@Parexel
Meet Martin Roessner, who has led Parexel’s global biostatistics services since 2010. Next week at #dpharm, Martin joins execs from @JanssenGlobal, @EliLillyandCo and @US_FDA to discuss innovation and efficiency in patient-guided #clinicaltrials.
-
Parexel
@Parexel
It’s that time of year for some disruptive thinking! Our senior leaders are gearing up for #dpharm2023. Catch @PeytonRHowell on Day 1 speaking with 7-time Olympic medalist & cancer survivor @shannonmiller96. Don't miss Jamie Macdonald and @kushalgohil on day 2!
-
Parexel
@Parexel
Breakthrough Therapy designation (BTD) from the FDA is a strategic opportunity for sponsors developing rare disease therapies.
Parexel's Mwango Kashoki MD MPH provides her insights in this latest issue of the "New Medicines, Novel Insights" newsletter.
#novelinsights -
Parexel
@Parexel
Our #regulatory teams help customers navigate the complexities of local regulatory policies.
Mwango discusses how her career at #fda shaped her and how she applies her expertise to support customers through the Breakthrough Therapy Designation process for #raredisease drugs. -
Parexel
@Parexel
Our São Paulo office offers spacious conference rooms, a lounge and library for comfortable breaks and a beautiful terrace with a stunning city view! See pictures of the space and team-building events with our colleagues in Brazil. #lifeatparexel #locationspotlight #parexelbrazil
-
Parexel
@Parexel
In this upcoming Endpoints webinar, Rosamund Round joins other experts to discuss how the financial burden to participate in clinical trials affects patient recruitment and why there is an unmet need for new industry standards that are fair, ethical and meaningful to patients.
-
Parexel
@Parexel
Amy Kissam-Sands shares how we address customer challenges in operational excellence and delivery. www.parexel.com/solutions/operational-excellence
-
Parexel
@Parexel
Karen McIntyre, VP, Global Site Alliances and Launch Excellence, recently shared her insights with @TrialsArena on the use of electronic investigator site files (eISFs) ─ how they need to evolve so site staff can spend less time on technology and more time with patients.
-
Parexel
@Parexel
Passionate about data analysis in healthcare? Parexel is looking for a #biostatistician!
In this role you'll work at a leading #clinicalresearch organization to help shape the future of medicine.
#recruitingwithheart #clinicaltrials -
Parexel
@Parexel
Some organizations have fully embraced #rbqm, while others have been reluctant or slower to adopt these strategies. At @CluePoints’ #rbqmlive event, Cris McDavid joins an esteemed panel to discuss the #rbqm journey and how to proactively plan for success.
#rbqmlive2023 -
Parexel
@Parexel
Parexel Chief Clinical Data & Digital Officer Stephen Pyke believes that to fully embrace #generativeai in #clinicalresearch, we must evaluate outputs carefully and balance access to information while safeguarding privacy. Read his insights in @PM360online www.pm360online.com/embracing-the-power-of-generative-ai-…
-
Parexel
@Parexel
The 3rd issue of the New Medicines, Novel Insights newsletter focuses on the exciting potential for #biosimilars in the U.S. Our experts focus on pricing & payer strategies to unlock the benefits of biosimilars and make high-value care accessible to more patients. #novelinsights
-
Parexel
@Parexel
Parexel understands the best pathways for navigating the complexity of developing advanced therapies.
Let us accelerate your CAGT development and maximize your chances of market success. Learn more: www.parexel.com/therapeutic-expertise/cell-and-gene-thera…
#cellandgenetherapy #novelinsights -
Parexel
@Parexel
Check out photos from our third Parexel Connect event in San Diego, where 75+ southern CA-based colleagues gathered to meet face-to-face, broaden their professional networks and get to know each other outside the office.
-
Parexel
@Parexel
Parexel joined @MakeAWishEastNC for their 2023 Wish Ball! 🌟 This inspiring event celebrates Make A Wish Foundation's mission to make wishes come true for local kids with critical illnesses. Parexel is proud to sponsor and support such a meaningful cause. #parexelwithheart
-
Parexel
@Parexel
❗Attention all site representatives❗
As a finalist for the #eagleaward, we take pride in our relationships with sites and are committed to working #withheart to help sites support the needs of patients. Tomorrow is the last day to vote so please consider casting yours -
Parexel
@Parexel
We believe that the best approach to compliance is a proactive one. In the latest article in the "New Medicines, Novel Insights" cell and gene report, our experts outline how to establish a proactive and phase-appropriate compliance strategy.
-
Parexel
@Parexel
Rare disease poses unique challenges for leaders hoping to drive successful #drugdevelopment. Rachel Smith joined @RocketPharma's Jonathan Schwartz and @AscidianTx's Jay Barth for a @PharmaVoice Biotech Roundtable on what it takes to make it in the rare disease space.
-
Parexel reposted
CluePoints
@CluePoints
We'll be kicking off day two of RBQMLive 2023 with a keynote panel discussion on the RBQM journey, and you won't want to miss this virtual adventure! 💻 Sign up to save your seat: rbqmlive.com/register-for-rbqm-live?hss_channel=tw-136557… #rbqmlive23 #rbqm
-
Parexel reposted
CluePoints
@CluePoints
We're thrilled to announce that Cris McDavid, esteemed #rbqm leader, will join us as a panelist on Day 2 of #rbqmlive 🌟 Cris has been at the forefront of transformative shifts in the clinical trial landscape. Peruse the agenda👉 rbqmlive.com/rbqm-live-2023-agenda/?hss_channel=tw-136557…
-
Parexel
@Parexel
Cancer diagnoses are a heavy weight to bear for the patient and their loved ones. As we approach this year's #lightthenight event, we asked team members impacted by blood cancers to share what they learned.
What advice would you share with others? -
Parexel
@Parexel
Congratulations to Gillian Baggott, this year's recipient of the Jayne Fountain Scholarship!
The scholarship honors Jayne Fountain, a Parexel Biostatistician from Sheffield who sadly lost her battle with cancer in 2021.
We are thrilled to award Gillian with this scholarship! -
Parexel
@Parexel
We are proud to be a finalist for the 2023 @MySCRS #eagleaward. In particular we want to recognize our dedicated CRAs, Site Alliance team members and all site-facing colleagues for the commitment and dedication they demonstrate to our site partners and patients every day.
-
Parexel
@Parexel
With the approvals of many new cell and gene therapies, we're moving into a new era of hope for patients. But not without challenges. In this report, our experts share insights that can help bring these complex treatments to market faster and more efficiently.
-
Parexel
@Parexel
💥 The "New Medicines, Novel Insights" newsletter has surpassed 100K subscribers! In the 2nd issue, we explore 3 trends that could impact patient access and market success of cell and gene therapies. Hint: fostering partnerships across the ecosystem is crucial. 🎯
-
Parexel
@Parexel
Understanding how to merge real-world data (RWD) in clinical trials is key to reducing burdens on sites and patients. Laura O’Donnell shares her team's experience in providing a hybrid model approach to support globally-diverse site participation for a retrospective cancer study.
-
Parexel
@Parexel
Are you passionate about cutting-edge clinical research? Want to make an impact on global healthcare? Join Parexel as a Clinical Research Associate (CRA)!
With our training programs and career development opportunities, you'll thrive in a supportive, forward-thinking culture. -
Parexel
@Parexel
Last week we took a poll, the results showed that 43% of you would like more guidance from the FDA on collecting and submitting data, while 39% are looking for more clarity on the FDA's definition of PED.
Find out how sponsors responded when the FDA asked them the same question. -
Parexel
@Parexel
In this podcast by PHARMA talkRADIO, Wyatt Gotbetter and Sangeeta Budhia discuss considerations for early market access planning ─ including inclusive data collection, payer models and the impact of new regulations and innovative trial design.
#raredisease -
Parexel
@Parexel
In this new article from @DrugInfoAssn, Angela Qu, SVP, Biomarker Genomic Medicine, explores the promises spatial biomarkers hold for precision medicine development as well as the challenges that must be addressed head-on to realize their full potential.
-
Parexel
@Parexel
👀 In case you missed it....
More than 92,000 people have subscribed to Parexel's LinkedIn newsletter!
In each installment of "New Medicines, Novel Insights," we'll provide strategies for designing clinical trials that are truly patient-led. Don't miss out on any #novelinsights -
Parexel
@Parexel
For Joe McFadden, @SOU_LnL_Fund’s work is deeply personal.
Diagnosed with an aggressive form of lymphoma in 2022, Joe is now in remission. He will co-lead Parexel’s effort to raise funds in support of blood cancer research and patients at LLS' #lightthenight this October. -
Parexel reposted
ACRO
@ACROhealth
Patients with advanced cancers and genetic diseases can find extraordinary hope in cell and gene therapies, but their development is often challenging. @Parexel lays out the patient experience, regulatory strategies, value propositions, and more. insights.parexel.com/cell-and-gene-therapy-report-home/p/1
-
Parexel
@Parexel
Do you have a desire to make a real difference in healthcare? At Parexel, we believe in nurturing talent and encouraging growth to help you thrive professionally and personally. You'll work alongside brilliant minds, embrace challenges and be part of a supportive community.
-
Parexel
@Parexel
We’re committed to working together with sites to improve the patient experience in clinical research. Learn more about how Parexel partners with sites for better patient outcomes and consider voting for Parexel for this year’s @MySCRS Eagle Award. www.parexel.com/solutions/early-development-and-innovatio…
-
Parexel
@Parexel
When should you engage with patient advocacy groups (PAGs)?
At every stage of the drug development lifecycle, says Vivian Liao, Project Leadership Director, at the ICF Rare Disease Symposium in China. -
Parexel
@Parexel
Regulatory agencies worldwide are inundated with new cell and gene therapy applications, making it difficult for sponsors to receive timely regulatory advice. Dr. Amy McKee shares her perspective as a former FDA regulator to help drug developers avoid the regulatory bottleneck.
-
Parexel
@Parexel
📢Introducing "New Medicines, Novel Insights," Parexel's new LinkedIn newsletter series! Stay ahead of the latest breakthroughs in the biopharmaceutical industry. Each newsletter will feature insights from our experts to help you deliver patient-focused drug development.
-
Parexel
@Parexel
Do you have a go-to story at the ready for interviews? Check out Talent Advisor Tara Jalali's top tips for nailing your next interview!
We have exciting career opportunities available and is hiring talented individuals to help us make a difference for patients around the world. -
Parexel
@Parexel
Parexel is delighted to announce we've once again earned a Silver Award in the 2023 @ecovadis Sustainability Rating program, the industry leader in measuring a company's environmental, social and ethical performance.
#environmentalsustainability #esg #sustainability #environment -
Parexel
@Parexel
Paris is one of the most beautiful cities in the world with its rich culture and historic buildings... and a Parexel office! In early 2021, our office in the City of Light moved to the BioPark, an area devoted to biotech companies and laboratories.
-
Parexel
@Parexel
At Parexel we're committed to partnering with sites every day to support the development of innovative new medicines.
In recognition of strong site relationships, voting is now open for the @MySCRS Eagle Award.
#eagleaward #clinicalresearch #clinicalresearchsites -
Parexel
@Parexel
A career in clinical data monitoring is incredibly rewarding. Clinical data monitors play a crucial role in advancing medical research and improving patient outcomes. They help demonstrate the reliability of study results leading to new treatments for patients around the world.
-
Parexel
@Parexel
If you’re a former Parexel colleague and interested in connecting with other talented individuals from around the world that have supported Parexel's efforts to make a difference for patients, we invite you to follow our Parexel Alumni Community on LinkedIn!
#parexelalumni -
Parexel
@Parexel
A cancer diagnosis affects the whole family. Lisa Kaufman knows firsthand, having served as the primary caregiver for her husband, Mark, when he was diagnosed with acute myeloid leukemia in 2018. While in treatment, he was unable to work or help care for their children.
Parexel
@Parexel
"A cancer diagnosis puts major strain on a family — financially, emotionally and physically," said Lisa. "The journey is tough, but we got through it as a family by staying present in the moment and having faith in Mark's medical team. We also had supportive friends and family.
Parexel
@Parexel
After receiving in-patient chemotherapy and a stem cell transplant from a donor in Israel, we're happy to share that Mark is doing well, back at work and living his best life. 💕
Look for more patient and caregiver stories as we gear up to #lightthenight this October with @LLS! -
Parexel
@Parexel
Angela Hirst, Project Director, identifies three strategies to accelerate your cell and gene therapy trials in her new article. Find out how Parexel is driving efficient site selection for CAGT research: insights.parexel.com/cell-and-gene-therapy-clinical-devel…
-
Parexel
@Parexel
Aleksei Zhmuro, Dir. Clinical Operations, participated in the recent Ukraine Recovery Conference in London as a representative of the clinical trials industry. See photos from the event where he and fellow delegates led a presentation on the state of clinical research in Ukraine.
-
Parexel
@Parexel
With more than 1.6 million transgender or nonbinary people in the U.S., it's alarming that less than 1% of clinical trials include participation from these patients.
Xoli Belgrave, Head of Clinical Trial Diversity at Parexel, spoke up for change in a recent @PharmaVoice article. -
Parexel reposted
Applied Clinical Trials
@Clin_Trials
🔴How to Incorporate the Patient Voice for Inclusive Medical Communications🔴
Thu, Jul 20, 2023 11:00 am EDT | 4pm BST | 5pm CEST with @Parexel
globalmeet.webcasts.com/starthere.jsp?ei=1620732&tp_key=7… -
Parexel
@Parexel
September and October cohort applications are open for the 2023 National Medical Fellowships' Diversity in Clinical Trials Research (NMF Dctr) Program, presented in collaboration with Parexel Academy.
The September cohort application deadline is Aug. 30
#clinicaltrials #dei -
Parexel
@Parexel
At Parexel, summer is a time for team building and celebration! Here's another glimpse at some of the recent Parexel summertime festivities around the world! ☀️🌍
#lifeatparexel -
Parexel reposted
The CSR Journal
@thecsrjournal
Dr Annappa Kamath, Senior Director, Integrated Solutions, @Parexel, discusses the role of Non-Profits and CSR in empowering rural women.
#skill #womenempowerment #unwomen #csr #nonprofit
thecsrjournal.in/empowering-rural-women-through-skill-dev… -
Parexel
@Parexel
Colleagues from the Clinical Pharmacology, Modeling and Simulation (CPMS) team had a great week at the internal CPMS meeting in Madrid, Spain and the 2023 PAGE Meeting in A Coruña, Spain! Team Parexel networked and enjoyed compelling presentations and poster sessions.
-
Parexel
@Parexel
More than 70 Parexel colleagues attended the DIA China 2023 Annual Meeting last month in Suzhou, driving conversations around advancements in real-world evidence studies, collaboration between EMA and FDA, patient-led clinical trials and more!
-
Parexel reposted
Andreas Lysandropoulos
@LysandropoulosA
75% of people with #dementia are not diagnosed. <50% of patients complete studies.
When patients co-design #alzheimers trials, there is 19% better chance for approval. We must work for #diversityequityinclusion & design trials together with #patients.
@Parexel talk at #aaic2023 -
Parexel
@Parexel
At #cposummit, @ClareGrace_CPO will share tangible steps you can take to develop a Patients-first approach in your organization.
Use the discount code: SPONSOR258 when you register to receive 15% off. www.parexel.com/about-us/events/chief-patient-officer-summit -
Parexel
@Parexel
Seeking a dynamic career in clinical research? Join our rapidly growing team in Mexico! We have exciting opportunities in all departments enabling you to play a pivotal role in healthcare while keeping patient needs at the forefront. insde.co/ao88
-
Parexel
@Parexel
At #aaic23 @lysandropoulosA, SVP and Global Head of Neuroscience, will help lead a discussion on accelerating and improving participation and quality in Alzheimer's Disease trials by integrating the patient voice throughout the development journey. #alzheimers #dementia
-
Parexel reposted
Applied Clinical Trials
@Clin_Trials
🔴How to Incorporate the Patient Voice for Inclusive Medical Communications🔴
Thu, Jul 20, 2023 11:00 am EDT | 4pm BST | 5pm CEST with @Parexel
globalmeet.webcasts.com/starthere.jsp?ei=1620732&tp_key=7… -
Parexel
@Parexel
In this @TrialsArena article, Rosamund Round and Liam Paschall discuss the current landscape of inclusivity for transgender, nonbinary and intersex patients in clinical research. www.clinicaltrialsarena.com/features/restrictive-lgbtq-bi…
-
Parexel
@Parexel
Meet and hear from Rebecca, an Associate Project Leader at Parexel, on the importance of empathy in building trust and psychological safety within her project teams.
#lifeatparexel #recruitingwithheart -
Parexel
@Parexel
Over the last 20 years, we've witnessed a comprehensive transformation of the Chinese pharmaceutical regulatory system.
In our newest "New Medicines, Novel Insights" report, experts offer ways to steer a cell or gene therapy through China’s two-tiered regulatory system. -
Parexel
@Parexel
Summer has arrived in numerous corners of the globe, and our summer festivities are in full swing! ☀️🌴
#lifeatparexel -
Parexel
@Parexel
Our team was in Boston last week for #dia2023, a meeting that continues to challenge our industry to reimagine drug development and enhance health outcomes and patient well-being. Thanks to all for sharing your perspectives and insights.
#parexelwithheart #patientsfirstThis media couldn't be displayed. See it on the original post. -
Parexel reposted
Health Advances
@HealthAdvances
In an effort sponsored by the Digital Therapeutics Alliance and led by our senior leaders Brandon Wade and Jeffrey Abraham, the definitive framework was developed to define and classify the full spectrum of #digitalhealth technologies.
Download here: dtxalliance.org/wp-content/uploads/2023/06/Guidance-to-In… -
Parexel
@Parexel
Understanding the person behind the patient is crucial for medical communicators. Writing for various audiences — while ensuring readability and inclusivity — can be challenging. @stacy_hurt, Sarah Yelling and David Gallienne share keys to successful patient communications here.
-
Parexel
@Parexel
Don't miss this incredible opportunity to hear from ex FDA and MHRA inspectors on the key FDA, EMA and MHRA updates applicable to Indian pharmaceutical manufacturers! Regulatory experts Mark Birse, Chris Middendorf, Lynne Ensor and Ramesh Dandu will offer their valuable insights.
-
Parexel
@Parexel
🎵Music boosts motivation and energy as well as fosters a sense of community. Tune into our Parexel Summer Vibes Playlist to embrace the season.🌞🎶
Drop your all-time favorite summer songs in the comments below, and let's create the ultimate summer soundtrack together! -
Parexel reposted
CISCRP
@CISCRP
Thank you to everyone who participated in our annual Medical Heroes Appreciation 5K Run & Walk on Tuesday, June 27th. A special thank you to our event sponsors: @IQVIA_global @Studykik @Parexel @amicusrx1 @moderna_tx SDC @javararesearch
-
Parexel
@Parexel
To understand a drug fully, researchers must study it in a broad range of patients including transgender & nonbinary people. Our team set out to investigate key barriers to gender diversity in #clinicalresearch and offer new ways of making trials more accessible and welcoming.
-
Parexel
@Parexel
Join us July 11 for a live webinar examining China's evolving clinical trial landscape. Our regulatory experts will share new strategies for navigating regulatory requirements and accelerating clinical development programs.
Register here: event.on24.com/wcc/r/4246442/F76A848EB4B8FA078C6E025D96AD… -
Parexel
@Parexel
Team Parexel took time from their busy week at DIA China to celebrate the grand opening of our new clinical trial supplies & logistics depot in Suzhou — a state-of-the-art facility designed to help us further our commitment to bringing more innovative drugs to patients faster!
-
Parexel
@Parexel
Congratulations to our colleague Dr. Phonemano (Mano) Thiravong on being named a 2023 Prout Performer! Germany's #proutperformer list recognizes professionals making contributions to and advocating for equal opportunities for LGBTQ+ persons at work.
#parexelwithpride #pridemonth -
Parexel
@Parexel
Join Parexel July 1 at STICKS & STONES in Berlin for Europe’s largest LGBTQ+ job fair!
Learn how you can join Team Parexel and help us further gender diversity in clinical research to ensure health equity for all. Stop by booth #113 to meet the team!
#sxs23 #parexelwithpride -
Parexel
@Parexel
We're delighted to have been honored last night at the 2023 #croleadershipawards in all 5 categories. We're also proud to be 1 of only 3 CROs to be recognized for 12 consecutive years — a testament to our amazing teams and commitment to making a difference for patients!
-
Parexel
@Parexel
Next up in our Pride Month celebration: a spotlight on our Parexel Pride Committee. This employee-led group includes passionate colleagues from across the globe and is a crucial driving force behind the activities and initiatives we support for our LGBTQ+ colleagues.
#pridemonth -
Parexel reposted
Society for Clinical Research Sites (SCRS)
@MySCRS
Brandon Doyle & Garo Kiledjian share insights on antiquated and discriminatory LGBTQIA+ exclusion criteria in trials and how the industry can work together to be more inclusive of this community ⇢ myscrs.org/scrs-talks/
-
Parexel reposted
BioVoice News
@BiovoiceNews
BIOVOICE MAGAZINE: Sanjay Vyas, Executive Vice-President, Paraxel shares his exclusive insights on the latest trends, market scenario, and outlook within Indian #cro industry.
Check out the exclusive interview in June 2023 Cover Story: biovoicenews.com/biovoice-emagazine-june-2023-issue-6-vol… -
Parexel reposted
Dave deBronkart
@ePatientDave
#dia2023 I *finally* get to meet THE @stacy_hurt !
-
Parexel
@Parexel
Thomas Pietsch, Global Head of Scientific Data Technology & AI, spoke to another packed crowd at our #dia2023 Innovation Showcase Theater this afternoon about the array of artificial intelligence technologies that are transforming the speed of #clinicalresearch.
-
Parexel
@Parexel
AI is the big topic today at #dia2023 ─ @stacy_hurt joined experts from @Microsoft Health Futures, @Roche, @HarbingerHlth and Dreyer Strategies for a panel on using artificial intelligence to advance healthcare and add efficiency for the benefit of patients.
-
Parexel
@Parexel
This rockstar panel at #dia2023, including @DrFabian202, @NHCouncil’s Karen Mancera-Cuevas, @moderna_tx's Diane Montross and our own Patient Advocacy Ambassador @stacy_hurt, went “beyond the why” and uncovered specific patient-led approaches to clinical trial design and conduct.
-
Parexel
@Parexel
Amy Adams, Sr. Dir. of Operational Excellence & Delivery, discusses efforts to advance the adoption of risk-based monitoring and principles with fellow members of the #rbqm working group. #dia2023
Parexel
@Parexel
An @ACROhealth study found that since 2019 the number of trials with at least one RBQM component has increased from 53% to 84%.
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Marwan Fathallah, Pres & CEO of @DrugInfoAssn, proclaiming #dia2023 as a #patientsincluded event during the opening plenary. As a patient, caregiver, advocate, and industry professional, I couldn’t be more proud to be here with my @Parexel colleagues✨#patientsfirst #illuminate
-
Parexel reposted
Stacy Hurt (she/her)🌻
@stacy_hurt
Kick off dinner at #dia2023 with my @Parexel #patientengagement colleagues 😊 We are so excited for the next few days of moving the needle for #patients in #drugdevelopment ✨
-
Parexel
@Parexel
.@stacy_hurt was a guest on DIA’s patient engagement series podcast. In episode one, Stacy, @ePatientDave and @pujita_vaidya discuss the definition, history and current state of patient engagement in clinical research.
See Stacy next week at the #dia2023 Global Annual Meeting! -
Parexel
@Parexel
Our team was thrilled to be with other passionate champions of advancing equity in the workplace! #catalystawards2022
Thank you to @Catalyst! We look forward to continuing to make work 'work' for women & creating an environment where all can flourish.
#thegreatreimagining -
Parexel
@Parexel
Let's talk about our differences and the important work that brings us together at #catalystawards2022. It's all about the patients. Swing by our booth!
#thegreatreimagining -
Parexel
@Parexel
First #catalystawards2022 Award Winner Storytellers virtual session of the day! Hear from two brilliant women who were offered opportunities that helped propel their careers.
#thegreatreimagining @CatalystInc -
Parexel
@Parexel
What an inspiring 2-part panel at #catalystawards2022 conference. Parexel leaders shared their experiences and outcomes on fostering inclusion in the workplace.
Follow some of the most insightful highlights.
#thegreatreimagining @CatalystInc -
Parexel
@Parexel
Honored to be named a #catalystawards2022 winner by @CatalystInc for our commitment to building inclusion and advancing women in the workplace. Click to learn more about our Catalyst Award-winning initiative and follow our feed tomorrow for live updates from the conference.
-
Parexel
@Parexel
It’s an honor to be a #catalystawards2022 winner, but our work doesn’t stop with the @CatalystInc Award. An inclusive and equitable future depends on continuous improvement, which is why we want to hear from you. Help us continue #thegreatreimagining journey by taking our poll.
-
Parexel
@Parexel
We are pleased to announce that @EQT Private Equity and @GoldmanSachs Asset Management have completed their acquisition of Parexel. To guide the next phase of our growth, a new Board of Directors has been named.






















































































































































































































































































































































































































































































































































































































































